Announcements

10 September 2024
Meet Us at the 2024 International Conference of the Korean Society for Molecular and Cellular Biology, 8–11 October 2024, Jeju, Republic of Korea


The 2024 International Conference of the Korean Society for Molecular and Cellular Biology will be held from 8 to 11 October 2024, in Jeju, Republic of Korea. The conference is organized by the Korean Society for Molecular and Cellular Biology, and promises a rich tapestry of scholarly exchange across various disciplines within biological and biomedical sciences.

The conference will feature four top keynote speakers in the field of life sciences, including two Nobel Prize winners, and scientists from more than thirty countries around the world participating in more than twenty scientific sessions on a variety of topics. The agenda includes symposiums showcasing pioneering research in life sciences, dedicated sessions for young academics, such as graduate students, postdoctoral researchers, and research professors, and a Bio Job Fair.

The following MDPI journals will be represented at the conference:

  • International Journal of Molecular Sciences;
  • Antioxidants;
  • Biophysica;
  • Current Issues in Molecular Biology;
  • Kinases and Phosphatases;
  • Metabolites;
  • Microorganisms;
  • Proteomes;
  • Bioengineering;
  • Biomedicines;
  • BioMed;
  • Biomolecules;
  • Cancers;
  • Genes;
  • Journal of Molecular Pathology;
  • Organoids;
  • Plants;
  • Non-Coding RNA;
  • Sci;
  • Journal of Fungi.

If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at booth #99 and answering any questions that you may have. For more information about the conference, please visit the following link: https://www.ksmcb.or.kr/icksmcb2024/main.html.

3 September 2024
Bioengineering | 10th Anniversary


This year marks the 10th anniversary of Bioengineering (ISSN: 2306-5354, CiteScore: 4.0), an international, scientific, peer-reviewed, open access journal focused on the science and technology of bioengineering that is published monthly online by MDPI. Its aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed, from theoretical concepts to education and applications.

Since the establishment of Bioengineering in 2014, the journal has published over 3800 papers, including more than 695 that have been cited at least 10 times. During the past 10 years, Bioengineering has significantly contributed to scientific advancements in the field of bioengineering.

We would like to express our sincerest gratitude to our readers, innumerable authors, anonymous peer reviewers, editors, and everyone who has worked for the journal, for your outstanding work in fostering the vision and supporting the mission of our journal. Without your support, we would never have achieved this significant milestone.

To celebrate the 10th anniversary of Bioengineering, we are arranging events and the release of special content. We hope that you will be able to join us in this celebration. For more information about our anniversary events, please visit: https://www.mdpi.com/journal/bioengineering/anniversary.

If you have any questions, suggestions, or recommendations, please do not hesitate to contact [email protected].

Bioengineering Editorial Office

29 August 2024
Meet Us at the 2025 BMES CMBE Conference, 3–6 Jan 2025, Carlsbad, CA, USA


Established in 1968, the Biomedical Engineering Society (BMES) is a professional society for students, faculty, researchers, and industry professionals in biomedical engineering.

The mission of BMES is to promote a collaborative and inclusive community to advance human health through education, discovery, and translation, which drives our research and educational initiatives, including webinars, chapter programs, and meetings. BMES has more than 6,800 members who share a vision of health and wellness for all through engineering innovation and a steadfast commitment to diversity, equity, and inclusion.

In addition, BMES shares scientific information to inspire the up-and-coming generation through four scientific journals, three special interest groups, and collaboration with other scientific societies to elevate the visibility and significant impact that the biomedical engineering community has worldwide as the thought-leaders behind the future of human health.

The 2025 BMES CMBE Conference will take place on 3–6 January 2025, in Carlsbad, CA. The theme is “Cell Engineering for Mechanomedicine and Rejuvenation”.

Conference-related submissions can be submitted to the following Special Issue, which will be granted a 20% discount: “New Sight of Vascular Engineering and Biomaterials: Updates and Future Directions”.

More details about the conference can be accessed at the following link: https://www.bmes.org/cmbe2025.

19 August 2024
MDPI’s 2023 Young Investigator Awards—Winners Announced


MDPI’s Young Investigator Awards recognize promising early career scientists, acknowledge their contributions, and foster collaboration within the scientific community. We are proud to announce the recipients for 2023, who were carefully selected by the journals’ esteemed Award Evaluation Committee.

We extend our heartfelt congratulations to the 79 winners of MDPI’s 2023 Young Investigator Awards for their excellent contributions in their research field. We look forward to seeing these rising stars continue to contribute to the advancement of science.

MDPI will continue to support and recognize the academic community. To explore details about the awardees by field, please visit the individual pages listed below:

Congratulations to all the winners for their exceptional contributions and dedication to advancing scientific research.

About MDPI Awards:
To support the academic community, particularly young researchers, and to enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help to elevate the profiles of talented individuals who have made outstanding achievements and are making significant contributions to advancements in their respective fields.

To find out more about MDPI awards, please click here.

13 August 2024
Join Us at the 2024 BMES Annual Meeting, 23–26 October 2024, Baltimore, USA


Conference: 2024 BMES Annual Meeting
Date: 23–26 October 2024
Location: Baltimore, USA

MDPI will be attending the 2024 BMES Annual Meeting as an exhibitor. We welcome researchers from different backgrounds to visit and share their latest ideas with us.

Established in 1968, the Biomedical Engineering Society (BMES) is a professional society for students, faculty, researchers, and industry professionals in the field of biomedical engineering. The conference aspect covers cancer treatment, heart disease, women’s health, global health disparities, and more. The meeting allows members to advocate for their innovative solutions, demonstrating their commitment to our society’s core value of health equity for all individuals. The Biomedical Engineering Society is governed by the BMES Board of Directors, and this board is elected from members of the society.

The following MDPI journals will be represented at the conference:

If you are planning to attend the above conference, please do not hesitate to start an online conversation with us before visiting. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.bmes.org/bmes2024.

6 August 2024
Meet Us at the Materials Science and Engineering Congress 2024, 24–26 September 2024, Darmstadt, Germany


MDPI will be attending the Materials Science and Engineering Congress 2024, which will be held from 24 to 26 September 2024 in Darmstadt, Germany. This event is organized by the German Society for Materials Science (DGM), which is the largest scientific and technical society in the field of materials science and engineering in Germany.

The areas of focus for the conference include the following:

  • Biomaterials;
  • Characterization;
  • Digital transformation;
  • Functional materials, surfaces and devices;
  • Circular materials;
  • Modeling and simulation;
  • Processing and synthesis;
  • Structural materials.

The following MDPI journals will be represented at the conference:

If you are planning to attend the above conference, please feel free to stop by our booth. Our delegates look forward to meeting you in person to answer any questions that you may have. For more information about the conference, please visit the following link: https://dgm.de/mse/2024/.

2 August 2024
MDPI Romania Author Training Sessions in May

In May, MDPI Romania held three author training sessions – one endorsing an external event and two stand-alone sessions.

The National Session of Scientific Student Communications took place at Technical University Cluj on 17 and 18 May 2024. MDPI Romania sponsored this event and contributed an author training session on the production of research papers and case study analyses. JRS Norbert Kiss gave a presentation called The World of Open Access to explain different open access publishing models and the benefits of open access publishing. His presentation highlighted the impact of open access publishing on scientific progress and innovation.

On 29 May 2024, MDPI Romania hosted an author training session for Ph.D. students, early career researchers, and professors at the Carol Davila University of Medicine and Pharmacy. In collaboration with Prof. Andreea Arsene, JRS Ioana Paunescu prepared two presentations: The Steps of the Publishing Process and Elaboration of a Peer Review Report. In her first presentation, she delved into MDPI’s history and mission, MDPI’s editorial process, and MDPI journals of various scopes that are accepting submissions. Her second presentation outlined the types of peer review, the contents of a peer review report by an MDPI reviewer, and the responsibilities of an MDPI reviewer.

MDPI Romania also hosted an author training session at the Iasi University of Life Sciences on 29 May 2024. JRSs Laurentiu Preda and Cosmin Artan gave four presentations: Efficient Writing of an ISI-Indexed Scientific Article, Benefits of Publishing in the Open Access Model, Various Methods of Open Access Publishing, and MDPI Guide for the Article Review Process. The first three presentations offered guidance on how to improve academic writing, the fourth focused on how to write peer review reports. A highly interactive discussion followed the presentations, during which the JRSs provided extensive answers to attendees’ questions.

MDPI is grateful for all the attendees, speakers, and organizers involved in these events. Through their enthusiasm and dedication, these events were great successes.

31 July 2024
Meet Us at the 36th EUROSENSORS Conference, 1–4 September 2024, Debrecen, Hungary


MDPI will be attending the 36th EUROSENSORS conference, which will be held from 1 to 4 September 2024 in Debrecen, Hungary.

EUROSENSORS is a series of highly successful conferences that began in Cambridge in 1987 and that has been the only European forum to cover the entire field of sensors, actuators, microsystems and nanosystems. It is the leading European conference devoted to the advancement of high technologies in the aforementioned fields, providing an excellent opportunity to bring together scientists and engineers from academia, research centres, national research institutes and companies to present and discuss the latest results in these fields.

For more than 35 years, the EUROSENSORS Conference was the largest European forum for scientists and engineers from academia, research institutes and companies, and especially for students to present and discuss the latest trends and results in Sensors, actuators, micro- and nanosystems. EUROSENSORS attracts more than 500 participants every year, mainly from Europe but also from abroad.

The following MDPI journals will be represented at the conference:

  • Sensors;
  • Biosensors;
  • Electronics;
  • Micromachines;
  • Nanoenergy Advances;
  • Actuators;
  • Analytica;
  • Biomimetics;
  • Drones;
  • Fibers;
  • JLPEA;
  • Nanomanufacturing;
  • Photonics;
  • Robotics;
  • Technologies;
  • Bioengineering;
  • Chemosensors;
  • JETA;
  • Telecom.

If you are planning to attend the conference, please feel free to stop by our booth (#13) and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following link: https://eurosensors2024.eu/.

24 July 2024
Meet Us at the 8th China-Europe Symposium on Biomaterials in Regenerative Medicine, 15–18 September 2024, Nuremberg, Germany


The 8th China-Europe Symposium on Biomaterials in Regenerative Medicine will be held from 15 to 18 September 2024, in Nuremberg, Germany. The conference is organized by Chinese Society for Biomaterials (CSBM) and European Society for Biomaterials (ESB).

Topics include the following:

  • Advanced metallic biomaterials;
  • Natural and synthetic polymers;
  • Bioceramics in regenerative medicine;
  • Advanced biocomposites;
  • Multi-functional hydrogels;
  • Nanomaterials and nanomedicine;
  • Biomaterials for bone regeneration;
  • Biomaterials for cartilage regeneration;
  • Biomaterials for nerve regeneration;
  • Vascular regeneration biomaterials;
  • Biomaterials in cancer microenvironment;
  • Marine biomaterials;
  • Biomaterials surfaces and interfaces;
  • Characterization and assessment of biomaterials;
  • Bio-imaging and molecular probe;
  • Cardiovascular biomaterials;
  • Dental biomaterials;
  • Biomaterials for drug delivery systems;
  • Biomaterials for in vitro disgnostics.

The following MDPI journals will be represented in the conference:

  • Journal of Functional Biomaterials;
  • Gels;
  • Bioengineering;
  • Fibers;
  • Journal of Composites Science;
  • Materials;
  • Macromol;
  • Coatings;
  • Pharmaceutics.

If you are attending this conference, please feel free to start a conversation with us by contacting us online. Our delegates look forward to meeting you in person at a booth and answering any questions that you may have. For more information about the conference, please visit the following link: https://www.cesb2024.org/.

10 July 2024
MDPI's Newly Launched Journals in June 2024

Five new journals covering multiple subjects have launched their inaugural issue in June 2024. We are excited to be able to share with you the newest research rooted in the value of open access.

We would like to express our deepest appreciation to all the Editorial Board Members and each journal will ensure its high-quality output using excellent editorial and rigorous peer review processes, to ensure that the articles achieve high impact and visibility.

Please feel free to browse and discover more about the new journals below.

Journal

Founding Editor-in-Chief

Journal Topics (Selected)

Anesthesia Research Logo

Prof. Dr. Marco Ranucci, IRCCS Policlinico San Donato, Italy
| Editorial | view inaugural issue

anaesthetic medications; blood and fluid management; pain management; critical care; critical illness | view journal scope | submit an article

Complications Logo

Dr. Giovanni E. Cacciamani, University of Southern California, USA
| Editorial | view inaugural issue

surgical/procedural complications; complications; perioperative adverse events; postoperative adverse events | view journal scope | submit an article

Laboratories Logo

Prof. Dr.  Gassan Hodaifa, Universidad Pablo de Olavide, Spain
| Editorial | view inaugural issue

laboratory management; laboratory safety; protective equipment; laboratory problems and challenges; laboratory Innovation | view journal scope | submit an article

Pets Logo

Prof. Dr. Jan S. Suchodolski, Texas A&M University, USA
| Editorial | view inaugural issue

companion animals health and disease; veterinary care and nutrition; genetics and genomics; behavior and welfare; human-animal relations | view journal scope | submit an article

Real Estate Logo

Prof. Dr. Pierfrancesco De Paola, University of Naples Federico II, Italy
| Editorial | view inaugural issue

real estate appraisal; economic and financial valuation of real estate projects; sustainable real estate; housing and urban economics | view journal scope | submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to send an application here, or contact the New Journal Committee ([email protected]) if you would like to create more new journals.

2 July 2024
Meet Us at the 11th WACBE World Congress on Bioengineering, 4–7 August 2024, Hong Kong, China


The 11th WACBE World Congress on Bioengineering will be held from 4 to 7 August 2024, in Hong Kong, China. The conference is organized by the World Association for Chinese Biomedical Engineers (WACBE) and hosted by the Hong Kong Polytechnic University.

Topics include the following:

  • AI and data sciences in biomedical engineering;
  • biomaterials, tissues engineering and regenerative medicine;
  • biomedical imaging, signal processing, and health informatics;
  • biomechanics, sports science, and rehabilitation;
  • biosensors, bionanotechnology and medical devices;
  • cellular, genomic and biomolecular engineering;
  • innovation, translation and entrepreneurship.

The following MDPI journals will be represented in the conference:

  • Bioengineering;
  • BioChem;
  • BioMed;
  • Biomimetics;
  • Life.

If you are attending this conference, please feel free to start a conversation with us by contacting us online. Our delegates look forward to meeting you in person at a booth and answering any questions that you may have. For more information about the conference, please visit the following link: https://www.wacbe2024.org/.

21 June 2024
Meet Us at the 50th International Micro and Nano Engineering Conference (MNE 2024), 16–19 September 2024, Montpellier, France


MDPI will be attending the 50th International Micro and Nano Engineering Conference (MNE 2024) held in Montpellier, France, from 16 to 19 September 2024.

The scientific topics of the conference cover all the domains impacted by micro/nano engineering activities:

  • T1 – METHODS and PROCESS: micro/nano fabrication methods and processes;
  • T2 – STRUCTURES and DEVICES: fabrication and integration of micro/nano structures and devices;
  • T3 – SYSTEMS: micro/nano systems for computing, communication, sensing and quantum applications;
  • T4 – BIO: micro/nano engineering for life and analytical sciences;
  • T5 (New) – SUSTAINABILITY: energy efficiency of micro/nano engineering and environmental and ecological applications.

The MNE conference is the flagship event of the International Society for Micro- and Nanotechnology (iMNEs). It has always been the leading international conference for micro- and nano-fabrication, manufacturing techniques and applications of the fabricated micro/nanostructures, devices and microsystems in electronics, photonics, energy, environment, chemistry and life sciences. The MNE brings together researchers and experts from all over the world to meet and discuss the latest research results and their applications. Furthermore, the conference aims to promote, involve and train young talent in the field of micro and nano engineering.

The following MDPI journals will be represented:

If you plan on attending this conference, feel free to stop by our booth at #42. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please see the following link: https://mne2024.imnes.org/.

20 June 2024
2023 Impact Factors for MDPI Journals Released


MDPI is pleased to announce the inclusion of 237 journals in the 2024 release of the Journal Citation Reports (JCR) and share the key results (see above).

This year, journals covered in the Emerging Sources Citation Index (ESCI) received category ranks together with journals in the Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI). Overall, 139 MDPI journals indexed in ESCI are included in the new unified rankings for the first time.

Enhanced Comparability of Data

According to Clarivate, "the creation of unified category rankings [provides] a simpler and more complete category view for the evaluation of journal performance. [...] The category-first approach simplifies journal performance assessment with a holistic view of all journals in each subject category."

We are thrilled to announce that 72% of our ranked MDPI journals (171 of 237) are above average, in Q1 or Q2. Twenty-nine of our journals received their first Impact Factor this year, accounting for more than 5% of the journals accepted into the Web of Science last year.

MDPI Journals Ranked in JCR

The following data includes all MDPI journals indexed in SCIE, SSCI, ESCI and AHCI.

Journal

Impact Factor

Rank Quartile

Category

Acoustics

1.3

Q3

Acoustics

Actuators

2.2

Q2

Engineering, Mechanical

Q2

Instruments & Instrumentation

Administrative Sciences

3.0

Q2

Management

Advances in Respiratory Medicine

1.8

Q3

Respiratory System

Aerospace

2.1

Q2

Engineering, Aerospace

Agriculture

3.3

Q1

Agronomy

Agriengineering

3.0

Q2

Agricultural Engineering

Agronomy

3.3

Q1

Agronomy

Q1

Plant Sciences

AI

3.1

Q2

Computer Science, Artificial Intelligence

Q2

Computer Science, Interdisciplinary Applications

Algorithms

1.8

Q3

Computer Science, Artificial Intelligence

Q2

Computer Science, Theory & Methods

Animals

2.7

Q1

Agriculture, Dairy & Animal Science

Q1

Veterinary Sciences

Antibiotics

4.3

Q1

Infectious Diseases

Q1

Pharmacology & Pharmacy

Antibodies

3.0

Q3

Immunology

Antioxidants

6.0

Q1

Biochemistry & Molecular Biology

Q1

Chemistry, Medicinal

Q1

Food Science & Technology

Applied Sciences

2.5

Q2

Chemistry, Multidisciplinary

Q1

Engineering, Multidisciplinary

Q3

Materials Science, Multidisciplinary

Q2

Physics, Applied

Applied System Innovation

3.8

Q2

Computer Science, Information Systems

Q2

Engineering, Electrical & Electronic

Q2

Telecommunications

Arts

0.3

N/A

Humanities, Multidisciplinary

Atmosphere

2.5

Q3

Environmental Sciences

Q3

Meteorology & Atmospheric Sciences

Atoms

1.7

Q3

Physics, Atomic, Molecular & Chemical

Audiology Research

2.1

Q1

Audiology & Speech-language Pathology

Axioms

1.9

Q1

Mathematics, Applied

Batteries

4.6

Q2

Electrochemistry

Q2

Energy & Fuels

Q2

Materials Science, Multidisciplinary

Behavioral Sciences

2.5

Q2

Psychology, Multidisciplinary

Beverages

3.0

Q2

Food Science & Technology

Big Data and Cognitive Computing

3.7

Q2

Computer Science, Artificial Intelligence

Q2

Computer Science, Information Systems

Q1

Computer Science, Theory & Methods

Bioengineering

3.8

Q2

Engineering, Biomedical

Biology

3.6

Q1

Biology

Biomedicines

3.9

Q2

Biochemistry & Molecular Biology

Q2

Medicine, Research & Experimental

Q1

Pharmacology & Pharmacy

Biomimetics

3.4

Q1

Engineering, Multidisciplinary

Q3

Materials Science, Biomaterials

Biomolecules

4.8

Q1

Biochemistry & Molecular Biology

Biosensors

4.9

Q1

Chemistry, Analytical

Q1

Instruments & Instrumentation

Q2

Nanoscience & Nanotechnology

Biotech

2.7

Q3

Biotechnology & Applied Microbiology

Birds

1.5

Q1

Ornithology

Brain Sciences

2.7

Q3

Neurosciences

Buildings

3.1

Q2

Construction & Building Technology

Q2

Engineering, Civil

C-Journal of Carbon Research

3.9

Q2

Materials Science, Multidisciplinary

Cancers

4.5

Q1

Oncology

Cardiogenetics

0.5

Q4

Cardiac & Cardiovascular Systems

Catalysts

3.8

Q2

Chemistry, Physical

Cells

5.1

Q2

Cell Biology

Ceramics

2.7

Q1

Materials Science, Ceramics

Q3

Materials Science, Multidisciplinary

Chemengineering

2.8

Q2

Engineering, Chemical

Chemistry

2.4

Q3

Chemistry, Multidisciplinary

Chemosensors

3.7

Q2

Chemistry, Analytical

Q2

Electrochemistry

Q1

Instruments & Instrumentation

Children

2.0

Q2

Pediatrics

Clean Technologies

4.0

Q2

Engineering, Environmental

Q2

Environmental Sciences

Q3

Green & Sustainable Science & Technology

Climate

3.0

Q2

Meteorology & Atmospheric Sciences

Clinics and Practice

1.7

Q2

Medicine, General & Internal

Clocks & Sleep

2.1

Q3

Clinical Neurology

Q3

Neurosciences

Coatings

2.9

Q2

Materials Science, Coatings & Films

Q3

Materials Science, Multidisciplinary

Q2

Physics, Applied

Colloids and Interfaces

2.5

Q3

Chemistry, Physical

Computation

1.9

Q2

Mathematics, Interdisciplinary Applications

Computers

2.6

Q2

Computer Science, Interdisciplinary Applications

Condensed Matter

1.9

Q3

Physics, Condensed Matter

Cosmetics

3.4

Q2

Biochemistry & Molecular Biology

Q2

Dermatology

Cryptography

1.8

Q3

Computer Science, Information Systems

Q2

Computer Science, Theory & Methods

Crystals

2.4

Q2

Crystallography

Q3

Materials Science, Multidisciplinary

Current Issues in Molecular Biology

2.8

Q3

Biochemistry & Molecular Biology

Current Oncology

2.8

Q2

Oncology

Data

2.2

Q3

Computer Science, Information Systems

Q2

Multidisciplinary Sciences

Dentistry Journal

2.5

Q2

Dentistry, Oral Surgery & Medicine

Dermatopathology

1.6

Q3

Dermatology

Diabetology

2.4

Q3

Endocrinology & Metabolism

Diagnostics

3.0

Q1

Medicine, General & Internal

Diseases

2.9

Q2

Medicine, Research & Experimental

Diversity

2.1

Q2

Biodiversity Conservation

Q3

Ecology

Drones

4.4

Q1

Remote Sensing

Earth

2.1

Q3

Environmental Sciences

Q3

Geosciences, Multidisciplinary

Ecologies

1.7

Q3

Ecology

Econometrics

1.1

Q3

Economics

Economies

2.1

Q2

Economics

Education Sciences

2.5

Q1

Education & Educational Research

Electronics

2.6

Q2

Computer Science, Information Systems

Q2

Engineering, Electrical & Electronic

Q2

Physics, Applied

Energies

3.0

Q3

Energy & Fuels

Entropy

2.1

Q2

Physics, Multidisciplinary

Environments

3.5

Q2

Environmental Sciences

Epigenomes

2.5

Q3

Genetics & Heredity

European Burn Journal

1.0

Q4

Critical Care Medicine

Q4

Dermatology

European Journal of Investigation in Health Psychology and Education

3.0

Q1

Psychology, Clinical

Fermentation

3.3

Q2

Biotechnology & Applied Microbiology

Fibers

4.0

Q2

Materials Science, Multidisciplinary

Fire

3.0

Q2

Ecology

Q1

Forestry

Fishes

2.1

Q2

Fisheries

Q2

Marine & Freshwater Biology

Fluids

1.8

Q3

Mechanics

Q3

Physics, Fluids & Plasmas

Foods

4.7

Q1

Food Science & Technology

Forecasting

2.3

Q2

Multidisciplinary Sciences

Forests

2.4

Q1

Forestry

Fractal and Fractional

3.6

Q1

Mathematics, Interdisciplinary Applications

Fuels

2.7

Q3

Energy & Fuels

Q3

Engineering, Chemical

Future Internet

2.8

Q2

Computer Science, Information Systems

Galaxies

3.2

Q2

Astronomy & Astrophysics

Games

0.6

Q4

Economics

Q4

Mathematics, Interdisciplinary Applications

Q4

Social Sciences, Mathematical Methods

Gastroenterology Insights

1.5

Q3

Gastroenterology & Hepatology

Gastrointestinal Disorders

0.9

Q4

Gastroenterology & Hepatology

Gels

5.0

Q1

Polymer Science

Genealogy

0.8

Q3

Ethnic Studies

Q4

Family Studies

Q3

Sociology

Genes

2.8

Q2

Genetics & Heredity

Geosciences

2.4

Q2

Geosciences, Multidisciplinary

Geriatrics

2.1

Q3

Geriatrics & Gerontology

Healthcare

2.4

Q2

Health Care Sciences & Services

Q2

Health Policy & Services

Hemato

0.9

Q4

Hematology

Hematology Reports

1.1

Q4

Hematology

Heritage

2.0

N/A

Humanities, Multidisciplinary

Q2

Multidisciplinary Sciences

Horticulturae

3.1

Q1

Horticulture

Humanities

0.3

N/A

Humanities, Multidisciplinary

Hydrology

3.1

Q2

Water Resources

Immuno

2.1

Q4

Immunology

Infectious Disease Reports

3.4

Q2

Infectious Diseases

Informatics

3.4

Q2

Computer Science, Interdisciplinary Applications

Information

2.4

Q3

Computer Science, Information Systems

Infrastructures

2.7

Q2

Construction & Building Technology

Q2

Engineering, Civil

Q2

Transportation Science & Technology

Inorganics

3.1

Q2

Chemistry, Inorganic & Nuclear

Insects

2.7

Q1

Entomology

International Journal of Financial Studies

2.1

Q2

Business, Finance

International Journal of Molecular Sciences

4.9

Q1

Biochemistry & Molecular Biology

Q2

Chemistry, Multidisciplinary

International Journal of Neonatal Screening

4.0

Q1

Genetics & Heredity

Q1

Pediatrics

International Journal of Turbomachinery Propulsion and Power

1.3

Q2

Engineering, Aerospace

Q3

Engineering, Mechanical

Inventions

2.1

Q2

Engineering, Multidisciplinary

ISPRS International Journal of Geo-Information

2.8

Q2

Computer Science, Information Systems

Q2

Geography, Physical

Q2

Remote Sensing

Journal of Cardiovascular Development and Disease

2.4

Q2

Cardiac & Cardiovascular Systems

Journal of Clinical Medicine

3.0

Q1

Medicine, General & Internal

Journal of Composites Science

3.0

Q2

Materials Science, Composites

Journal of Developmental Biology

2.2

Q3

Developmental Biology

Journal of Functional Biomaterials

5.0

Q1

Engineering, Biomedical

Q2

Materials Science, Biomaterials

Journal of Functional Morphology and Kinesiology

2.6

Q1

Sport Sciences

Journal of Fungi

4.2

Q2

Microbiology

Q1

Mycology

Journal of Imaging

2.7

Q3

Imaging Science & Photographic Technology

Journal of Intelligence

2.8

Q1

Psychology, Multidisciplinary

Journal of Low Power Electronics and Applications

1.6

Q3

Engineering, Electrical & Electronic

Journal of Manufacturing and Materials Processing

3.3

Q2

Engineering, Manufacturing

Q1

Engineering, Mechanical

Q2

Materials Science, Multidisciplinary

Journal of Marine Science and Engineering

2.7

Q1

Engineering, Marine

Q2

Engineering, Ocean

Q2

Oceanography

Journal of Personalized Medicine

3.0

Q2

Health Care Sciences & Services

Q1

Medicine, General & Internal

Journal of Sensor and Actuator Networks

3.3

Q2

Computer Science, Information Systems

Q2

Telecommunications

Journal of Theoretical and Applied Electronic Commerce Research

5.1

Q1

Business

Journal of Xenobiotics

6.8

Q1

Toxicology

Journal of Zoological and Botanical Gardens

2.1

Q2

Biodiversity Conservation

Journalism and Media

2.0

Q2

Communication

Land

3.2

Q2

Environmental Studies

Languages

0.9

N/A

Language & Linguistics

Q2

Linguistics

Laws

1.3

Q1

Law

Life

3.2

Q1

Biology

Logistics

3.6

Q2

Management

Q2

Operations Research & Management Science

Lubricants

3.1

Q2

Engineering, Mechanical

Machine Learning and Knowledge Extraction

4.0

Q2

Computer Science, Artificial Intelligence

Q2

Computer Science, Interdisciplinary Applications

Q2

Engineering, Electrical & Electronic

Machines

2.1

Q3

Engineering, Electrical & Electronic

Q2

Engineering, Mechanical

Magnetochemistry

2.6

Q2

Chemistry, Inorganic & Nuclear

Q3

Chemistry, Physical

Q3

Materials Science, Multidisciplinary

Marine Drugs

4.9

Q1

Chemistry, Medicinal

Q1

Pharmacology & Pharmacy

Materials

3.1

Q3

Chemistry, Physical

Q2

Materials Science, Multidisciplinary

Q1

Metallurgy & Metallurgical Engineering

Q2

Physics, Applied

Q2

Physics, Condensed Matter

Mathematical and Computational Applications

1.9

Q2

Mathematics, Interdisciplinary Applications

Mathematics

2.3

Q1

Mathematics

Medicina

2.4

Q1

Medicine, General & Internal

Membranes

3.3

Q2

Chemistry, Physical

Q2

Engineering, Chemical

Q2

Materials Science, Multidisciplinary

Q2

Polymer Science

Metabolites

3.4

Q2

Biochemistry & Molecular Biology

Metals

2.6

Q3

Materials Science, Multidisciplinary

Q2

Metallurgy & Metallurgical Engineering

Methods and Protocols

2.3

Q3

Biochemical Research Methods

Microbiology Research

2.1

Q3

Microbiology

Micromachines

3.0

Q2

Chemistry, Analytical

Q2

Instruments & Instrumentation

Q3

Nanoscience & Nanotechnology

Q2

Physics, Applied

Microorganisms

4.1

Q2

Microbiology

Minerals

2.2

Q2

Geochemistry & Geophysics

Q2

Mineralogy

Q2

Mining & Mineral Processing

Modelling

1.3

Q3

Engineering, Multidisciplinary

Molbank

0.6

Q4

Chemistry, Organic

Molecules

4.2

Q2

Biochemistry & Molecular Biology

Q2

Chemistry, Multidisciplinary

Multimodal Technologies and Interaction

2.4

Q3

Computer Science, Artificial Intelligence

Q2

Computer Science, Cybernetics

Q3

Computer Science, Information Systems

Nanomaterials

4.4

Q2

Chemistry, Multidisciplinary

Q2

Materials Science, Multidisciplinary

Q2

Nanoscience & Nanotechnology

Q2

Physics, Applied

Neurology International

3.2

Q2

Clinical Neurology

Neurosci

1.6

Q3

Clinical Neurology

Q4

Neurosciences

Nitrogen

1.6

Q4

Environmental Sciences

Non-Coding RNA

3.6

Q2

Biochemistry & Molecular Biology

Q2

Genetics & Heredity

Nursing Reports

2.4

Q1

Nursing

Nutrients

4.8

Q1

Nutrition & Dietetics

Oceans

1.5

Q3

Marine & Freshwater Biology

Q3

Oceanography

Optics

1.1

Q4

Optics

Organics

1.4

Q3

Chemistry, Organic

Particles

1.7

Q3

Astronomy & Astrophysics

Q2

Physics, Nuclear

Q3

Physics, Particles & Fields

Pathogens

3.3

Q2

Microbiology

Pathophysiology

2.7

Q2

Pathology

Pediatric Reports

1.4

Q3

Pediatrics

Pharmaceuticals

4.3

Q2

Chemistry, Medicinal

Q1

Pharmacology & Pharmacy

Pharmaceutics

4.9

Q1

Pharmacology & Pharmacy

Pharmacy

2.0

Q3

Pharmacology & Pharmacy

Philosophies

0.6

Q2

History & Philosophy of Science

N/A

Philosophy

Photonics

2.1

Q2

Optics

Physics

1.5

Q2

Physics, Multidisciplinary

Plants

4.0

Q1

Plant Sciences

Plasma

1.9

Q3

Physics, Fluids & Plasmas

Polymers

4.7

Q1

Polymer Science

Polysaccharides

4.7

Q1

Polymer Science

Processes

2.8

Q2

Engineering, Chemical

Prosthesis

2.8

Q4

Materials Science, Biomaterials

Proteomes

4.0

Q2

Biochemistry & Molecular Biology

Psychiatry International

1.2

Q4

Psychiatry

Publications

4.6

Q1

Information Science & Library Science

Quantum Beam Science

1.3

Q3

Instruments & Instrumentation

Q3

Materials Science, Characterization & Testing

Q4

Quantum Science & Technology

Quaternary

2.3

Q2

Geosciences, Multidisciplinary

Reactions

2.2

Q3

Chemistry, Multidisciplinary

Recycling

4.6

Q2

Green & Sustainable Science & Technology

Religions

0.7

N/A

Religion

Remote Sensing

4.2

Q2

Environmental Sciences

Q1

Geosciences, Multidisciplinary

Q2

Imaging Science & Photographic Technology

Q2

Remote Sensing

Reports

0.8

Q3

Medicine, General & Internal

Reproductive Medicine

1.1

Q4

Obstetrics & Gynecology

Q4

Reproductive Biology

Resources

3.6

Q2

Environmental Sciences

Q3

Green & Sustainable Science & Technology

Risks

2.0

Q2

Business, Finance

Robotics

2.9

Q2

Robotics

Safety

1.8

Q3

Public, Environmental & Occupational Health

Scientia Pharmaceutica

2.3

Q3

Pharmacology & Pharmacy

Sensors

3.4

Q2

Chemistry, Analytical

Q2

Engineering, Electrical & Electronic

Q2

Instruments & Instrumentation

Separations

2.5

Q3

Chemistry, Analytical

Sexes

1.2

Q2

Medicine, General & Internal

Q3

Psychology, Multidisciplinary

Q2

Social Sciences, Interdisciplinary

Q2

Womens Studies

Smart Cities

7.0

Q1

Engineering, Electrical & Electronic

Q1

Urban Studies

Social Sciences

1.7

Q2

Social Sciences, Interdisciplinary

Societies

1.7

Q2

Sociology

Soil Systems

2.9

Q2

Soil Science

Solids

2.4

Q3

Chemistry, Physical

Q3

Materials Science, Multidisciplinary

Sports

2.2

Q2

Sport Sciences

Stats

0.9

Q4

Mathematics, Interdisciplinary Applications

Q3

Statistics & Probability

Surfaces

2.3

Q3

Chemistry, Physical

Q3

Materials Science, Multidisciplinary

Surgical Techniques Development

0.1

Q4

Surgery

Sustainability

3.3

Q2

Environmental Sciences

Q2

Environmental Studies

Q3

Green & Sustainable Science & Technology

Symmetry

2.2

Q2

Multidisciplinary Sciences

Systems

2.3

Q1

Social Sciences, Interdisciplinary

Technologies

4.2

Q1

Engineering, Multidisciplinary

Telecom

2.1

Q3

Telecommunications

Thalassemia Reports

0.6

Q4

Hematology

Tomography

2.2

Q2

Radiology, Nuclear Medicine & Medical Imaging

Toxics

3.9

Q2

Environmental Sciences

Q1

Toxicology

Toxins

3.9

Q2

Food Science & Technology

Q1

Toxicology

Tropical Medicine and Infectious Disease

2.8

Q2

Infectious Diseases

Q2

Parasitology

Q1

Tropical Medicine

Universe

2.5

Q2

Astronomy & Astrophysics

Q2

Physics, Particles & Fields

Urban Science

2.1

Q3

Environmental Sciences

Q3

Environmental Studies

Q2

Geography

Q3

Regional & Urban Planning

Q2

Urban Studies

Vaccines

5.2

Q1

Immunology

Q1

Medicine, Research & Experimental

Vehicles

2.4

Q2

Engineering, Mechanical

Q2

Transportation Science & Technology

Veterinary Sciences

2.0

Q2

Veterinary Sciences

Vibration

1.9

Q3

Engineering, Mechanical

Q3

Mechanics

Viruses

3.8

Q2

Virology

Water

3.0

Q2

Environmental Sciences

Q2

Water Resources

World

2.0

Q2

Economics

Q2

Political Science

Q1

Social Sciences, Interdisciplinary

World Electric Vehicle Journal

2.6

Q2

Engineering, Electrical & Electronic

Q2

Transportation Science & Technology

Source: 2023 Journal Impact Factors, Journal Citation Reports TM (Clarivate, 2024)


About MDPI

A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to open science by making more research free and accessible to everyone. Over 3.5 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of 6000 professional, well-trained staff members, and an in-house article submission platform that was designed to ensure efficient processes within its 440 fully open access titles.

14 June 2024
Meet Us at the World Conference on Carbon 2024, 14–19 July 2024, Shenzhen, Guangdong, China


The World Conference on Carbon 2024 will be held from 14 to 19 July 2024, in Shenzhen, Guangdong, China. The conference is co-organized by the Shenzhen Science Technology and Innovation Commission, Shenzhen University of Advanced Technology, Tsinghua Shenzhen International Graduate School, and Institute of Metal Research, Chinese Academy of Sciences.

Topics include the following:

  • Nanocarbons: graphene, graphdiyne, CNTs, and fullerenes;
  • Graphite, diamond, porous carbon, coal, coke, etc.;
  • Carbon fiber and their composites;
  • Carbon for energy storage and conversion;
  • Carbon for environment;
  • Carbon for biology, health, and medicine;
  • Carbon for electronics and optoelectronics;
  • Carbon 2024 Emerging Young Scientist Symposium.

The following MDPI journals will be represented in the conference:

  • C — Journal of Carbon Research;
  • Bioengineering;
  • Materials;
  • Sustainability;
  • Fibers;
  • Molecules;
  • Electrochem;
  • Surfaces;
  • Energies;
  • Chemosensors.
If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at booth #11 and answering any questions that you may have. For more information about the conference, please visit the following link: http://carbon2024.sz-graphene.ac.cn/eindex.html.

7 June 2024
MDPI Calls for Greater Open Access to Science for Ocean Protection

On UNESCO’s 2024 Oceans Day, MDPI encourages the scientific community to increase the accessibility of ocean research to accelerate ocean conservation.

Basel, Switzerland, June 7, 2024: MDPI, a leading open access (OA) publisher, is proud to announce its active support for World Oceans Day 2024, celebrated under UNESCO’s Ocean Decade framework. MDPI’s CEO, Stefan Tochev hopes that “the latest ocean research can be made freely accessible to help empower scientists and communities at large to save our oceans,” under UNESCO’s Ocean Decade until 2030.

Open Access: A Catalyst for Ocean Action

MDPI’s presence at the UNESCO Ocean Decade Conference 2024 highlights our unwavering commitment to using OA to advance ocean science, support research communities, and promote sustainable ocean management.

"Our involvement in the UNESCO Ocean Decade Conference underscores MDPI's commitment to the underfunded Ocean SDG. By promoting OA to scientific articles and books on SDGs, we aim to inspire critical actions," said Tochev. "Our initiatives, like the World Sustainability Award and Emerging Sustainability Award, further demonstrate our dedication to advancing sustainability.”

Showcasing MDPI’s Contributions to Ocean Research

Over the past three years, MDPI has published 30,000 papers focused on ocean research and related topics. Key MDPI journals contributing to this body of work include:

  • Journal of Marine Science and Engineering (4.9k papers)
  • Remote Sensing (2.6k papers)
  • Sustainability (2k papers)
  • International Journal of Molecular Sciences (IJMS) (1.7k papers)
  • Marine Drugs (1.5k papers)
  • Water (1.5k papers)

These publications highlight MDPI’s contributions to ocean science, reinforcing our role in the broader sustainability agenda by promoting blue innovation and economy.

Additionally, MDPI has launched Oceans, an international, peer-reviewed forum specifically aimed at publishing studies related to all branches of oceanography with an emphasis on the functioning of the ocean and the sustainable use of its resources and ecosystem services.

Affirming MDPI’s Commitment to Ocean Science

MDPI’s commitment to OA is pivotal in addressing critical global challenges, from climate change to ocean sustainability. Our efforts resonate with Outcome 4 of the UNESCO Ocean Decade action roadmap: an accessible ocean with open and equitable access to data, information, technology, and innovation. By aligning with UNESCO’s goals, MDPI continues to contribute to shaping a sustainable future for our oceans, reinforcing our position as a forward-thinking publisher dedicated to environmental stewardship and scientific excellence.


For more information, contact Rui Duarte at [email protected] or +41764313242.


About MDPI

A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to open science by making more research free and accessible to everyone. Over 3.5 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of over 6000 professional, well-trained staff members, and an in-house article submission platform that was designed to ensure efficient processes within its 430 fully open access titles.

 

5 June 2024
MDPI Sets a New Benchmark for Publishing Excellence


95% of authors rate MDPI’s publication process as excellent or good, setting a new benchmark in scientific publishing – reveals 2023 Annual Report. 

Basel, Switzerland, June 4, 2024: MDPI, the leading open access (OA) publisher, proudly announces the release of its 2023 Annual Report, detailing remarkable achievements and reaffirming its leadership in advancing OA publishing. In 2023, MDPI received 655,065 submissions, of which 285,244 articles were published. The company now commands a 17% market share in gold open access articles, with a median publication time of six weeks.

Stefan Tochev, MDPI's CEO, stated, "As a pioneer in open access publishing, MDPI has long been a game-changer in the scholarly community, serving millions of authors around the world to ensure the latest research is freely available. Reflecting on our incredible journey at MDPI, 2023 has been marked by growth in paper submissions, ambitious projects and initiatives aimed at improving our internal processes and delivering top-notch services to our scientists."

MDPI's 2023 Annual Report highlights several key achievements:

  • 17% market share in gold open access articles across all disciplines.
  • Record satisfaction rates: 95% of authors, 82% of reviewers, and 85% of guest editors.
  • Enhanced editorial standards and feedback processes.
  • Increased reach and impact with 54 new MDPI journal inclusions in Scopus, 29 in Web of Science, and 77 in DOAJ.

MDPI’s unwavering commitment to advancing OA has transformed the landscape of scholarly publishing, making high-quality research freely accessible to the global scientific community. The continuous improvement in our editorial standards and feedback processes underscores MDPI’s dedication to ensuring academic integrity and excellence.

Global Reach and Collaboration

MDPI’s global footprint continues to expand, with authors from diverse regions: 37% from Asia/Pacific, 36% from Europe, 15% from the Americas, and 12% from other parts of the world. The company’s fully OA platform attracted nearly 14 million monthly visitors in 2023, reflecting its widespread influence in the scientific community.

Commitment to Partnerships

With over 800 institutional partners, MDPI continues to demonstrate its dedication to providing reliable and collaborative publishing services. The introduction of a transparent flat-fee model highlights MDPI's ongoing efforts to enhance affordability and support to the academic community. For more details read our 2023 Annual Report.

For more information, contact Rui Duarte at [email protected] or +41764313242.


About MDPI

A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to open science by making more research free and accessible to everyone. Over 3.5 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of over 6000 professional, well-trained staff members, and an in-house article submission platform that was designed to ensure efficient processes within its 430 fully open access titles.

 

4 June 2024
MDPI Insights: The CEO's Letter #12 - First Term as CEO, Tu Youyou Award, Books Report

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Renewed Term as CEO of MDPI

I released the first CEO Letter at the end of June 2023, reflecting on my first month as CEO. Looking back at the first release, I’m pleased to see a marked consistency of content – from talking about open access (OA) and highlighting the great work being done at MDPI, to bringing together the science community with our conferences and building relations with our editorial board members and our industry as a whole.

For example, in the first letter, I highlighted our meeting with Dr. Eric O. Freed, the founding and current Editor-in-Chief (EiC) of our journal Viruses. Meeting with Eric is a pleasure, as he has a strong commitment and clear vision for the journal. 

On 21 May, 2024 we met with EiC Prof. Dr. Antonino Carbone, and Section EiC Prof. Dr. Alberto Signore (pictured on the left), of our journal Hemato (tracked for Impact Factor, and indexed in Scopus), showing our continued and active collaboration with our chief editors to develop the visions for the journal. Over the course of the day, we gathered feedback and gained an understanding of the journal's expectations and focus on strategic growth.

Reflections on my first year as CEO: achievements and initiatives

During my first year as CEO, there have been many remarkable moments, including a strong focus on bringing people together, focusing on company communications and performance.

According to a recent study of 3,400 people across 10 countries, “Managers impact employees’ mental health (69%) more than doctors (51%) or therapists (41%) — and even the same as a partner (69%).” This is an important topic for me, and perhaps that’s why I place a high value on management culture due to its tangible impact on people’s lives.

When I joined MDPI, I created a weekly meet-up for the Corporate Marketing department and their team leads. On the final Thursday of every month, we hold a Global Marketing meet-up to present projects, share knowledge, and conduct training. For years, I’ve maintained the tradition of ending each of our monthly global calls with a group photo to boost morale, motivation, and productivity, and to finish on a positive note.

In keeping with this, when I stepped into the role of CEO, I launched a bi-weekly management meeting, chairing over 20 MDPI Management Team meetings in my first year. These sessions provide an opportunity for managers to present their team’s work, focusing on their achievements and the challenges they face, while at the same time creating space for sharing knowledge.

“I firmly believe that OA is the future of publishing”

I co-organized and co-led the 2023 MDPI Strategy Management meeting this past October, from which we established an Executive Task Force that meets monthly to prioritize projects aimed at building MDPI into the world’s most trusted publisher. To achieve our goals, we as managers need to maintain collaborative communication and connect to the bigger picture.

As CEO, I focused on leadership communication by publishing 12 CEO Letters, one for each month of my tenure, to share more about MDPI news and achievements. I also produced ten videos to help further communicate our message.

I was happy to attend eight publishing and conference events, including STM in Frankfurt and Washington, APE, and R2R, and facilitate critical company meetings with Elsevier, Web of Science, ResearchGate, DOAJ, and others. It was a pleasure to meet and have discussions with key organizations and governing bodies such as CAS in China and ANVUR in Italy.

The best part was the opportunity to visit seven MDPI offices across Europe and Asia-Pacific, meeting with local managers and colleagues and supporting them in person. As part of this, I conducted training sessions while continuing to lead the Corporate Marketing department.

Looking ahead

My goal for my second year as CEO is to continue building on the initiatives from the past, including leadership communications, public relations, educational marketing, and company culture, while representing MDPI to the best of my ability. Additionally, I have a few new projects I hope to launch that I believe will be valuable to MDPI and the industry at large.

I firmly believe that OA is the future of publishing, and I am grateful to be in a position to advocate for this belief as part of MDPI, the world's leading open access publisher.

Thank you to our staff and industry friends for your genuine support in this role.

Impactful Research

Nominations Open for the Prestigious Tu Youyou Award 2024

I am pleased to share that MDPI has opened nominations for the 2024 Tu Youyou Award, a prestigious recognition established in honour of Professor Tu Youyou, Nobel Laureate, whose work has significantly transformed the global fight against malaria.

The Tu Youyou Award offers CHF 100,000

In 2015, Professor Tu Youyou was awarded the Nobel Prize in Physiology or Medicine for her discovery of artemisinin, significantly reducing mortality rates from malaria and shaping global health policies. Artemisinin-based combination therapies (ACTs) are now the standard treatment endorsed by the World Health Organization (WHO), saving countless lives, especially in regions heavily burdened by malaria.

MDPI Special Issue

To mark Professor Tu’s 80th birthday in 2009, MDPI’s journal Molecules issued a Special Issue focusing on her contributions to medical research. Recognizing her continuous contribution, MDPI created the Tu Youyou Award in 2016 to honour outstanding achievements in natural products and medicinal chemistry.

The deadline for nominations is 31 December 2024

Nominations are open to scientists excelling in natural products and medicinal chemistry. Eligible nominators include academic institutes, universities, and societies. The deadline for nominations is 31 December 2024, with the winners to be announced on 30 April 2025. The Tu Youyou Award offers CHF 100,000, split equally among the winners.

MDPI encourages the academic community to nominate individuals who have demonstrated excellence and innovation in line with Professor Tu’s legacy. This award not only honours individual achievement but also encourages further scientific exploration and discovery in critical areas of medicine.

This award embodies our deep commitment to groundbreaking research that drives societal progress and celebrates the legacy of one of the greatest medical innovators of our time.

Inside MDPI

2023 MDPI Books Report

In past CEO letters, I have highlighted our publishing process and the impactful peer-reviewed articles that represent the core output of scholarly publishing. However, scholarly books are another pillar of publishing that MDPI also services, which our core audience may not be fully aware of. In this section, I highlight the 2023 MDPI Books report, released by our MDPI Books team in May 2024.

Download the 2023 MDPI Books Report

In the report, you will find a summary of MDPI Books’ 10th anniversary, the books indexed in the Web of Science Book Citation Index, our market outreach, and our outlook for 2024.

MDPI Books celebrated its 10th anniversary in 2023

MDPI Books published its first OA Reprint, “From the Renaissance to the Modern World,” in 2013. Over the past ten years, MDPI Books has seen a significant increase in both the volume and nature of published Reprints. As of December 2023, our catalogue includes a total of 7,369 Reprints, with 1,811 of them added in 2023 alone. MDPI Books includes monographs, book series, edited books and reprints of special issues and topical collections, among other book types.

We’re also celebrating the 10-year MDPI anniversary of Laura Wagner, Head of MDPI Books.

Laura Wagner (Head of Books Division)

Laura holds a Bachelor’s degree in Art History and History from the University of Basel. After her studies, she started her career at an art gallery in Basel.

Since joining MDPI in 2014, Laura has held several roles within the company. This included editorial work, development of reprint and book services, and the temporary management of the journal Arts.

Currently Laura holds the role of Head of Books Division and is in charge of the development and strategic direction of MDPI Books.

MDPI Books indexed in Web of Science Book Citation Index

Another milestone in 2023 was the indexing of four book titles in the Web of Science Book Citation Index. The indexing of our open access books is crucial for their reach and accessibility, ensuring higher visibility within the open science community.

  1. Self-Representation in an Expanded Field: From Self-Portraiture to Selfie, Contemporary Art in the Social Media Age by editor Ace Lehner
  2. Towards Socially Integrative Cities: Perspectives on Urban Sustainability in Europe and China by editors Bernhard Müller, Jian Liu, Jianming Cai, Paulina Schiappacasse, Hans-Martin Neumann, and Baojun Yang
  3. Transitioning to Gender Equality by editors Christa Binswanger and Andrea Zimmermann
  4. Under Construction: Performing Critical Identity by editor Marie-Anne Kohl

If you would like to learn more about MDPI Books, please visit: www.mdpi.com/books

If you are thinking of writing or editing a book, you can submit your proposal at www.mdpi.com/books/publish-with-us, or email us at [email protected].

Coming Together for Science

Polymers 2024 – Polymers for a Safe and Sustainable Future

Our conference team successfully managed the Polymers 2024 – Polymers for a Safe and Sustainable Future international conference which took place from 28–31 May 2024 in Athens, Greece. The conference was chaired by Prof. Dr. Dimitrios Bikiaris and Prof. Dr. Konstantinos Triantafyllidis from the Aristotle University of Thessaloniki, Greece, and Dr. Ioanna Deligkiozi from AXIA Innovation, Germany. In total, the conference had 259 accepted abstracts and over 300 attendees from 22 different countries.

The conference featured three keynote speakers and 12 invited speakers, including esteemed scholars from Europe, Asia, Africa, and Canada. It included 60 selected talks and 189 posters, chosen by the 24 members of the Scientific Committee along with the three Conference Chairs. The event explored the latest scientific advancements and innovations in polymer science, focusing on creating safe, sustainable, and environmentally friendly materials. Emphasizing green polymer chemistry and the use of bioresources, the conference promoted the synthesis of biobased and biodegradable polymers.

The conference featured esteemed scholars from Europe, Asia, Africa, and Canada

Conference awards

The conference also presented three awards: two sponsored by the journal Polymers – The Best Poster Award (€500) and the Best Oral Presentation Award (€600) – and one sponsored by Ossila, the Best Student Poster Award (€500).

Thank you to our 16 sponsors, three partnering societies (Hellenic Polymer Society, European Polymer Federation, and North American Thermal Analysis Society [NATAS]) and eight media partners.

Upcoming in-person event

1–4 August, 2024
The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science
Location: Singapore

The AI Sensors 2024 Conference will unite innovators and experts in the realms of sensors, sensing technology, and artificial intelligence.

Find more upcoming MDPI events here.

Closing Thoughts

3rd World Forum Principles of Scientific Publications

I’m pleased to share that MDPI sponsored and attended the 3rd World Forum on Principles of Scientific Publications, which took place from 22–24 May in Malaga, Spain. The event brought together academic professionals and leading researchers to discuss critical topics in the realm of publishing and research. Presentation topics included Open Science, AI in Publishing, Predatory Journals, Fake Publications, Challenges for Non-native English Speakers, and more.

“It was great to see strong support from MDPI authors in the audience”

MDPI presentations


Stefan Tochev (CEO, MDPI) presenting at the 3rd World Forum Principles of Scientific Publications

I had the privilege of attending and presenting at the event, along with my colleague Dr. Enric Sayas (Business Analyst, MDPI) from our Barcelona office, who explored the ethical concerns and opportunities brought by AI in publishing.

I took the opportunity to present on Open Science, the benefits of Open Access, and MDPI’s performance, operations, and investment in ethics. Special thanks to Evan Escamilla (Project Manager, MDPI Books) and Facundo Santomé (Sr. Marketing Manager, MDPI) who also joined the conference.

It was great to see strong support from MDPI authors in the audience who shared their positive experiences publishing with us. Their story reflects the experience of the vast majority of authors who choose to work with MDPI.

We also encountered some conservative views on OA, which created an opportunity for open discussion aimed at addressing concerns about OA and MDPI. Engaging in such discussions is important, as scepticism sometimes arises from misinformation or from a misunderstanding of who we are and how we operate. When we engage in open and honest discussion, we tend to see people getting a better understanding of MDPI, which helps address any misconceptions they may have had.


Left to right: Dr. Enric Sayas (Business Analyst, MDPI), Stefan Tochev (CEO, MDPI), Facundo Santomé (Sr. Marketing Manager, MDPI), and Evan Escamilla (Project Manager, MDPI Books) at 3rd World Forum Principles of Scientific Publications

Stefan Tochev
Chief Executive Officer
MDPI AG

31 May 2024
Meet Us at the 8th EUROBIOFILMS 2024 Meeting, 26–29 June 2024, Copenhagen, Denmark


MDPI will be attending the 8th EUROBIOFILMS 2024 meeting, which will be held from 26 to 29 June 2024 in Copenhagen, Denmark.

The program will include all aspects of biofilms, from bench to bedside, and from environment to chronic infections, presented by internationally recognized researchers.

The venue is the modern Panum Institute, Faculty of Health and Medical Sciences, Copenhagen University, situated next to Rigshospitalet—both are internationally recognized centers for biofilm research and are accessible by several bus-lines and close to the center of Copenhagen.

The following MDPI journals will be represented at the conference:

If you are planning to attend the above conference, please feel free to stop by our booth (#8) and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following link: https://eurobiofilms2024.dk/.

23 May 2024
Transfer Service in MDPI

We are pleased to announce MDPI’s Transfer Service.

This service provides a convenient method of transferring your manuscript file, along with any reviewer comments, to another journal within our publishing portfolio.

We are committed to helping authors find the right home for their research, and we will provide authors with guidance and technical support through all stages of the transfer process. Authors will be able to choose to transfer in the following two situations:

1. Select alternative journals on submission.

2. Authors are encouraged to transfer manuscripts to other MDPI journals.

More details about the Transfer Service can be found at the following link:

https://www.mdpi.com/authors/transfer-service

17 May 2024
Tu Youyou Award—Open for Nominations

In acknowledgment of the groundbreaking achievements of Professor Tu Youyou, the Nobel laureate credited with the discovery of artemisinin, MDPI is proud to announce the Tu Youyou Award. This award, inaugurated in 2016, seeks to honor scholars who excel in the fields of natural products chemistry and medicinal chemistry.

Prize:

  • CHF 100,000 in total (If there is more than one winner, the prize will be divided equally amongst the winners);
  • An award medal for each winner.

Who should be nominated?

  • Scientists with outstanding achievements and contributions in the fields of natural products chemistry and medicinal chemistry.

Who can submit a nomination?

  • Academic research institutes
  • Universities
  • Academic societies

Any personal nominations are not accepted.

How do I submit a nomination?
Candidates’ institutional affiliations need to submit their nominations for final candidates to the Tu Youyou Award Team directly by email after internal screening, and each institution can only nominate a maximum of two candidates for each edition of the Tu Youyou Award. Please note that the nominations cannot be modified once they are submitted and confirmed by the Tu Youyou Award Team.

Required nomination materials:
Nomination Form (Download)

Schedule:
Nomination deadline: 31 December 2024;
Winner announcement: 30 April 2025.

Contact:
Tu Youyou Award Team ([email protected])

More information can be found on the Tu Youyou Award official website. For any inquiries, do not hesitate to contact the Tu Youyou Award Team.

16 May 2024
MDPI Romania Author Training Academic Events in April

MDPI Romania sponsored four events over the month of April, contributing author training sessions to each event.

The NutriSciLabs 2024 conference was held at the Carol Davila University of Medicine and Pharmacy on 12 April 2024. Organized by the Association of Students from the Faculty of Pharmacy Studies, the conference aimed to enhance students’ academic writing and research skills, and bolster their confidence in participating in the academic world. Ioana Paunescu, journal relations specialist for MDPI Romania, led the training session. Paunescu first outlined MDPI’s history and core values, then explained academic writing techniques, ethics, and similarity percentages. The presentation covered the entire editorial process, highlighting the amount of attention paid to details throughout manuscript processing. Paunescu also discussed common errors that authors make while writing, and how to avoid such errors.


On 13 April 2024, the NextGEN 2.0 Student Conference took place at the Babes-Bolyai University of Cluj-Napoca. NextGen Healthcare organized this event with the university’s European Students’ Society to discuss European and international current affairs. MDPI Romania contributed an author training session called Steps of the Publication Process. Irina Codruta Zaharia, journal relations specialist, began the session with a general introduction of MDPI before diving into different article types, different layout formats, possible journals to submit to, the MDPI submission checklist, and the MDPI editorial process. By explaining the fundamentals of writing and publishing academic papers, Zaharia imparted valuable industry knowledge to the curious minds present. Participants were eager to engage with Zaharia in the subsequent Q&A session.


Celebrating its 20th anniversary this year, the International Conference “Students for Students” has long been a gathering place for undergraduate and postgraduate students of all nationalities to present their work and exchange ideas with each other. This year’s conference was held on 18 April 2024, with MDPI Romania contributing an author training session called The World of Open Access. Key speakers included Dr. Norbert Kiss from MDPI Romania and Prof. Dragos Horvath from Strasbourg University. Dr. Kiss discussed the history of open access, differences between open access publishing and traditional publishing, and implications for open access in the future. Attendees expressed keen interest in the subject, approaching Dr. Kiss with questions about academic publishing as well as his career trajectory.


Most recently, on 26 April 2024, MDPI Romania sponsored the National Symposium of Students from Geology and Geophysics Faculties. The AAPG Students Chapter at the Babes-Bolyai University organized this event as an opportunity for geology students from all Romanian universities to present their work and confer with other researchers. Dr. Kiss gave his lecture The World of Open Access at this event as well.


MDPI is thankful to all the participants, speakers, and organizers who attended these events. Through their enthusiasm and dedication, these events were great successes.

2 May 2024
MDPI Insights: The CEO's Letter #11 – 2023 Annual Report, MDPI Awards, STM

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

2023 Annual Report

This is an exciting time of year at MDPI, as we have just released our annual report 2023, recapping the past year and sharing the progress and changes that took place during it.


Stefan Tochev (CEO, MDPI)

Reflecting on 2023, I can't help but think of the changes that have occurred not only at MDPI but also within our industry as a whole. In light of this, I’m reminded that change is the only constant, and that for a publishing enterprise that has experienced rapid growth, adapting to change becomes not only a necessity but also a catalyst for sustained success.

Looking back on the significant ground we covered in 2023, I am pleased to report that the year was marked by a rise in paper submissions, along with a range of initiatives aimed at improving our internal processes and delivering top services to our scientists.

2023 Top-line MDPI Numbers

An important priority for 2023 was to strengthen our editorial policies. Despite a notable increase in the number of papers submitted from 603,000 to 655,000 (+8.6%), there was a decrease in the number of papers published from 303,000 to 285,000 (-5.9%), consistent with the overall trend in the scholarly publishing market. MDPI’s market share in gold open access articles published reached 17% in 2023 (according to Dimensions data).

2023 Open Access Numbers

For over two decades, MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020. This trajectory is deeply rooted in our history and reflects our unwavering commitment to, and vision for, an open future. This momentum continued in 2023, with 39% of the 4.16 million articles and reviews published as gold full-OA, 15% as gold hybrid-OA, 8% as bronze-OA, and 3% as green-OA, relative to 35% behind a paywall. In terms of gold OA (full or hybrid) articles and reviews published, MDPI leads the way in terms of total articles published in 2023.

MDPI is the trusted and preferred OA publisher for the scholarly community

However, in 2023, we saw a downward trend in publication numbers compared to 2022. This trend was also seen in total OA publications. While the number of submissions increased, the decline in MDPI publications can be attributed to several factors, such as improved scrutiny in our peer-review process, including the evaluation of content scope and higher rejection rates, and a post-pandemic decrease in research related to COVID-19 papers.

Download 2023 MDPI Annual Report.
Access 2023 Digital Report.

Impactful Research

Recognizing Scholars – MDPI Awards

MDPI is committed to empowering young researchers as they embark on their careers. In 2023, our journals hosted a total of 400 awards, receiving 8,839 applications and nominations. The evaluation committees selected 959 winners, with the total budget for these awards amounting to CHF 546,500.

For more information about MDPI awards, applications, and winners, please click here

The following awards recognize scholars and the impact of their research, including Young Investigator Awards, Best PhD Thesis Awards, and Travel Awards for junior researchers.

MDPI Awards – The following awards require an application or a nomination.

Young Investigator Award (CHF 1000–2000 for each winner)
This award acknowledges the achievements of young investigators in research areas relevant to the journal’s scope. Candidates must have received their PhD no more than 10 years prior to the award announcement date and must be nominated.

Best PhD Thesis Award (CHF 500–800 for each winner)
This award recognizes young scholars who have completed outstanding PhD theses in research areas relevant to the journal’s scope. It aims to encourage them to continue their excellent work and make further contributions to their field.

Travel Award (CHF 500–800 for each winner)
This award encourages junior scientists to present their latest research at academic conferences relevant to the journal’s scope, thereby increasing their impact.

Distinguished Scholars
Additionally, 220 awards were granted to the most distinguished authors and reviewers in our journals through Best Paper Awards and Outstanding Reviewer Awards. The following awards are selected by the editorial staff of the journal and do not require an application or a nomination. They exemplify the excellent contributions made by our authors, reviewers, and editors.

These awards exemplify the excellent contributions made by our authors, reviewers, and editors

Best Paper Award (CHF 200–500 for each winner)
This award is granted annually to highlight publications of high quality, scientific significance, and extensive influence.

Outstanding Reviewer Award (CHF 500 for partial winners)
This award is given annually to recognize reviewers who generously contribute their time to reviewing papers and demonstrate thoroughness, professionalism, and timeliness in their reviews.

MDPI also offers awards for specific topics in various research fields:

Carbon Neutrality Award (CHF 500–800 for each winner)
Sponsored by MDPI journal Sustainability, this award recognizes applicants who have made exceptional academic or societal contributions to carbon neutrality, either in general or in relation to a specific carbon-neutrality-related issue.

Intelligent Manufacturing Award (CHF 500–800 for each winner)
Administered by MDPI journal Machines, this award is presented to an individual who has made outstanding academic or societal contributions to the field of intelligent manufacturing.

Granted: World Sustainability Awards

Inside MDPI

MDPI Opens Office in Seoul, Korea and Appoints Claude Seo as Office Manager

As CEO of the world’s leading OA publisher, I am pleased to announce the official opening of our Korean branch office. With this addition, MDPI now operates 21 offices in 12 countries worldwide, improving on our position as a truly global publisher. This expansion represents more than just an increase in our physical footprint; it is a pivotal step in our ongoing commitment to making scientific knowledge more accessible across the globe.

MDPI now operates 21 offices in 12 countries worldwide, improving on our position as a truly global publisher


Claude Seo (MDPI Korea Office Manager, Seoul)

Claude Seo, who has over 15 years of experience in the academic publishing industry, has been appointed as the Office Manager of the Seoul office. The launch of our Seoul office allows us to better support the Korean scientific community and to further promote the publication of OA journals in the region.

Reflecting on his role, Claude shared that he is:

“Delighted to have been entrusted with this position within MDPI, the no. 1 scholarly OA publisher. As we establish our presence in Korea, we are dedicated to integrating ourselves into the local community and contributing to its vibrant culture. Our commitment goes beyond business growth; it is about creating a more informed and innovative society by embracing and promoting diversity within the scientific community.”

Sungkyunkwan University Joins MDPI’s Institutional Open Access Program

Additionally, I am pleased to share that Sungkyunkwan University has joined MDPI’s Institutional Open Access Program (IOAP). This program offers free access to MDP’s online submission system for institutions and provides APC discounts to affiliated authors. Thirteen major Korean universities, including Sungkyunkwan University, Kyunghee University, Chung-Ang University, and the Catholic University of Korea, have adopted IOAP in Korea.

Learn more about MDPI’s collaboration in Korea in my previous CEO Letter, in which I recap our visit to Seoul, South Korea.

Coming Together for Science

4th MMCS: Harnessing the Power of New Drug Modalities

Our conference team successfully managed the 4th Molecules Medicinal Chemistry Symposium, held from 24–26 April in Barcelona, Spain. It was chaired by Prof. Dr. Diego Muñoz-Torrero from the Institute of Biomedicine (IBUB), University of Barcelona, Spain, and Prof. Dr. Simona Collina from the University of Pavia, Italy. In total, there were 84 accepted abstracts and 102 conference attendees from 22 different countries.


From left to right: Prof. Dr. Rino Ragno (Scientific Committee), Dr. Maria Emilia Sousa (Scientific Committee), Prof. Dr. Claudio Viegas Jr. (Scientific Committee), Prof. Dr. Simona Collina (Chair), Prof. Dr. Diego Muñoz-Torrero (Chair), Alvina Wu (Managing Editor, MDPI), Prof. Dr. Roman Dembinski (Scientific Committee), Prof. Dr. Mariana Spetea (Scientific Committee).

The event comprised 12 Invited Speakers, 35 Selected Talks, 10 Flash Poster Presentations, and 39 Posters. The overarching topic of the conference was the impact of the emergence of new drug modalities on drug discovery, with thematic sessions covering topics such as photoactivatable drugs, candidates targeting RNA and epigenetic targets, covalent modifiers, and the development of new anti-cancer agents, among other medicinal chemistry projects.

We are pleased to have received feedback from attendees highlighting the professional approach of the conference chairs and participants, the high quality of the talks, and the overall outstanding organization on the part of the MDPI conference team.

Thank you to the conference sponsors, Fluorochem and IBUB, and to our partnering societies, The Spanish Society for Biochemistry and Molecular Biology (SEBBM), and the Spanish Society of Medicinal Chemistry (SEQT).

Upcoming In-Person Event

28–31 May, 2024
Polymers 2024 – Polymers for a Safe and Sustainable Future
Location:
Athens, Greece
Conference Chairs: Prof. Dr. Dimitrios Bikiaris, Prof. Dr. Konstantinos Triantafyllidis, Dr. Ioanna Deligkiozi
We look forward to welcoming experts Prof. Damià Barceló, Prof. Minna Hakkareinen, and Prof. Armando J. D. Silvestre to this event.

Find more upcoming MDPI events here.

Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

A Report from the Future – STM US Annual Conference 2024


Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli and Dr. Ioana Craciun from MDPI’s Scientific Office Board.

MDPI has for a long time been a sponsor of the STM Annual Conferences, held yearly in the US and Frankfurt, and is a trusted partner and supporter of the STM organization. While I have attended the Frankfurt conference for the past three years, this was my first time visiting the Washington, DC session, and I am glad I did.

Although it was a brief trip, I greatly appreciated the opportunity to attend in the company of my colleagues Dr. Giulia Stefenelli and Dr. Ioana Craciun from MDPI’s Scientific Office Board. They always help map some of the new industry trends against MDPI’s operational framework and guidelines. It’s a great group for kicking ideas back and forth on what we can apply at MDPI.

In my experience, STM never fails to deliver. It’s always a great conference for reconnecting with fellow publishers, industry friends, and vendors. As usual, STM this year curated a diverse range of speakers and panels, who proferred valuable knowledge and insights from outside our industry, delivering thought-provoking insights into our field. An example of this was the ‘Trust Panel’ session, which included Alan Schiffres (Managing Director, InfoLinx), who shared a number of the learnings about fraud and risk management from his 40 years in financial services, to help address some of the challenges we are currently facing in the area of publishing integrity.

Launch of STM Trends 2028 Panel

I particularly enjoyed the ‘Launch of STM Trends 2028 Panel’, which presented a report focused on the integration of humans and machines in scholarly publishing. The session highlighted themes such as AI, digitization, and the evolving research ecosystem. The report envisions a future where technology blurs the lines between human and machine involvement in research processes, with significant implications for trust, reputation, and equity. While this presents opportunities for connectivity and knowledge dissemination, it also poses challenges such as disinformation, fragmentation, and geopolitical tensions. We must rely on a wise combination of technology and human agency to navigate this complex landscape and will have to carefully examine its potential impacts on communication and scholarly publishing.

MDPI has joined the STM Integrity Hub. Click here to learn more.

While every presenter brought their own knowledge and personal touch, I was particularly pleased to encounter new speakers such as Heather Whitney (Research Assistant Professor, Radiology, University of Chicago) and Igor Grossmann (Professor of Psychology, University of Waterloo, Canada). Having studied Sociology at the University of Guelph, I have a soft spot for fellow social scientists from Canada, and I was very impressed by Igor’s presentation on ‘The Social Scientist: A View from the Future’ and his participation in the panel session ‘The Future Beyond the Article,’ which was one of my favourites from the conference, given the diversity of perspectives from the panel speakers.

Memorial Park in Washington, DC

On a personal note, this was my first-time visiting Washington, DC, and I’m glad we took an afternoon to visit the Memorial Park, with its incredible monuments to figures ranging from Martin Luther King, Jr. to Abraham Lincoln. The magnitude of the monuments is deeply impressive. I particularly appreciated the Thomas Jefferson memorial and the following quote, which I think speaks to the importance of change and adaptation. It’s something we can apply not only in our industry but also in our personal lives.

"I am not an advocate for frequent changes in laws and constitutions, but laws and institutions must go hand in hand with the progress of the human mind. As that becomes more developed, more enlightened, as new discoveries are made, new truths discovered and manners and opinions change, with the change of circumstances, institutions must advance also to keep pace with the times. We might as well require a man to wear still the coat which fitted him when a boy as a civilized society to remain ever under the regimen of their barbarous ancestors."

– Excerpted from a letter to Samuel Kercheval, July 12, 1816.

Stefan Tochev
Chief Executive Officer
MDPI AG

30 April 2024
MDPI Opens Office in Seoul, Korea and Appoints Claude Seo as Office Manager

MDPI, the leading Open Access (OA) publisher, announced on Monday that it opened its Korean branch office on 29th April 2024. With this addition, MDPI now operates 21 offices in 12 countries worldwide. Claude Seo, with over 20 years of experience in the academic journal publishing industry, including Nature Publishing Group (NPG), has been appointed as the Office Manager of the Seoul office.

With the establishment of a Seoul office, MDPI aims to actively support Korea scientific communities to further promote the publication of OA journals in the region. As of the end of 2023, Korea ranked sixth worldwide in both submissions and publications of MDPI research papers. MDPI is the number one OA publisher in Korea.


Sungkyunkwan University Joins MDPI’s Institutional Open Access Program

In addition, MDPI announced that Sungkyunkwan University joined MDPI’s Institutional Open Access Program (IOAP). This program offers free access to MDPI online submission system for the institutions and APC discounts to affiliated authors. Thirteen major Korean universities, including Sungkyunkwan University, Kyung Hee University, Chung-Ang University and Catholic University of Korea, have adopted IOAP in Korea.

OA aims to break down barriers that have traditionally restricted access to science, ensuring that knowledge is available to all, regardless of financial situation or institutional affiliations. Authors, academia, and scientific communities are rapidly moving toward OA. MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020.


MDPI CEO Visits Seoul, Korea

In March, Stefan Tochev, Chief Executive Officer (CEO) of MDPI, visited Korea and met with various stakeholders including government agencies, research and academic institutions, universities. During his visit, Stefan highlighted that MDPI continues to pave the way for a world where science is accessible to all, supporting a global community of inclusive innovation and collaborative solutions.

Stefan expressed excitement about the new venture, stating, "Today marks a significant milestone for MDPI as we celebrate the opening of our new office in Seoul, Korea. This expansion is more than just an increase in our physical footprint, it is a pivotal step in our ongoing commitment to making scientific knowledge more accessible, participatory, and inclusive across the globe."

Claude Seo, reflecting on his new role, commented, "I am delighted to have been offered this position of trust within MDPI, the no. 1 scholarly OA publisher. As we establish our presence in Korea, we are dedicated to integrating into the local community and contributing to its vibrant culture. Our commitment goes beyond business growth; it is about creating a more informed and innovative society by embracing and promoting diversity within the scientific community.”

For further inquiries, please contact our Seoul office directly.


About MDPI

A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to open science by making more research free and accessible to everyone. Over 3.3 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of 6000 diligent, well-trained staff members, and an in-house article submission platform that was designed to ensure efficient processes within its 430 fully OA titles.

15 April 2024
Meet Us at the 12th World Biomaterials Congress (WBC 2024), 26–31 May 2024, Daegu, Korea


MDPI will attend the 12th World Biomaterials Congress (WBC 2024) as an exhibitor. We invite researchers from different backgrounds to visit and share their latest ideas with us.

The WBC is a large-scale academic conference supported by the IUSBSE, a global association in the field of biomaterials. The 12th World Biomaterials Congress will attract more than 4,000 participants from all over the world. Participating experts can gather and share the latest information and knowledge in the diverse areas within biomaterials research.

The following MDPI journals will be represented at the conference:

If you are planning to attend the above conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following website: https://www.wbc2024.com/.

7 April 2024
Meet Us at the 28th International Conference on Miniaturized Systems for Chemistry and Life Sciences—Micro-Total Analysis Systems (µTAS 2024), 13–17 October 2024, Montréal, Canada


MDPI will be attending the 28th International Conference on Miniaturized Systems for Chemistry and Life Sciences—Micro-Total Analysis Systems (µTAS 2024) held in Montréal, Canada, from 13 to 17 October 2024.

The µTAS International Conference series is the premier forum for reporting research results in microfluidics, lab-on-a-chip, organ-on-a-chip, wearables, BioMEMS, microfabrication, 3D printing, nanotechnology, integration, materials and surfaces, analysis and synthesis, and detection technologies for chemistry, life sciences, and biomedicine. µTAS 2024 will feature plenary and keynote talks from world luminaries and will offer an opportunity for students and scientists to deliver oral and poster presentations selected from submitted abstracts to a global audience of experts in their area. µTAS 2024 will also include networking and social session for students, minorities, young faculty, and an array of industry exhibitions and presentations, as well as a wonderful cultural experience in Montréal.

During this conference, MDPI will welcome researchers from different backgrounds to visit and share their latest views and research with us.

The following MDPI journals will be represented:

If you plan on attending this conference, feel free to stop by our booth at #50. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please see the following link: https://microtas2024.org/.

2 April 2024
MDPI Insights: The CEO's Letter #10 - South Korea, IWD, U2A, Japan

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts


Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Stefan Tochev (CEO, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), during media meetings at Prain Agency office in Seoul, South Korea.

Visit to Seoul, South Korea

During my recent visit to South Korea, I had the privilege of meeting various stakeholders, including representatives of government, research institutions, and academia, to understand their needs and communicate MDPI’s commitment to accessible science. Accompanied by my colleagues Dr. Giulia Stefenelli and Dr. Jisuk Kang, I engaged with the Korean scientific community, which is increasingly embracing open access (OA).

As the leading OA publisher in South Korea, MDPI is trusted by local authors and in 2023 enjoyed an approximately 30% share of the OA market. South Korea ranks sixth globally for MDPI in terms of research papers submitted and published.

MDPI and South Korea by Numbers

As at 30 March, over 76,000 MDPI articles have been authored by individuals affiliated with Korean institutions. We have over 1,800 active editorial board members (EBMs) from South Korea, with more than 880 EBMs having an H-index between 26 and 50, including 10 serving as Chief Editors.

“South Korea is the sixth-largest contributor to our total publications”

Over the past five years (2019–2023), nearly 120,000 authors affiliated with South Korean institutes have published with MDPI. Specifically in 2023, we received approximately 25,000 submissions from South Korean authors, publishing close to 13,000 articles, resulting in a rejection rate of 47.4%, which is not far below MDPI’s overall rejection rate of 56.4% in 2023.

Institutional Partnerships with South Korea

I am pleased to share that MDPI has more than 825 institutional partnerships worldwide, with 12 in South Korea, including Kyunghee University, Chung-Ang University, and Inha University, among others.


Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), and Stefan Tochev (CEO, MDPI) fielding media questions at Prain PR Agency office in Seoul, South Korea.

Over the past three years (2021–2023), we have had some of the most prestigious academic universities ranked among the top 10 Korean institutions publishing with MDPI. Seoul National University had the highest number of publications with MDPI during those three years, publishing nearly 6,000 papers. Universities such as Korea University and Yonsei University also rank among the top 10 Korean institutions publishing with MDPI.

MDPI Hosts Seminar for Academia and Media

As the world’s leading OA publisher, MDPI is actively democratizing science. This is reflected in the seminars we hosted on 21 March to address questions about our editorial processes and ethical standards. The visit garnered media coverage, reflecting our mission to providing high-quality services and fostering open dialogue in the community.

“MDPI is actively democratizing science”

MDPI in the News


Stefan Tochev (CEO, MDPI) leading a seminar on OA and MDPI at Prain PR Agency office in Seoul, South Korea.

Media coverage generated by our visit to Seoul included the following stories:

“Open access is an unstoppable trend…it will lead the development of the knowledge ecosystem.”

“Papers that the public needs, anyone can use quickly… low-quality publishing is a misunderstanding.”

I greatly appreciate the contributions of everyone who took the time to meet with us, share their stories, and hold us accountable for continuing to provide high-quality publishing services while identifying areas for improvement. I am also excited to announce that we have opened an MDPI office in Seoul and will release a press release on MDPI.com, with details, by the end April 2024. The purpose of the office is to establish a local presence to connect with and support the South Korean academic community through institutional partnerships, conferences, author workshops, stakeholder communications, and more.

Impactful Research

Featured Articles on Women’s Leadership and Healthcare

In celebration of International Women’s Day (8 March 2024), MDPI curated a collection of research articles on various topics, including women’s leadership, reproductive health, preventive healthcare, and a selection of articles from our journal Women.

Women’s Leadership

Women’s Reproductive Health

Women’s Preventive Healthcare

Featured Articles in MDPI Journal Women

Below are a few articles from Women, our journal focused on women’s health, the social determinants of health, and the healthcare system that serves women. The aim of Women is to encourage academics to publish their experimental and theoretical results in detail, to aid reproducibility, and in an engaging style, to aid comprehensibility.

Inside MDPI

 

Championing Women’s Healthcare and Access to Healthcare Information

MDPI colleagues from our offices joined in celebrating #IWD2024. In doing so, we emphasized key missions that encompass:

  • Empowering women to assume leadership and decision-making roles in both business and science.
  • Helping women and girls make informed decisions about their health.
  • Recruiting and developing female talent and fostering inclusive workplace environments.

“We are thrilled to recognize the accomplishments of women scientists”

I am proud to see our colleagues enthusiastically supporting the International Women’s Day call to ‘Inspire Inclusion!’ The heart-hands in the collage below symbolize our appreciation of the achievements of women researchers and the recognition of the trailblazers who have courageously made a mark on societies past and present.

We are thrilled to recognize the accomplishments of women scientists through our many MDPI awards and by highlighting success stories. As inspirational figures, female scientists are paving the way for the next generation of women aspiring to pursue careers in engineering, life sciences, computing, and various other STEM fields.

“I consider myself lucky because I work with incredibly talented women who inspire me every day.”
– Dr. Alessandra Pasut, Winner of MDPI's ‘Biology 2023 Young Investigator Award’

“It’s really important to find a supportive and enabling environment in which to do your science; it would have a big impact on you as a person and on your scientific outputs.”
– Dr. Rhea Longley, Winner of the ‘Pathogens 2023 Young Investigator Award’

Open-access publishing, in particular, allows early-career women researchers to share their work more widely, potentially attracting mentorship opportunities and collaborations. This support is crucial for career development and advancement.

Coming Together for Science

MDPI Joins United2Act in Collective Fight to Stop Paper Mills

In my February 2024 CEO Letter, I highlighted some of our recent initiatives aimed at bolstering our commitment to research integrity, including joining the STM Integrity Hub and expanding our Research Integrity and Publication Ethics team (RIPE). Continuing our efforts in coming together for science, I am pleased to share our participation in the United2Act initiative.

The text below is taken from our official announcement:

United2Act represents an international group of stakeholders in the publishing industry committed to addressing the collective challenge posed to research integrity by paper mills.

Scientists and academic publishers have increasingly noted the alarming proliferation of paper mills, recognized as fraudulent entities seeking to manipulate the publication process for financial profit. These entities engage in fraudulent practices such as falsifying or fabricating data, selling co-authorship of fake papers, manipulating peer review, and including inappropriate citations. These actions pose a significant threat to the integrity of the scholarly record, prompting widespread concern among those involved in the academic community.

MDPI has been actively contributing to combat the undermining of the scientific record. Our editors employ a set of tools to detect potential ethical breaches within a manuscript and to tackle the issue of fake papers.

United2Act’s consensus statement is the outcome of a virtual summit held in May 2023. It involved the participation of research bodies, publishers, researchers/sleuths, universities, and publishing infrastructure from 15 countries and resulted in a Consensus Statement outlining five key areas of action for all stakeholders:

  • Education and awareness
  • Improve post-publication corrections
  • Facilitate and organise research on paper mills
  • Enable the development of trust markers
  • Facilitate dialogue between stakeholders

MDPI is committed to promoting transparency and integrity in scholarly publishing and is continuing to work closely with the scientific community toward this goal.

Closing Thoughts


Left to right: Ryo Hirayama (Marketing Specialist, MDPI), Takashi Sasabe (Marketing Specialist, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Stefan Tochev (CEO, MDPI), at MDPI’s office in Tokyo, Japan.

Visit to Tokyo and Kyoto, Japan

In March, I had the opportunity to visit our Tokyo office and engage with stakeholders in Tokyo and Kyoto. During the visit, I also recorded a video message to welcome Japanese scholars working with MDPI and to highlight our operations in Japan.

We held meetings with Editors-in-Chief, librarians, scholars, and external consultants to gather feedback on our efforts to enhance our reputation and explore additional steps we can take in that direction. Japan's rich cultural heritage, characterized by tradition, respect, and formality, provided valuable insights into meeting the publishing needs specific to Japan.

Japan’s Open Access statistics

Over the years, we have seen a shift from subscription-only to gold OA publishing in Japan, despite the lack of an official mandate. Here are some statistics:

  • 2012: 68% of articles were subscription-only, 6% were green Open Access, and 8% were gold Open Access.
  • 2016: 55% of articles were subscription-only, 6% were green Open Access, and 20% were gold Open Access.
  • 2022: 43% of articles were subscription-only, 7% were green Open Access, and 39% were gold Open Access.

To learn more about the history of OA in Japan as well as about future trends, please read this blog post.

“Japan is the ninth-largest contributor to our total publications”


Left to right: Stefan Tochev (CEO, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI) visiting Kyoto University in Kyoto, Japan.

MDPI and Japan by Numbers

As at 1 April, over 50,000 MDPI articles have been authored by scholars affiliated with Japanese institutions, making the country the ninth-largest contributor to our total publications. Over the past three years (2020–2023), nearly 90,000 authors affiliated with Japanese institutes have published with MDPI, and we have collaborated with over 4,600 Guest Editors from Japan.

In 2023, we published over 8,200 papers from authors associated with Japanese institutions. MDPI collaborates with 41 institutional partnerships in Japan, including the University of Tokyo, Hokkaido University, and Nagoya University. We have over 2,100 active EBMs from Japan, more than 1,050 EBMs having an H-index between 26 and 50, including 13 serving as Editors-in-Chief.

General Feedback – a side note

A general takeaway from our discussions with stakeholders from around the world is that negative perceptions of MDPI often stem from misinformation, misconceptions, or misunderstandings about MDPI and our practices. While we acknowledge our mistakes and work diligently to address them, maintaining a strong editorial procedure and robust peer-review process, I find that educating stakeholders about our how we do what we do and our ongoing improvements tends to help shift opinions.

That said, we recognize the importance of addressing individual concerns. We take feedback seriously and are continuously working to get better while not compromising the core principles that millions of authors appreciate about MDPI.

Stefan Tochev
Chief Executive Officer
MDPI AG

15 March 2024
Interview with Dr. Dora Allegra Carbone, Author of a Highly Viewed Article of Bioengineering

Dr. Dora Allegra Carbone is one of the authors of the highly viewed article entitled “Potential of Porous Substrate Bioreactors for Removal of Pollutants from Wastewater Using Microalgae”, published in Bioengineering (ISSN: 2306-5354).

Dr. Dora Allegra Carbone completed her Ph.D. at the University of Federico II, Italy, in 2017, specializing in microalgal biotechnologies. During her doctoral research, she concentrated on optimizing growth systems for biomass production. This involved comparing traditional liquid bioreactors with newer solid-state systems, including the notable Twin-layer system, which she studied while conducting research at the University of Cologne, Germany. In 2018, she expanded her studies on microalgae and their growth, focusing further on immobilized systems, once again examining the Twin-layer system, also at the University of Cologne. After returning to Italy in 2019, she continued her work in algology across various areas, such as co-cultivating different organisms and treating wastewater at different institutions until 2021. Since then, she has dedicated herself to teaching and scientific outreach. 

The following is an interview with Dr. Dora Allegra Carbone:

1. Could you please briefly introduce the main research content of the published paper?
The paper talks about a new technology, the Porous Substrate Bioreactors (PSBRs), which allows microalgae growth on an immobilized system and solves some problems linked to standard suspended cultivation. This technology seems to bring interesting results in wastewater treatment. This paper is the result obtained by PSBRs in this field.

2. Could you describe the difficulties and breakthrough innovations encountered in this research?
PSBRs represent an innovative technology demonstrating promising outcomes across various facets of microalgae cultivation, such as astaxanthin production. These systems have exhibited several advantages in wastewater treatment compared to classic suspended cultivation methods, including enhanced cost-effectiveness, reduced water consumption, and elevated levels of biomass productivity. Therefore, they present themselves as compelling alternatives to traditional methods in rural areas and small-scale decentralized systems within urban settings, such as hospitals. Nonetheless, a significant challenge lies in adopting these systems for large-scale applications. The scaling-up process necessitates a sustainable operation, incorporating automated algal biomass harvesting. Hence, future research should prioritize addressing these obstacles to facilitate the successful integration and utilization of PSBR technology in wastewater treatment and other biotechnology fields.

3. What made you decide to publish a bioengineering article? Why did you choose Bioengineering?
I have had previous publications with MDPI, and I have always found them to be reliable. Throughout my career, I have considered MDPI to be a top-notch publisher for research. Additionally, I have come across several bioengineering papers published by them, and they consistently exhibit high quality and are quite interesting as well. The Bioengineering journal produces valuable work which makes them trustworthy, and I would not hesitate to recommend them.

4. What was your experience publishing with Bioengineering?
My experience with this journal has been exceptional. The editorial team is truly efficient. They consistently respond promptly to my inquiries and provide helpful support whenever needed. Moreover, I have found that the time it takes for my work to be published is remarkably fast, which has been incredibly beneficial for my work.

5. How do you think open access impacts authors?
Open access increases the visibility of scientific papers without barriers; consequently, the number of citations and the impact factor significantly increase. As a result, this process amplifies the recognition of research and offers greater opportunities for young scientists to succeed in their respective fields.

6. What do you hope that readers will get from your paper?
I sincerely hope the readers recognize the PSBRS system's immense potential in wastewater treatment. Certainly, with further in-depth studies and ongoing research, this technology can significantly enhance wastewater treatment processes on both small and large scales. It promises substantial improvements in efficiency, effectiveness, and environmental sustainability. Embracing and advancing the development of PSBRS technology could prove instrumental in addressing pressing challenges in wastewater management, benefiting communities and ecosystems alike.

4 March 2024
MDPI Insights: The CEO's Letter #9 - Romania, Research Integrity, Viruses

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts


Reka Kovacs (Deputy Office Manager, MDPI), Stefan Tochev (CEO, MDPI), and Sandra Ana Spatariu (Office Manager, MDPI) at the MDPI office in Cluj, Romania.

MDPI’s Impact on Romania

In February, I visited our office in Cluj, Romania. I worked closely with our senior office managers and various teams, including the departments of training, marketing and conferences, as well as our journal relationship specialists, reviewing our service to the local scholarly community. During the visit, I also met with representatives from Babes-Bolyai University and the Technical University of Cluj-Napoca. Our multifunctional Romanian office plays an important role in supporting our collaborations with the local market as well as helping to meet MDPI’s overall business needs.


Feedback and strategy meeting with a group of MDPI’s Journal Relationship Specialists at the MDPI office in Cluj, Romania.

With 22,436 articles, Romania ranks as a top 20 contributing country to MDPI’s total number of papers published as at 28 February 2024. This highlights the importance of our collaboration with Romanian-affiliated authors and the growing opportunity to support their publishing needs. MDPI is one of the few academic publishers with a significant presence in Romania, boasting over 360 colleagues across our offices in Bucharest and Cluj. We are also proud to hire colleagues from local institutions to launch their careers within publishing.

Romania ranks as a top 20 contributing country.

The Numbers: 2019–2023

MDPI has seen a healthy increase in submissions from Romanian authors over the past three years, from 8,439 in 2021 to 11,866 by end of 2023, with most submissions going to journals such as Sustainability, Medicina, Diagnostics, IJMS, Applied Sciences, and JCM. From 2019 to 2023, MDPI published articles from 32,145 authors affiliated with Romanian institutions. Over those years, we have worked with Romanian Guest Editors on nearly 3,000 occasions to support their Special Issue and Topical collections.

With more than 300 Editorial Board Members from Romania, 34 appear on the board of Mathematics, 27 on Materials, 19 on Polymers, 18 on Coatings, and 16 on Molecules, while three serve as Section Editors-in-Chief (SEiC) on our journals Coatings (3.4 IF, 4.6 Citescore), Magnetochemistry (2.7 IF, 3.5 Citescore), and Chemosensors (4.2 IF, 3.9 Citescore).

Institutional Open Access Programs

Our commitment to working with institutions is evident in Romania, where we have established eight Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Bucharest, the University of Medicine and Pharmacy Cluj-Napoca, and most recently the National Institute for Laser, Plasma and Radiation Physics.

Our growth and presence in Romania are a true testament.

We also have IOAP agreements with Babes-Bolyai University and the Technical University of Cluj-Napoca, where I had the opportunity to meet senior stakeholders during my visit. Below are a few photos capturing our meeting with Prof. Radu Silaghi-Dumitrescu (Head of Faculty of Chemistry, Babes-Bolyai University) at the MDPI office in Cluj, Romania, along with a photo from our meeting with Vice Deans Nicoleta Cobarzan, Nicoleta Ilies, and Hoda Gavril, from the faculty of Civil Engineering at the Technical University of Cluj, Romania.


Our growth and presence in Romania are a true testament to the service we provide to the scholarly community and the relationships we foster in that region. We look forward to continuing to support Romanian scholars and institutions by providing a valuable and trusted experience with MDPI, the leader in open access publishing.

Impactful Research

MDPI Joins the STM Integrity Hub

MDPI has long been a supporter and partner of STM, with our involvement ranging from sponsoring and attending events to helping organize event programs. By joining the STM Integrity Hub, we aim to further our commitment to STM initiatives aimed at safeguarding the integrity of science.

“We are pleased to welcome MDPI as the 35th organisation participating in the Hub. This expansion is critical, as every new member enhances our capacity to prevent fraudulent submissions from entering the academic record.”

Joris van Rossum, Director of Research Integrity, STM

MDPI operates in full alignment with STM Integrity Hub's values of shared data and experiences. We strongly believe in collaboration and open exchange for the purposes of creating a holistic approach to support research integrity at MDPI itself and across the entire academic publishing industry. The Integrity Hub is an excellent example of how publishers can come together to jointly address industry-wide challenges related to research integrity, such as manuscripts that breach research integrity standards and paper-mills.

I look forward to our Research Integrity and Publication Ethics Team (RIPE) team immersing themselves in this initiative, exchanging information, best practices, and tools for the benefit of the entire scholarly ecosystem. We believe that ethical publishing standards should be implemented across the board, and we aim to be rigorous in our approach, addressing research integrity issues and improving the impact of published research.

Inside MDPI

MDPI Expands Research Integrity and Publication Ethics Team (RIPE)

In addition to external collaborations and joint initiatives aimed at further strengthening our commitment to research integrity, we are also enhancing our internal efforts. This includes improving our processes and guidelines and expanding our teams and departments to ensure quality assurance throughout our publishing process.

We are pleased to announce the expansion of our Research Integrity and Publication Ethics Team (RIPE) at MDPI. The RIPE team has recently welcomed new colleagues, each bringing unique skills and a personal commitment to prioritize ethical considerations in all our work.

The demand for research integrity and high ethical standards in academic publishing is steadily rising across our industry. Our expanded RIPE team will work to enhance and align our practices with industry best practices, ensuring excellence in research integrity and publication ethics.


Stefan Tochev (CEO, MDPI) introduces Dr. Tim Tait-Jamieson (Research Integrity Lead, MDPI) for his presentation on MDPI’s Retraction and Approval Process to a group of Journal Relationship Specialists at the MDPI office in Cluj, Romania: “The demand for research integrity and publication ethics is steadily rising across our industry.”

Introducing our Research Integrity and Publication Ethics Team

Led by Dr. Tim Tait-Jamieson (Research Integrity Lead), the RIPE team comprises Dr. Ivana Resanovic (Research Integrity Manager), Dr. Lavinia Rogojina (Research Integrity Manager), Ms. Diana Apodaritei (Research Integrity Specialist), Dr. Zoltan Mihaly (Research Integrity Specialist), Mr. Aleksandar Đukić (Research Integrity Specialist), Ms. Ana Stankovic (Research Integrity Specialist), and Ms. Anna Pena (Publication Ethics Assistant).

Please click here to access everything that you need to know about MDPI’s Research and Publication Ethics.

With this span of complementary roles, the RIPE team collaborates directly with journal editorial teams and works closely with various departments, including our Scientific Office Board and our Journal Relationship Specialists. The team’s primary objectives are to help prevent issues regarding research integrity and publication ethics during peer review, uphold MDPI’s ethics policies, adhere to industry standards, and resolve publication ethics and research integrity issues and complaints.

Quality Updates to Special Issues Oversight

At MDPI, we are committed to reviewing policies pertaining to the quality of research. In this blog post, Shaheena Patel (Communications Associate, MDPI), outlines two recent updates to MDPI journal processes. These updates pertain to Special Issue (SI) quality guidelines, in line with criteria provided by COPE and DOAJ. Alongside the SI updates, details regarding the new minor corrections policy introduced in 2024 are provided in the blog.

The two updates we implemented include greater oversight and the verification of Guest Editor credentials. These guidelines require that Editors-in-Chief (EiCs) and Editorial Board Members (EBMs) take responsibility for overseeing SIs.

PS. Thank you, James Butcher, for featuring this up in your 67th issue of the Journalogy newsletter.

Read more:

Coming Together for Science

Viruses 2024 – A World of Viruses

I am pleased to share the success of our MDPI conference Viruses 2024 – A World of Viruses, held 14-16 February, in Barcelona. With 240 registrations, this event brought together top scientists, researchers, and industry experts from 40 countries to share their findings on the latest developments in viral pathogenesis and immune responses.

Attendees gathered for the 5th edition of the Viruses’ conference, where we hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes, along with 14 invited speakers, 47 selected speakers, and nine flash poster presenters, to discuss the most significant issues in virology today.

Recap on the #Viruses2024 Conference

Take a look at the key moments from MDPI’s Viruses event and please join us in commemorating a gathering for global knowledge and cooperation. A heartfelt thank-you to all attendees; their passion and engagement played a crucial role in making this event an engaging success!

Below are calls to action from the keynote speakers encouraging collaboration and communication:

“There’s never been a better time than now to really take the power that we have both in terms of basic research and also in biotech and pharma to develop antiviral agents.” - Dr. Charles M. Rice, The Rockefeller University, New York, USA

“The collaboration between labs is absolutely essential. Improving initial detection and improving communication is a must for all of us working in science.” - Prof. Dr. Luis Enjuanes, National Center of Biotechnology (CNB-CSIC), Madrid, Spain

Our thanks go to our sponsors and partnering societies, our Viruses journal and editorial team, our Barcelona colleagues, and the social media, conference and other MDPI teams for making this event a memorable occasion. View the event gallery here.

Upcoming In-Person Event

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities
Location: Barcelona, Spain

Esteemed speakers at MMCS 2024 include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.

Find more upcoming MDPI events here.


Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Researcher to Reader (R2R) Conference

From 20–21 February 2024, I had the pleasure of attending the Researcher to Reader (R2R) conference in London, which MDPI has proudly sponsored over the years. The conference programme offered a variety of session formats, including workshops, panel discussions, debates, interviews, presentations, and lightning talks, with opportunities to discuss relevant topics.

We take pride in supporting the scientific community, bringing researchers across the world together to network, exchange ideas and share the latest in science and publishing. In 2023, MDPI invested close to 2 million CHF in sponsoring over 2,000 scientific and publishing-related conferences worldwide.

R2R Peer Review Innovations Workshop

I found the R2R conference to be engaging, with the workshops being particularly enjoyable. My colleague Giulia Stefenelli (Chair of Scientific Office Board) and I participated in the “Peer Review Innovations” workshop, which spanned four sessions over the two days. These sessions explored the future of peer review and how we can improve the peer review process for everyone involved. Notably, the large majority of attendees expressed their opinion that peer review, as currently practiced, requires significant improvement. Together, we collaborated on potential immediate and long-term improvements and innovative processes, aiming to create an ecosystem beneficial to all stakeholders by strengthening submission systems with the aim of reducing threats and making authors more responsible for their work. We also discussed the opportunity for academic institutions to better scrutinize the quality of the work produced and submitted to journals.

Our group comprised publishers, software providers, librarians, and more, bringing diverse perspectives to the discussions. These interactions were relevant to MDPI’s ongoing conversations, providing insights to our efforts. The session also made me appreciate that MDPI is doing well, as the group discussions included the subject of various quality checks that we have already embedded in our processes, ensuring that we keep abreast of industry standards.

The need for an optimized system to incentivize the activities of editors and reviewers was also a focus of discussion, as well as the support that reviewers need from publishers via the provision of strong reports through fixed forms, questionnaires and training.

At MDPI, we are currently auditing our reviewer program to improve reviewer recognition, guidelines, and methods for identifying suitable reviewers, while maintaining our commitment to quality and timeliness.

Congratulations to Mark Carden, Conference Director, and the R2R team for organizing a productive and successful event. PS: The break times were greatly appreciated as well!

Stefan Tochev
Chief Executive Officer
MDPI AG

31 January 2024
MDPI Insights: The CEO's Letter #8 - Altmetric and Flat Fee Agreement

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI and Digital Science Meeting

At MDPI, we are committed to providing our authors with the essential tools to publish, promote, and track their research. In line with this commitment, we have established a longstanding collaboration with Digital Science, a company specializing in research data and analytical insights for the research community. Our collaboration integrates their Altmetric tool, offering us and our authors the ability to track a variety of sources that monitor and report attention surrounding publications.

As part of our collaboration, we recently hosted Cathy Holland, Director of Global Publisher Business Development, and Helen Cooke, Managing Director of Publisher Sales, from Digital Science, at our MDPI headquarters in Basel, Switzerland.


Left to right: Facundo Santomé (Senior Marketing Manager, MDPI), Constanze Shelhorn (Indexing Manager, MDPI), Cathy Holland (Director of Global Publisher Business Development, Digital Science), Helen Cooke (Managing Director of Publisher Sales, Digital Science), and Stefan Tochev (CEO, MDPI) in front of MDPI headquarters in Basel, Switzerland.

During our meeting, we discussed MDPI’s publishing philosophy and explored further avenues for collaboration. We look forward to continuing our partnership with Digital Science, aiming to improve our services yet further and meet the needs of our authors more closely than ever.

What is Altmetric?

You will notice that MDPI articles feature an Altmetric score, a colourful doughnut capturing the score in the upper right corner of the article page. This score represents ‘alternative metrics,’ as distinct from traditional metrics such as Impact Factor, CiteScore, and Scimago Journal Rank.

Altmetrics complement traditional citation-based metrics by capturing online discussions related to a specific research topic. By analyzing both sets of data, we can obtain a comprehensive understanding of the attention a particular research output receives and the sources in which it is mentioned.

“Almetric provides visual insights into where research is being discussed”

Sources Tracked by Altmetric


Altmetric badge showing the Altmetric score and colour-coded mention sources.

Altmetric monitors various sources, categorizing them into segments such as policy documents, peer reviews, Wikipedia, news and blogs, and social media, among other sources. Each category is identifiable by a specific colour.

The Altmetric badge provides visual insights into where the research is being discussed. A more colourful badge indicates broader mentions across multiple platforms. Such tracking enables us to gauge the extent of an article’s online dissemination, noting that increased visibility may correlate with higher citation rates.

Read more:

Impactful Research

Ten High-Altmetric Articles Published by MDPI

As at 30 January 2024, Altmetric has tracked 670,500 MDPI research outputs from MDPI, resulting in over 4.3 million mentions. This includes over 71,894 mentions in policy and patents and 294,714 mentions in news and blogs, with some achieving an Altmetric score as high as 28,754.

So, what is a good Altmetric score? There are various ways to put this score into context. You can find out more about the score in context and how to evaluate your work by this means.

Here are ten MDPI papers ranking in the top 5% of all research outputs scored by Altmetric.

“Accuracy in Wrist-Worn, Sensor-Based Measurements of Heart Rate and Energy Expenditure in a Diverse Cohort”

J. Pers. Med. 2017, 7(2), 3; https://doi.org/10.3390/jpm7020003

Altmetric page: https://mdpi.altmetric.com/details/20477344

Altmetric shows that this article appeared in 253 news stories from 209 outlets including Forbes, BBC, and Fox News.

“Daylight Saving Time and Acute Myocardial Infarction: A Meta-Analysis”

J. Clin. Med. 2019, 8(3), 404; https://doi.org/10.3390/jcm8030404

Altmetric page: https://mdpi.altmetric.com/details/57654628

Altmetric shows that this article appeared in 295 news stories from 207 outlets including Forbes, The Atlantic, and New York Times.

“The Preliminary Analysis of Cave Lion Cubs Panthera spelaea (Goldfuss, 1810) from the Permafrost of Siberia”

Quaternary 2021, 4(3), 24; https://doi.org/10.3390/quat4030024

Altmetric page: https://mdpi.altmetric.com/details/111086701

Altmetric shows that this article appeared in 182 news stories from 134 outlets including CBC News, CNN, and National Geographic.

“Not the Cat’s Meow? The Impact of Posing with Cats on Female Perceptions of Male Dateability”

Animals 2020, 10(6), 1007; https://doi.org/10.3390/ani10061007

Altmetric page: https://mdpi.altmetric.com/details/83796184

Altmetric shows that this article appeared in 124 news stories from 98 outlets including VICE, CNN and The Guardian.

“Behaviour and Welfare Impacts of Releasing Elephants from Overnight Tethers: A Zimbabwean Case Study”

Animals 2022, 12(15), 1933; https://doi.org/10.3390/ani12151933

Altmetric page: https://mdpi.altmetric.com/details/133463915

Altmetric shows that this article appeared in 192 news stories from 186 outlets.

How do I use altmetrics?

Altmetric Explorer provides a detailed step-by-step guide and instruction video for first-time users of the tool. The guide includes useful diagrams that make it easy to get started.

Sharing Research Online

For research to be tracked across different sources, Altmetric needs a research output with a persistent identifier: a DOI, ISBN, PubMed ID, handle ID, etc. When sharing research, it is important to include a link to the original research output.

“An Update on Eukaryotic Viruses Revived from Ancient Permafrost”

Viruses 2023, 15(2), 564; https://doi.org/10.3390/v15020564

Altmetric page: https://mdpi.altmetric.com/details/142929875

Altmetric shows that this article appeared in 250 news stories from 180 outlets including CTV, Fox News, and CNN.

“The Global Problem of Insufficient Sleep and Its Serious Public Health Implications”

Healthcare 2019, 7(1), 1; https://doi.org/10.3390/healthcare7010001

Altmetric page: https://mdpi.altmetric.com/details/53406248

Altmetric shows that this article appeared in 252 news stories from 168 outlets including BBC, Harvard Business Review, and Forbes.

“A Detailed Review Study on Potential Effects of Microplastics and Additives of Concern on Human Health”

Int. J. Environ. Res. Public Health 2020, 17(4), 1212; https://doi.org/10.3390/ijerph17041212

Altmetric page: https://mdpi.altmetric.com/details/86529137

Altmetric shows that this article appeared in 197 news stories from 150 outlets including BBC, The Tribune, and World Economic Forum.

“An Empirical Study of Chronic Diseases in the United States: A Visual Analytics Approach to Public Health”

Int. J. Environ. Res. Public Health 2018, 15(3), 431; https://doi.org/10.3390/ijerph15030431

Altmetric page: https://mdpi.altmetric.com/details/34714141

Altmetric shows that this article appeared in 232 news stories from 149 outlets including Forbes, New York Times, and Harvard Business Review.

“Garden Scraps: Agonistic Interactions between Hedgehogs and Sympatric Mammals in Urban Gardens”

Animals 2023, 13(4), 590; https://doi.org/10.3390/ani13040590

Altmetric page: https://mdpi.altmetric.com/details/142934305

Altmetric shows that this article appeared in 172 news stories from 168 outlets including BBC.

Inside MDPI

MDPI Annual Meeting Celebrations in China

On Thursday 25 January, over 1,300 MDPI colleagues from our two offices in Beijing gathered to kick off MDPI’s traditional ‘Annual Meetings.’ These celebrations take place in MDPI’s offices across China, including Dalian, Tianjin, Wuhan, and Nanjing.

The evenings include performances, informative talks and presentations, awards, and entertainment, providing an ideal platform to recognize our colleagues, celebrate their achievements, and set our sights on the future.

“It is essential that we stay connected and share best practices”

I sent a video congratulating everyone on their work and sharing our vision of building MDPI into the most trusted OA publisher, highlighting the roles each of us has to play in achieving that goal.

Unfortunately I could not join in person, but you may recall my recent trip, when I visited our offices in Beijing and Wuhan, which I look forward to visiting again this year.

Although our headquarters are in Basel, Switzerland, and we are expanding throughout Europe and North America, the majority of MDPI’s workforce is in China and throughout the Asia-Pacific region, including offices in Singapore, Thailand, Japan, and newly opened office in South Korea. It is essential that as a global organization, we stay connected and share best practices in order to grow collectively and continue providing the exceptional service to our authors.

The Annual Meeting is a moment to reflect and enjoy the year’s hard work and dedication.

I extend our best wishes to all for the Chinese New Year (Xīnnián kuàilè)!

Coming Together for Science

MDPI and TU Delft Adopt Flat Fee Model in Extended Partnership

We are excited to announce a renewed three-year partnership with Delft University of Technology (TU Delft) in the Netherlands. This collaboration introduces a fixed lump-sum fee, covering publishing costs from 2024 to 2026.

“This initiative reflects our dedication to transparent and inclusive publishing”

TU Delft-affiliated authors will enjoy cost-free publishing in any MDPI journal during this period, aligning with our commitment to removing barriers for open access publishing. The agreement supports Plan S compliance and facilitates a seamless publishing process for TU Delft corresponding authors. This initiative reflects our dedication to transparent and inclusive publishing, providing stability and predictability both for authors and for institutions.

For further details on our Institutional Open Access Program (IOAP), please contact us.

Benefits to MDPI’s IOAP

At MDPI we have a long tradition of partnerships, including our Institutional Open Access Program (IOAP). IOAP supports institutions through simplification, access, transparency, APC discounts, and institutional repository deposits. The program simplifies administrative processes, offers central payment, and allows easy opting in and out. Participants gain free access to Susy, MDPI’s online submission system, with extensive article metadata and exportable data. APC discounts and Book Processing Charge discounts are available for affiliated authors. Automated deposits to institutional repositories and streamlined matching of papers to IOAP participants enhance the overall experience.

For further information, see our IOAP FAQ.

Closing Thoughts

Reflections on the 2024 APE Conference

MDPI was proud to co-sponsor the Academic Publishing in Europe (APE) 2024 Conference that took place in Berlin, Germany, from 9–10 January 2024.

The conference theme, ‘Keep the Conversation Going!’, explored the evolving landscape of scholarly communication. APE is one of the key conferences I make a point to attend each year. January offers a valuable opportunity to engage with new contacts, reconnect with familiar faces, and participate in impactful discussions and presentations among professionals, scholars, and practitioners in the field.

“It's fascinating to see how other publishers are leveraging AI”

Highlights

Some of the standout panels for me include: the role of the UN Sustainable Development Goals (SDGs) within the publishing industry. It was encouraging to hear the current status quo, though I was eager also to learn about the exciting projects planned for 2024 and beyond. These will allow us to track progress in subsequent years. At MDPI, we remain committed to promoting Open–Access (OA) content on SDGs through scientific articles and books. Furthermore, we extend our commitment to sustainability by financially supporting researchers through initiatives such as the World Sustainability Award and the Emerging Sustainability Leader Award, as well as waiving the APC for feature papers on each SDG.

In recent years, discussions on AI have become increasingly prominent at such conferences. It’s fascinating to see how other publishers are leveraging AI to meet the evolving needs of their audiences while at the same time using it to safeguard the scientific process. Other engaging panels that I enjoyed included updates on transformation beyond transformative agreements, the principles of lean change, incentive structures related to research integrity, and the panel on reviewer incentives.

“We can share best practices and lessons learned”

Incorporating MDPI’s Insights into Conferences

I must confess that I sometimes feel overlooked when MDPI is not invited to participate in crucial industry discussions. As the leading open access publisher and the third-largest publisher overall, we possess extensive experience in many of these areas and can offer valuable contributions to these discussions. We can share best practices, lessons learned, and our thinking about future trajectories. For instance, in panels discussing reviewer incentives, at MDPI we offer a discount voucher to reviewers for future submissions, reflecting our commitment to fostering a robust peer review process. In 2022 alone, MDPI collected over 1.4 million peer review reports, informing the decision-making processes of our editors. Given our expertise in these areas, it would be natural to include MDPI in such discussions. I therefore extend an invitation to future conference organizers to consider MDPI for speaking engagements and collaborative opportunities.

Stefan Tochev
Chief Executive Officer
MDPI AG

25 January 2024
Acknowledgment of the Reviewers of Bioengineering in 2023

In recognizing the exceptional efforts of our reviewers in 2023, we express our sincere gratitude for upholding the high standards of Bioengineering. Their commitment ensured the rigorous peer review that is integral to quality academic publishing.

In 2023, Bioengineering received 5766 review reports, from 4227 reviewers. This past year, we worked with reviewers from 87 countries and regions, reflecting the diversity in our collaboration with research communities. Their dedication shapes scholarly discourse and advances global research. The editorial team expresses gratitude for the vital role played by each reviewer in the Bioengineering family throughout 2023, and we look forward to their continued support in 2024.

The following are the reviewers who have consented to show their names:

A. Raja Annamalai Kinga Turzó
Aalap Chokshi Kishore Bingi
Abdelghani Dahou Klaus Peter Latté
Abdolhassan Kazemi Kok Beng Gan
Abdolreza Jamilian Konstantin Kozlov
Abdorreza Mesgar Konstantin Yarygin
Abdul Jatoi Koyeli Girigoswami
Abdullah Amru Indera Luthfi Krishna Kant
Abdulnaser M. Alshoaibi Krisztina Nikovics
Abhishek Jha Kunal Pal
Abraham Pouliakis Kuntal Maity
Abul Doulah Kuosheng Cheng
Adebowale Obalalu Lan Lin
Adel Elamri Lanju Mei
Adel Girgis Laszlo Csirmaz
Adem Ozcelik Lateef Ahmad
Afzal Hussain Laura Bulgariu
Agnishwar Girigoswami Laura Burattini
Agostino Guida Laura Gastaldi
Ahmad Bazli Ramzi Laurent Dewasme
Ahmad Hassanat Leila Allahqoli
Ahmed Abass Leonardo Pagnotta
Ahmed El-Fiqi Leonid Bystrykh
Ahmed El-Shanshory Leslie Pendrill
Ahmed Fatimi Leticia Xochitl López Martínez
Ahsan Sarwar Rana Lev Kazakovtsev
Aike Qiao Lewis Gladius
Ajay Kumar Yagati Li Wang
Ajinkya Pawar Liana Anicai
Akalesh Verma Liangtao Yang
Akira Sakai Lin Zhang
Akmalbek Bobomirzaevich Abdusalomov Lina Vieira
Alaa Adawy Linda Paternò
Alberto Battistel Lioua Kolsi
Alberto Porta Lisandro Lovisolo
Alberto Rodriguez-Archilla Liudmila Gerasimova-Meigal
Aleksander Mendyk Loganathan Rangasamy
Aleš Fidler Lorenzo Faggioni
Alesandr Krasnov Luca Fredianelli
Alessandra Giuliani Luca Redaelli De Zinis
Alessandro Di Rienzo Lucia Barra
Alessio Paladini Lucia Rocco
Alexander Gusev Luciano Bissolotti
Alexander Laemmle Ludovic Tricoire
Alexander Meigal Luigi Perotti
Alexander Moskalensky Luis Coelho
Alexander Netrusov Luis Dias
Alexander Novikov Luis Mariano Esteban
Alexander Panich Lukas Holzer
Alexander Pyatakov Mabel Noemí Brunotto
Alexander S. Machikhin Maciej Zaborowicz
Alexander Shtil Mahdi Roozbeh
Alexandre de Brevern Mahmoud Elbattah
Alexandre Vetcher Mahmoud Tabrizi
Alexandru Lavric Mahmud Iwan Solihin
Alexey Beskopylny Makoto Nakamura
Alexey Ruchay Malaya Nath
Alexey Smolin Małgorzata Chojak
Alfonso Maria Ponsiglione Manel Santafe
Alfred Ankrah Manoj Sharma
Ali Al-juboori Mansi Gandhi
Ali Salehzadeh-Yazdi Manuel Prado-Velasco
Ali Zarrabi Manuel Rodríguez-Ortega
Amar Nath Chatterjee Manuela List
Ami Mehta-Doshi Maqsood Ahmed Siddiqui
Amid Shakeri Marat Leonidovich Rudakov
Amine Khaldi Marc C. A. Stuart
Amir Benzaoui Marcelo Suzuki
Amirmasoud Ahmadi Marcin Kozuch
Amirtharajan Rengarajan Marco Invernizzi
Amit Banerjee Marco Schieppati
Amjad Abu Hasna Marco Zedda
Ammar Saleem Marcos Brioschi
Amr Arafat Marek Pagáč
Amr shehabeldine Marga López
Amritlal Mandal Margaret Saha
Amro Amara Maria A. Bonifacio
Amroune Salah Maria Botelho
Ana Joaquina Perez-Berna Maria D. Rikkou-Kalourkoti
Ana Maria Buzaleh Maria Federica De Riccardis
Ana Rita Caseiro Santos Maria Giovanna Gandolfi
Anatoly Karavaev Maria Giovanna Scioli
André Lopes Maria Jose De Jesus Valle
Andre Luiz Costa Maria Lepore
Andre van Zundert Maria Luiza Mello
Andrea Bagno Maria Pia Cavatorta
Andrea Barucci Maria Pia Ferraz
Andrea Capodaglio Maria-Elissavet (Mariliza) Nikolaidou
Andrea Maria Patelski Marian Simka
Andrea Mastinu Mariana Domnica Stanciu
Andreas G. Tsantes Mariana Ferdes
Andrei Vasile Nastuta Mariana Floria
Andrei Victor Sandu Marija M. Vuksanović
Andrej Savic Marina Carbone
Andres Barajas-Solano Marina Piscopo
Andres-Amador Garcia-Granada Mario Amatria
Andrew J. Mário Vaz
Andrew Kolarik Marioara Avram
Andrey Bogomolov Marisa Varrenti
Andrey Kovalev Markus Neureiter
Andrii Kondratiev Markus Oertel
Andrzej Kasperski Marta Carvalho
Angela De Bonis Martin Meier
Angelo Naselli Martine Pithioux
Anna Kabłak-Ziembicka Marzia Segù
Anna Paradowska-Stolarz Masashi Mizuguchi
Anna Scotto d'Abusco Massimo Corsalini
Anran Ran Massoud Amini
Antonio Di Martino Mati Pääsuke
António Manuel de Amaral Ramos Matteo Bruno Lodi
Antonio Nenna Matthew Bernards
Antreas Kantaros Maximilian Deußing
Anuchit Jitpattanakul Mayur Virarkar
Anurag Satpathy Md Belal Bin Heyat
Anusha Ekanayaka Md Sofiqul Islam
Apostolos Tsolakis Megat Syahirul Amin Megat Ali
Arafa Aly Mehdi Bahrami
Arash Kia Mehdi Mogharabi-Manzari
Arda Isik Mehran Emadi Andani
Arianna Carnevale Meijuan Chen
Arkalgud Ramaprasad Meir Barak
Arnaldo Santos Mengze Xu
Arnulfo Ramos-Jiménez Michael Arkas
Arulselvan Palanisamy Michael Brimacombe
Arup Acharjee Michael Gray
Arvind Negi Michael Liebman
Asmaa Abdella Michael Shestopalov
Ateeq Ur Rehman Michaela Cellina
Athanasios Papadopoulos Michel Roethlisberger
Athina Angelopoulou Michele Boffano
Atkinson Irina Michitaka Yoshimura
Aydi Abdelkarim Mieszko Wieckiewicz
Ayhan Celik Mikhail Kostik
Ayhan Esi Mikhail Ryazantsev
Babak Chehroudi Milan Poudel
Bao Yang Milan Toma
Baolei Guo Milos Kojic
Barbara Jasiewicz Min Dai
Bart Vande Vannet Ming-Der Lin
Bartosz Małkiewicz Mingjian Shi
Basanta Kumar Biswal Mingzhu Sun
Batyrkhan Omarov Miran Kondrič
Bennett Amaechi Mircea Ioan Popa
Beom Sun Chung Mithun Rudrapal
Bernard Hernandez Mizuho Nishio
Bikash Koli Dey Mohamad Shahgholi
Bilal Kirmani Mohamed Abuzaid
Bing Wang Mohamed Ali
Bo Luan Mohamed Jaber
Bogdan Ene-Iordache Mohamed Trabia
Bogdan Gherman Mohammad Ashfaq
Bogdan Istrate Mohammad Etoom
Bogdan Oancea Mohammad Hossein Moattar
Bogdan Socea Mohammad Reza Daliri
Bogdan Tutunaru Mohammad Rezapour
Bogdan Walkowiak Mohammed Abdullah
Bogomir Milojevic Mohammed Emran
Bohan Yin Mohammed H. Alsharif
Bojan Masanovic mohammed hawash
Boris A. Galitsky Mohammed Salman Shazeeb
Boris Dzantiev Mohammed Shuaib
Braden Fleming Mohammed Zakariah
Bruce Milthorpe Monica Betta
Bruno Bonnechère Mónica Martins
Camillo La Mesa Monika Łopuszańska-Dawid
Cândida Malça Monika Papież
Carla Masala Monika Prakash
Carlos A. García-González Morteza Taheri
Carlos Cerdán Santacruz Mostafa Kamal Masud
Carlos F. Geraldes Muahammad Atiq Ur Rehman
Carlos Hall Mubarak Mustapha
Carlos López-de-Celis Muhammad Akram
Carlos Miguel Marto Muhammad Altaf Khan
Carlos Rovere Muhammad Khalis Abdul Karim
Carlos Torres-Torres Muhammad Sardaraz
Carmen Gaidau Muhammad Shafiq
Carmen Hernandez Muhammad Tariq
Carmen Zaharia Muhammed Yildirim
Carson Leung Muhammet Baykara
Catherine Park Mukesh Meena
Cevat Erisken Munho Ryu
Chandra Mishra Murat Koklu
Chang Wei Hsieh Murni Sarian
Chang Won Jeong Mustafa Bayram
Changli Zhao Mustafa Demirci
Changzheng Chen Myles Jones
Chao Wang Nafisa Gull
Chao Zhang Nagavendra Kommineni
Charity Ngoatle Nahum Rosenberg
Cheng Chen Naiying Mao
Cheng Yang Naji Kharouf
Chenzhen Zhang Nan Yang
Cherng-Yuan Lin Narongchai Autsavapromporn
Chetta Massimiliano Natale Musso
Chhavi Sharma Natalia Chumakova
Chiara Martinelli Nathan K. Evanson
Chichun Pan Neelamadhab Padhy
Chih-Kun Hsiao Nejc Umek
Chris Wei Zhou Nektarios Kalyvas
Christian Gernhardt Nenad Ignjatović
Christian Maibohm Neofytos Komninos
Christian Müller Nianfeng Sun
Christie Ying Kei Lung Nicola Armstrong
Christoph Berliner Nicolas Joudiou
Christophe A. Marquette Nicoletta Cera
Christos Papaneophytou Nicos Maglaveras
Christos Rahiotis Nikita Minaev
Cinzia Franchin Nina Anfinogenova
Clare Selden Nir Erdinest
Claudio De Lazzari Nithesh Naik
Colleen M. McDowell Nitish Nayak
Congqiang Zhang Nizar Faisal Alkayem
Constantin Munteanu Noriko Takegahara
Constantinos Koutsojannis Noureddine Issaoui
Cristiana Corsi Nuno Mendes
Cristina Chircov Oleg Shichalin
Cristina Gluhovschi Olexander Barmak
Curtise K. C. Ng Olga Lyublinskaya
Cyrille Blondet Omid Akhavan
Dachang Zhu Omneya Attallah
Dalia Medhat Onur Güler
Dan-Alexandru Szabo Orion Itzhak
Dandan Tu Oscar de Lucio
Daniel Aguado Otávio Augusto Chaves
Daniel Dalla Torre Othmane Merah
Daniel Pozza Panagiotis Mallis
Daniel Torres-Lagares Pankaj Attri
Daniela Opriş-Belinski Paola Manini
Daniele Corbo Paolo Benna
Daniele Panetta Paolo Boffano
Daniele Ugo Tari Paolo Cavoretto
Daniil Bratashov Paolo Spinnato
Danijela Budimir Mršić Paolo Zaffino
Danilo Lofaro Paris Jafari
Danish Javeed Pascal Pineau
Dariusz Mikołajewski Patricia Godoy
Darko Božanić Patrick Martin
Daryoush Shahbazi-Gahrouei Paul Annus
Dave Mangindaan Paul Soto
David Greenhalgh Paul Sundaram
David Lea-Smith Paula Daza-Navarro
Davide Barbagallo Paulo J. Palma
Davide Bizzoca Paulo Santiago
Davide Borroni Pavel Makarevich
Davut Karayel Pavel Rehak
De Gong Pawan Kumar
Debarati Paul Pedro Gomes
Deborah Verran Pedro Morouço
Deepti Shrivastava Peer Kämmerer
De-Li Shi Perrey Stephane
Delly Ramadon Peter Fennema
Dengfeng Li Peter Gaengler
Despina Kalogianni Peter Liddle
Devanand Venkatasubbu Gopinath Peter Mukli
Dhiraj Bhatia Peter Neubauer
Dianbao Zhang Peter Piko
Diego Romano Perinelli Peter Trosan
Dieter Dirksen Petr Masliukov
Dilovan Zebari Philip Hublitz
Dimitrios Tzachanis Philip Moore
Dinesh Veeran Ponnuvelu Philippe Gorce
Dirk Henrich Pichad Khejornsart
Dmitry Gryadunov Pier Nicola Sergi
Dmitry Kiselev Piero Antonio Zecca
Dmitry Markov Pietro Hiram Guzzi
Domenico Spinelli Ping Wang
Dominik Dłuski Pingfan Hu
Domonkos Varga Piotr Dobrowolski
Donatella Delle Cave Piotr Karauda
Dong Zhang Piotr Kurcok
Don-Gey Liu Piya Temviriyanukul
Dongrui Ma Piyush Baindara
Dongwoo Kim Pradeep Panda
Dong-Wook Han Priti Prasanna Maity
Dora Luz Almanza Ojeda Qaiser Riaz
Dragana Gabric Qi Shao
Dragana Zagorac Qian Ma
Drago Beslo Qian Wang
Dragos Apostu Qiang Peng
Dulani Meedeniya Qianrong Qi
Ebrahim Karami Qiao Lin
Ebrahim Kouhsari Qiguo Rong
Ebtesam Al-Suhaimi Qin Xiang Ng
Eduardo Nakano Qing Feng
Ekaterina Naumenko Qinhe Zhang
Elamparuthi Ramasamy Qiuyun Xu
Elena Helerea Rachid Touzani
Elena Salernitano Rade M. Babić
Elena Tchetina Radian Popescu
Eleuterio A. Sánchez Romero Radu Racovita
Elham Asgari Rafał Bachorz
Elisa Belluzzi Raghvendra Pratap Singh
Elisa Viladés Rahul Mandal
Elnaz Pashaei Rajagopal Maheswar
Elsa Chan Rajamani Devaraj
Elsa Marisa Vieira Rajiv Singla
Eman Mehanna Rajni Verma
Emanuela Chiarella Raluca Nicu
Emanuele Piuzzi Ramasubba Reddy Palem
Emanuele Torti Ramgopal Kashyap
Emerson Venancio Rami Suleiman
Enrique Berjano Rana Youness
Enrique Cuan-Urquizo Ratna Kishore Velamati
Enwu Liu Ravichandran Manickam
Erfan Tirkolaee Ravindra Kumar
Eric Chappel Rayaz A. Malik
Eric Fujiwara Rebekka Heitmar
Eric Goulet Récsán Zsuzsa
Eric Ramirez Reinaldo Rodríguez-Ramos
Erik Steen Redeker Remington L. Nevin
Erika de Alvarenga Renato Melo
Erman Çakıt Reza Razaghi
Esra Imamoglu Ricardo Cartes
Eugene Loos Riccardo Beltrami
Eugenio Mattei Ripon Sarkar
Eugenio Vocaturo Rita Cordeiro
Eui Chul Lee Rob Fowkes
Evangelia Sarantopoulou Robert Friedman
Everaldo Silvino dos Santos Robert W. Caldwell
Evgeny Mirkes Roberto Castiglione
Ewa Korzeniewska Roberto de Fazio
Ewa Oledzka Roberto Gatta
Ewa Piątkowska Rodolfo Reda
Fábio Fernandes Rogerio Buchaim
Fábio Lanferdini Ronald Moore
Fabrizio Barberis Roong Jien Wong
Fabrizio Fiori Roozbeh Abedini-Nassab
Facundo Almeraya-Calderón Rosalinda Inguanta
Fahad Ahmad Roseline Ogundokun
Fahim Sufi Rosella Cataldo
Fahmi Khalifa Rossella Cacciola
Faming Wang Rubén San-Segundo
Farhad Ali Ruchire Eranga Wijesinghe
Farkhondeh Asadi Runwen Yao
Fateh Mebarek Oudina Runze Li
Fatemeh Khatami Rupesh Kumar Chikara
Fausta Lui Ryan Peterson
Federico Barrino Ryota Hosomi
Federico Berton Saadullah Abbasi
Federico Solla Sadaf Bashir Khan
Feng Li Sadiq Abdulhussain
Feng Ma Saeed Roshani
Fengjie Zhao Saima Imran
Fengyuan Zhao Salil Bharany
Fernanda Lopes Salvatore Giordano
Fernanda Medeiros Borsagli Salvatore Saccone
Fernanda Mesquita Saman Parvaneh
Fernanda Tonelli Samet Memiş
Fernando Sanchez Lasheras Samo Fokter
Fidelis Ajibade Samuel Samnick
Filipe Pinto Samuele Sutera
Filippo Cademartiri Samy Sayed
Filomena Salazar Sandeep Kumar Mishra
Florian Recker Sandeep Urandur
Francesca Zotti Sanika Suvarnapathaki
Francesco Claps Sanjay Kumar Singh
Franco Zanini Sara Abdelsalam
Frank A. Schildberg Saravanan Ramiah Shanmugam
Frederico Vieira Sarfaraz Niazi
Fredrik Huss Satoshi Yamaguchi
G.P Ramesh Satyendra Tiwary
Gábor Hornyánszky Saurabh Sharma
Gabriel-Ionut Plavan Savvas Lampridis
Gador Canton Sebastian Glowinski
Gagandeep Singh Sebastiano Cicco
Galina Kurlyandskaya Sergey Kolotilov
Gang Chen Sergey Tkachev
Gang Li Sergii Babichev
Gary Garcia Molina Serkan Yílmaz
Gema Navarrete Sezer Okay
Gemma Palazzolo Shahjada Selim
Genki Yoshikawa Shahrokh Hatefi
George Fragulis Shahzadi Tayyaba
George Livanos Shaik Gouse Peera
George Manis Shailendra Maurya
George Paraskevas Shaobin Wang
George Thompson Shaode Yu
George Verros Shao-Yi Hsia
Georgios Panos Shenghong He
Ghada Atteia Allah Shichao Ding
Gian Andrea Pelliccioni Shigeki Kamitani
Gianandrea Pasquinelli Shikha Sharma
Giancarlo Condello Shilin Liu
Gilbert Lim Shireesh Srivastava
Giner Alor-Hernández Shiv Dutt Purohit
Giou-Teng Yiang Shiwei Liu
Giovanni Buzzaccarini Shoushui Wei
Giovanni Diraco Simon Fox
Giovanni Levi Simona Ascanelli
Giulia Festa Singara Singh Kasana
Giuseppe Brunetti Siu Hong Dexter Wong
Giuseppe Cirillo Sivakumar Nuvvula
Giuseppe Milone Sivarao Subramonian
Giuseppe Trusso Sfrazzetto Sivasakthivel Ramkumar
Glauco Chisci Siyuan Zhao
Gloria Cerasela Crisan Sladjana Stajčić
Gopichandh Danala Slawomir Jakiela
Gordana Wozniak Knopp Sohail Mumtaz
Gordon Alderink Solomon Viswas Raja
Gregory Chagnon Somdutt Mujwar
Grzegorz Cieślar Somenath Chakraborty
Grzegorz Sobota Sonia Ronchey
Grzegorz Zieliński Sophie Alvarez
Guankui Wang Sorin J. Brull
Gurkan Bayar Sorina Dinescu
Gurmail Paddan Sotiria Vrouva
Gustavo Costa Sotirios Kalfas
Gustavo Fernandes Soumya Basu
Haidi Ibrahim Soumya Nayak
Haishan Zeng Soumya Srivastava
Haiyan Yang Sourav Banerjee
Hajime Hajime Srijit Das
Hamed Barabadi Srikanth Prabhu
Hamed Hatami-Marbini Stefan Fischer
Hamed Nosrati Stefan Kranz
Hamed Taherdoost Stefano Di Paolo
Hamid Ghasemi Stefano Restaino
Hamid Tebyaniyan Stephan Havemann
Hanrui Wang Steven Murray
Hanseob Jeong Sudarsu Venkata Ramanaiah
Hans-Jürgen Federsel Sudi Patel
Hao Wu Sulev Kõks
Hao Zhang Suman Lama
Haradhan Kolya Suparerk Janjarasjitt
Harikumar Rajaguru Supriyo Ray
Hariprasath Manoharan Surendra Sarsaiya
Hartmut F. Witte Suresh Anand Sadananthan
Hasan Zulfiqar Syed Furqan Qadri
Haw-Ming Huang Syed Muzahir Abbas
Hayes Phil Syoichi Tashiro
He Zhang Tadeusz Mikolajczyk
Hemali Rathnayake Taha Mastura Mohammad
Hemangi Bhonsle Tahereh Jafary
Heng Bo Jiang Taj Mohammad
Henrique Neiva Takahiro Wada
Henry Atkinson Takaomi Arai
Hervé Reychler Takeharu Tsuge
Hesham Moustafa Takuya Koie
Hiam Alquran Tamás Haidegger
Hisao Haniu Taner Sar
Hong Tang Taner Tuncer
Hongqing Yu Tania Colasanti
Hongyu Ren Tarek Mohamed
Hooman Shafaee Tarik Kivrak
Hossam Nabwey Tatiana Rakitina
Huihua Yuan Teruya Komatsu
Hunter Moseley Thach Nguyen
Hyeuknam Kwon Thanavel Rajangam
Iacopo Cappellini Thayne Kowalski
Ignacio Bosch Thierry Ribeiro
Igor Gruic Thomas Boland
Igor Vujović Thomas Dippong
Ihsan Hamawand Thomas Lindner
Ilaria Cacciotti Thorsten Kuczius
Ilaria Girolami Tiago Ribeiro
Ilaria Marcantoni Tianming Zhao
Ilya Klabukov Tirath Raj
Iman Yazdi Tohru Yamada
Imtiaz Ahmad Tomasz Marciniak
Inbarasan Muniraj Tomasz Szymborski
Inderbir Singh Tommaso Greco
Indrajeet Kumar Tomohiro Torii
Ines Aguinaga-Ontoso Tomomi Yamazaki
Ioan Petean Tongran Qin
Ioan Tudosa Torbjörn Ledin
Ioannis Kosmas Torsten Malm
Ioannis Tsoulos Toshiyo Tamura
Ion Cosmin Puia Tugay Ayasan
Ionel Alexandru Checherita U. Vijayalakshmi
Ionut Schiopu Ugo D'Amora
Iqram Hussain Umapathi Reddicherla
Irena Jekova Usman Ghafoor
Irene Buj-Corral Vadim Elagin
Irene Chiesa Vaidotas Marozas
Irfan Khan Valeria Allizond
Irina Le-Deygen Vangelis Daskalakis
Irina Negut Vangelis Karalis
Ismail Ben Abdallah Vasil Garamus
Ismail Fidan Vassilios Papadopoulos
Ítala Marx Venkata Krishna Kowthavarapu
Iurii Krak Venugopal Rao Soma
Ivan Bratchenko Vesna Mandic-Markovic
Ivan Cuk Viacheslav Voronin
Ivan Ivanov Vikram Dalal
Ivo Dumic-Cule Viktoriya Davydova
Ivona Bago Vinay Shivanna
Jabar H. Yousif Vinay Vakharia
Jacopo Lamanna Vincenzo Taormina
Jaganmay Sarkar Vineet Kumar
Jaison Jeevanandam Vinoth Kumar
Jakub Szabelski Vítor Carvalho
James Chow Vittorio Rampa
James Chung-Wai Cheung Vivek Chavda
Jamshed Iqbal Vladimir Galaktionov
Jamshid Piri Voula Georgopoulos
Jan Gajewski Vrinda Gote
Janusz Kluczynski Vyacheslav Ryabov
Jaroslava Halper Wacław Kuś
Javad Hassannataj Joloudari Wansu Park
Javed Ali Khan Warawut Chaiwong
Javier Martin Weerawat Limroongreungrat
Jayshri Kulkarni Wei Feng
Jean-Michel Guenet Wei Yan
Jeanne Wilson-Rawls Weihua Huang
Jeffrey Jones Weihua Yang
Jennifer Gubitosa Weiping Li
Jeong Yeon Kim Weizhen Hou
Jesús Pastor Wen Shi
Jeyasakthy Saniasiaya Wenbin Shi
Ji Young Cho Wendy Bollag
Jia Wen Wenguang Yang
Jiacheng Zhang Wenji Piao
Jianan Zhao Wenjie Zhou
Jianhua Wu Wenjing Ma
Jianqi Wang Wenqiang Wei
Jie Wang William Berg
Jie Zhang Wim Buijs
Jihoon Moon Wito Richter
Jiling Feng Wi-Young So
Jilong Liu Woo-Jong Kim
Jimmy T. Efird Xavier Navarro
Jin Li Xiaobo Li
Jingan Li Xiaobo Wu
Jingjing Yang Xiaodong Zhou
Jingyi Xue Xiaohu Zhao
Jin-Hyuck Park Xiaolei Peng
Jinjun Xia Xiaoqiang Zhang
Jinkun Geng Xiaowei Zhang
Jinlong Liu Xiaoyang Guan
Jintamai Suwanprateeb Xiaoyang Liu
Jinwei Xie Xin Guo
Jinze Xu Xin Song
Joao Carmo Xin Tong
João Marcelo Teixeira Xingchun Gao
João Paulo Tribst Xinjun Feng
Joaquim Carreras Xinyu Ling
Jochen Salber Xuan Mu
Jochen Schmid Xudong Ji
Jochen Winter Xuejun Liu
John A. StCyr Xueming Zhang
John Ayeelyan Xueqin Gao
John M. Perry Yang Zhang
John Nicholson Yanru Lou
John Stanford Yaoxiang Li
Jolanta Szymańska Yasemin M. Akay
Jonas Kurniawan Yekta Can
Joni H. Ylostalo Yeliz Karaca
Jorge Arede Yeong-Min Yoo
Jorge Grasa Yi Wang
Jorge Ordonez-Llanos Yi Zhang
José Francisco González Prieto Yide Zhang
Jose L. Martinez-de-Juan Yifan Ma
Josefa Gonzalez-Santos Yi-Lang Chen
Joseph Christakiran Moses Yin Zhao
Jovan Gardasevic Ying Yang
Jozsef Sarosi Yingji Mao
Juan Manuel Belda Lois Yinglei Song
Juan Manuel Gutiérrez Yizhang Wu
Juan Shan Yoo Tanabe
Juern W. P. Schmelzer Yosra Soltan
Julius Höhne Young Hye Song
Juliusz Huber Young Zoon Kim
Jun Long Lim Yu Knyazev
Junaidi Khotib Yu Zhang
Jung Woo Sohn Yuan-Yang Cheng
Juris Burlakovs Yu-Chi Lee
Juvenal Rodriguez Yufang Shen
Jwayoung Kim Yukun Yang
Kai Bin Liew Yulia Alexandrovskaya
Kai Li Yun Ling
Kailing Yu Yunn-Hwa Ma
Kamalan Kirubaharan Amirtharaj Mosas Yuxin Tong
Kamil Reza Khondakar Yves Bayon
Kamyar Khoshnevisan Zaihua Duan
Karel Kostev Zapryana Denkova
Kari Stone Zhaoxi Sun
Karim Kriaa Zhen Wang
Katarzyna Krukiewicz Zhengwei Huang
Katrin Bauer Zhengzhi Mu
Kavitha Subash Zhengzhong Tan
Kayode Oshinubi Zhibin Zhou
Ke Cheng Zhiguo He
Keigi Fujiwara Zhijie Wang
Kelin Du Zhiping Liu
Kelly De Jesus ZhuangJian Liu
Kenichi Kimura Zhuhuang Zhou
Kenji Hayashida Zhuofu Liu
Kenneth Lim Zia Ullah Arif
Kevin Dzobo Zihao Ding
Khaled Aboshanab Zihao Ou
Khalid Raza Zizhu Zhang
Kijoon Lee Zsolt Piróth
Kim Jin-Chul Zygmunt Pojda

2 January 2024
MDPI Insights: The CEO’s Letter #7 - Nobel Laureates Entrust MDPI with Their Research

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Nobel Prize Laureates Entrust MDPI with Their Research

The Nobel Prize stands as a hallmark of distinction, honouring ground-breaking research across disciplines. Annually, the Nobel Prizes are awarded in six categories: Physics, Chemistry, Medicine or Physiology, Literature, Peace, and Economic Sciences.

Through the years, renowned scholars have entrusted MDPI with their work. As at December 2023, 26 Nobel laureates have contributed to more than 75 articles across 25 MDPI journals, including: Antibiotics, Applied Sciences, Biology, Biomedicines, Cancers, Catalysts, Cells, Crystals, Entropy, Games, IJMS, Life, Materials, Micromachines, Molecules, Pharmaceuticals, PharmaceuticsPhotonics, Quantum Beam Science, Remote Sensing, Sensors, Solids, Universe, Vaccines, and Viruses.

The best of the best trust us with their work.

Nobel Prize Laureates Who Have Published with MDPI

We are proud to list the names of Pierre Agostini, Hiroshi Amano, Werner Arber, Aaron Ciechanover, Robert H. Grubbs, Oliver Hart, Gerard ‘t Hooft, Michael Houghton, Harald zur Hausen, Katalin Karikó, Jean-Marie Lehn, Gérard Mourou, Ferid Murad, Shuji Nakamura, William Nordhaus, Kostya S. Novoselov, Giorgio Parisi, Charles M. Rice, Alvin E. Roth, Donna Strickland, K. Barry Sharpless, George F. Smoot, Anne L’Huillier, Drew Weissman, Kurt Wüthrich, Ada Yonath.

The privilege of hosting such contributors resonates deeply with our editorial teams. For instance, in this interview, the Editor-in-Chief (EiC) of Universe speaks on the significance of publishing a paper by Nobel laureate Gerard ’t Hooft within the journal.

2023 Nobel Prize Winners Published by MDPI

Nobel Prize Winners, 2023: Katalin Karikó, Drew Weissman, Anne L’Huillier (Ill. Niklas Elmehed © Nobel Prize Outreach)

Three laureates from the 2023 Nobel Prize cohort have trusted MDPI as their publishing platform. Notably, in a 2022 Pharmaceutics paper, molecular biologist Katalin Karikó and her team presented a methodology for evaluating mRNA capping efficiency, pivotal for therapeutic applications. Pharmaceutics had previously dedicated a Special Issue to “mRNA Therapeutics: A Themed Issue in Honor of Professor Katalin Karikó”, spotlighting ten articles from August 2021 to February 2022.

In the journal Vaccines, Professor Drew Weissman, collaborating with scholars from Pennsylvania University and George Mason University, contributed an influential review titled “Nanomaterial Delivery Systems for mRNA Vaccines”. His collaborative efforts spanned five papers across MDPI journals between 2021 and 2023.

Furthermore, Anne L'Huillier of Lund University, only the fifth female recipient of the Physics Prize, co-authored an article in Applied Sciences focusing on "Advanced EUV and X-Ray Optics". Similarly, Pierre Agostini, an Emeritus Professor from Ohio State University, co-authored an article featured in the special issue "Attosecond Science and Technology: Principles and Applications".

We extend heartfelt congratulations to all Nobel Prize laureates and express sincere gratitude for their confidence in MDPI as a platform for their scholarly contributions.

Read more:

Impactful Research

MDPI Journals Newly Indexed in 2023

The aim of indexing is to enhance the quality and credibility of published research, ensuring that researchers access the most credible resources available. While the principle behind citation indexing is straightforward, it remains one of the most dependable methods for tracking an idea's evolution across various scientific disciplines.

Throughout the year, MDPI works to expand the reach of our publications across premier multidisciplinary databases like Web of Science, Scopus, EBSCO, and ProQuest. This initiative is spearheaded by MDPI's Indexing team, under the leadership of Dr. Constanze Schelhorn.

In 2023, MDPI achieved 54 new acceptances in Scopus, 29 in Web of Science, 52 in EBSCO, and 83 in DOAJ: Directory of Open Access Journals.

The team prioritizes ensuring that our journals feature in numerous specialized databases, including PMC, PubMed, MEDLINE, Inspec, CAS, and FSTA, among others. Currently, MDPI collaborates with over 65 renowned international databases, consistently enhancing our database affiliations annually.

MDPI’s journals are indexed in all major global databases.

Furthermore, we collaborate with universities and government organizations to list our journals in country-specific ranking lists and relevant institutional repositories. This ensures compliance with requirements often set by funders or institutions for authors to publish in specific journals.

Web of Science Adds 24 MDPI Journals to Emerging Sources Citation Index (ESCI)

Clarivate recently analysed MDPI’s new journals, resulting in 24 journals, mainly established in 2020, being added to the ESCI in November and December 2023. Additionally, five journals passed this assessment earlier in the year. For a complete list of our journals in Web of Science, refer here. Journals in the ESCI meet 24 quality criteria, ensuring editorial rigor. They may be considered for inclusion in broader indices like the Science Citation Index Expanded (SCIE), the Social Sciences Citation Index (SSCI), or the Arts and Humanities Citation Index (AHCI), based on four impact criteria.

Read more:

Inside MDPI

MDPI Appoints New Chief Operating Officer (COO)

Alistair Freeland returned to MDPI and assumed the role of Chief Operating Officer in November 2023, a position he previously held from 2013 to 2019. He succeeds Dr. Yu Lin, who will remain a member of MDPI’s Board of Directors, overseeing significant financial decisions for the company. I would like to express my sincere thanks to Dr. Yu Lin for his service as COO.

Alistair brings extensive experience not only in scholarly publishing but also in technology and business management. Prior to rejoining MDPI, he was associated with SIX Group, the entity responsible for Switzerland's financial market infrastructure. There, he played a pivotal role in developing the blockchain-based platform SDX (SIX Digital Exchange), which has gained traction among major Swiss banks and the Swiss National Bank.

As COO, Alistair will collaborate with the MDPI management team to improve the practices and services we offer to scholarly communities. I am pleased to welcome Alistair back to MDPI and look forward to his contributions going forward.

Coming Together for Science

MDPI’s 2024 In-Person Academic Events Schedule

MDPI's Conference Team is dedicated to organizing and hosting in-person academic events across Europe, Asia-Pacific, and North America. We recognize conferences as invaluable platforms for scientific collaboration, scholarly exchange, discussions on contemporary topics, networking, and forging collaborations.

Here's a glimpse of the notable events we currently have scheduled for 2024:

14–16 February, 2024
Viruses 2024 – A World of Viruses
Location: Barcelona, Spain
We are honoured to feature Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes as keynote speakers for this 5th edition.
Event details

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities 
Location: Barcelona, Spain
Esteemed speakers include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.
Event details

28–31 May, 2024
Polymers 2024 – Polymers for a Safe and Sustainable Future
Location:
Athens, Greece
We look forward to welcoming renowned experts like Prof. Damià Barceló, Prof. Minna Hakkareinen, and Prof. Armando J. D. Silvestre to this event.
Event details

1–4 August, 2024
The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science
Location: Singapore
The AI Sensors 2024 Conference will unite innovators and experts in the realms of sensors, sensing technology, and artificial intelligence.
Event details

Upcoming events with details to be announced:

  • September 2024, Materials 2024 – Basel, Switzerland
  • 1921 September 2024, International Conference on Nanomaterials Sciences 2024 – Beijing, China
  • October 2024, ncRNA 2024 – Basel, Switzerland
  • November 2024, Pharmaceuticals 2024 – Barcelona, Spain
  • 2226 November 2024, International Conference on Science of Electronics – Wuhan, China
  • Stay tuned for more details on the Sustainable Publishing Forum 2024.

Click here for all upcoming MDPI events.

Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Reflecting on 2023 and Looking Ahead to 2024

As we approach 2024, I reflect on the incredible journey we’ve had together at MDPI this year. The past 12 months have been marked by ambitious projects and initiatives to improve our internal processes, and a commitment to continue delivering top-notch services to our stakeholders. I’d like to thank each and every one of our staff members for contributing to the positive experiences our stakeholders have reported in our surveys. Your dedication to speed, efficiency, and effective communication with our stakeholders is very much recognized and appreciated.

Becoming a stronger organisation

While we have encountered challenges in 2023, it’s important to understand that these are a part of our growth process. Difficulties provide us with opportunities to reflect, address problems at their roots, and ultimately evolve into a stronger organization. Our stakeholders expect us to overcome tough times, and it’s an expectation that we have for ourselves.

I extend my sincere appreciation to every MDPI employee, from our editorial office and IT department to marketing, indexing, IOAP, societies, Scientific Office board, products, production, conferences, finance, operations, admin, and beyond. To our newest team members, a warm welcome; to our longstanding colleagues, your dedication is invaluable.

“I am committed to taking MDPI to a new level of excellence.”

Interacting with many of you during my visits to our offices and representing MDPI at external events has been a personal highlight. I am deeply grateful to Dr. Lin for entrusting me with the role of CEO of MDPI. Looking forward, I am committed to working closely with our management team to lead MDPI and take it to a new level of excellence, aiming to establish it as the most trusted publisher in open access worldwide. This is a collective endeavour, with each of us shaping MDPI’s reputation. I therefore encourage us to take pride in our work, as it represents not only our craft but also MDPI as a whole.

Accountability and communication

As we look forward to 2024, there’s a lot to be excited about. Together, we’ll navigate challenges, seize growth opportunities, and refine our practices. To solidify MDPI’s position as the premier open access publisher globally, we must bolster accountability, improve stakeholder communication, share MDPI’s best practices, champion the open access philosophy, and educate stakeholders about our mission, methodologies, and motivations.

Thank you for engaging with the CEO Letter over the past six months of 2023. I will continue to release this newsletter as a method of sharing the great work being done at MDPI. Please feel free to connect directly with any insights or questions.

Here’s to a joyous and prosperous 2024!

Stefan Tochev
Chief Executive Officer
MDPI AG

30 November 2023
MDPI Insights: The CEO’s Letter #6 - MDPI Spain Summit and ResearchGate

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI Spain Summit


Stefan Tochev (CEO, MDPI) gives the opening speech at the MDPI Spain Summit.

On Friday 10 November 2023 I was in Barcelona, Spain, to deliver the opening presentation and participate in a panel at MDPI’s Spain Summit, a two-day event, inspired by our salon events in China.

With 16 Editors-in-Chief (EiCs) and 20 Editorial Board Members (EBMs) in attendance, the event, organized by our conference team and Barcelona office, featured presentations on open access (OA), MDPI, and publishing market trends in Spain.

The event provided a great opportunity to engage with stakeholders from various MDPI journals, including Nutrients, Vaccines, Buildings, IJMS, and others. We were able to gather feedback and have open conversations around manuscript quality, the peer-review process, and journal development, as well as accreditation agencies.

The main objective of this Summit was to bring together Editors representing MDPI journals across various disciplines within Spanish universities and research centers, primarily from the Barcelona area. The aim was to facilitate an open and fruitful discussion regarding the development of their journals, the future of OA in Spain, and to provide meaningful interactions and networking opportunities.

Connecting with Editorial Board Members


Stefan Tochev in conversation with Summit participants: "Our EBMs are passionate about the journals they serve."

Interacting with our EBMs in person provides a valuable opportunity to show how important it is to us to connect with them, hear their perspectives on their journals and learn more about their own experience collaborating with MDPI.

From my conversations, it was clear that our EBMs are passionate about the journals they serve. I know the advice they provide may sometimes involve just small tweaks, but these can lead to important improvements. As the saying goes, small hinges swing open big doors.

As at November 2023, MDPI has over 6,300 EBMs affiliated with Spanish institutions, with more than 30 of them serving as EiCs or section EiCs. Furthermore, over 68,000 Spanish scholars have contributed as reviewers in MDPI journals.

Open Access in Spain

In 2023, Spain implemented legislation mandating immediate OA for all publicly funded research, aligning with the EU’s Plan S initiative to expedite the transition to OA. The Spanish government also approved a four-year, €23.8 million annual budget for the first national OA strategy, aiming to make publicly funded research freely accessible upon publication. This strategy aims to strengthen the quality and transparency of research in Spain, and to help promote movement towards a digital, low-carbon economy.

For further details of Spain's OA policy and the history of government mandates, click here.

Spain has already seen a notable decline in subscription-only articles, decreasing by 62% over a 10-year period, while gold OA increased by 42%. Green OA slightly decreased, suggesting a shift towards publishing in gold OA journals rather than traditional subscription-based ones. Here are some statistics from Scopus. 

A big thank-you to the various MDPI teams, including our conference team and the Barcelona office, for organizing this very successful event!


MDPI colleagues from various offices gathered to host and support the first MDPI Spain Summit, in Barcelona, Spain.

I think this type of gathering has the potential to become an annual event in various locations. For example, Manchester could be an option, as we have over 30 EiCs and over 3,000 EBMs in the UK, a top market for MDPI that publishes high-quality research.

Impactful Research

769 Editorial Board Members of MDPI Journals Recognized as Highly Cited Researchers in 2023

Congratulations to our 769 Editorial Board Members from 40 countries/territories who have been awarded Highly Cited Researcher status for 2023 by Clarivate. This recognition is based on their outstanding scientific research contributions and significant influence in various fields, as evidenced by Web of Science data.

Click here to view the full list of 769 Editorial Board Members.

Clarivate's Highly Cited ResearchersTM list identifies individuals with exceptional impact in scientific and social science domains over the past decade. Their papers rank in the top 1% of citations in 21 fields analysed in ‘Essential Science Indicators,’ showcasing their substantial influence.

This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.

These researchers demonstrate exceptional influence, representing a small fraction of contributors pushing the boundaries of knowledge, contributing to global well-being, sustainability, and security.

Congratulations to these scholars for their remarkable achievement: we are honoured to have them on board with our journals!

Inside MDPI

Corporate Marketing and Communications Strategy Session


Members of MDPI’s Corporate Marketing & Communications team.

For the past few years, I have led the Corporate Marketing & Communications department in our annual strategy session.

This typically involves 2–3 days of focused sessions covering key topics including budgeting, hiring targets, campaign reviews, and planning for the upcoming year, department strategy, and structure.

We are constantly exploring ways to optimize the Corporate Marketing & Communications department to support MDPI’s primary objectives and better convey the MDPI story while serving the scholarly community.

The strategy session also serves as a team-building activity, during which the team voted on bowling!

Strategy Session

In this strategy session, we looked at how to align our teams in order to better streamline our content with our campaigns, build a dedicated marketing team to strategically support our core MDPI products, expand our communications teams and functionalities to focus on company-critical campaigns and press releases, align our new brand design system with our marketing initiatives, set up a community and engagement team to support various teams with their outreach and communication efforts, and increase our use of data in the evaluation of campaign performance.

To grow in these areas, we will be hiring for various positions, including those of Public Relations Manager, Communications Manager, Internal Communications Manager, Campaign Manager, Marketing Associate, and Editorial Engagement Manager.

I am grateful for the way our Corporate Marketing & Communications department has grown and gelled over the years, and I look forward to supporting the department teams and their ideas for the future.

Coming Together for Science

ResearchGate and MDPI Partner to Boost the Visibility of Open Access Content through Journal Home


Stefan Tochev (CEO, MDPI) and Sören Hofmayer (Co-Founder and Chief Strategy Officer, ResearchGate) meet in Berlin, Germany to take their ongoing discussion further.

When I assumed the role of CEO at MDPI, my primary focus was to initiate the building of essential partnerships and collaborations within our industry. After all, I am a firm believer in achieving our goals by helping others achieve theirs and focusing on co-opetition wherever there is an opportunity. I first touched on the notion of co-opetition in MDPI Insights: The CEO's Letter #3, particularly when discussing collaborations with Elsevier.

In light of this, Sören Hofmayer (Co-Founder and Chief Strategy Officer at ResearchGate) and I connected recently to continue a discussion that had been ongoing for months. I was quickly brought up to speed and felt there was an opportunity for MDPI journals to pilot the Journal Home service that ResearchGate had launched. This would provide a new way for MDPI to engage with authors and readers and amplify the visibility of our journals.

While I receive many offers and opportunities for discussions with vendors, I am a firm believer that timing is everything, and in this case, the time for us is now. Sören and I met in person during my recent visit to Berlin and decided to proceed with piloting ten MDPI journals with the Journal Home service.

The press release below provides further details.

Press Release: Berlin (Germany) and Basel (Switzerland), 15 November 2023

ResearchGate, the professional network for researchers, and MDPI, the largest open access publisher in the world and a pioneer in open access publishing, today announced a partnership that will see ten of MDPI’s open access journals benefit from an enhanced presence on ResearchGate through its innovative Journal Home offering.  

This new partnership will expand the reach and visibility of MDPI’s participating flagship journals with ResearchGate’s highly relevant community of more than 25 million researchers globally.

Around 210,000 version-of-record articles from these 10 titles will be readily available on ResearchGate, including the full archive material and all new articles as they are published. These journals also benefit from enhanced brand visibility, with dedicated journal profiles, prominent representation on all associated article pages and all relevant touchpoints across the ResearchGate network – keeping the journals top-of-mind with their reader and author audiences. All articles covered by the new partnership will automatically be added to the authors’ publication records in ResearchGate. This not only reduces MDPI authors’ needs for direct management but also offers them valuable insights into the impact of their work, including data about readership and citations.

Closing Thoughts

November is Men’s Health Awareness Month


Stefan Tochev (CEO, MDPI) listening to music as he writes at a coffee shop in Basel, Switzerland.

November is dedicated to raising awareness of various men’s health issues. I have been fortunate to have positive male role models in my life, and I strive to share my experiences with others.

I used to take part in Movember, growing my moustache throughout November to raise awareness and funds and to help “change the face of men’s health.” With male family and friends impacted by physical and mental health issues, I have recently become more interested in men’s overall well-being.

Men often face stigma involving the perceived need always to be strong and have things figured out. Recently, I’ve had meaningful conversations with male friends and colleagues about issues we rarely discuss, and it was a positive experience.

Various factors impact men’s health and well-being, all too easily leading to risky health behaviours including a lack of health awareness, poor health education, and negative, culturally induced, behaviour patterns in our work and personal lives. I hope we can break down these barriers in our work environment.

Healthy men help build healthy families and a healthy society

Men are less likely than women to seek help with their physical and mental health struggles. This is a reminder to prioritize your overall well-being. I hope that as men, we will continue to open up to one another, becoming vulnerable in order to share what we are going through. By sharing and by supporting each other, we can learn and grow together. You are not alone, and when you fall, you can still get up and stand tall.

From one broski to another, you are loved and appreciated. I hope this mindset carries into December and beyond.

Mindfulness

Our content team recently released a handful of articles on mindfulness, a practice that I believe provides a good opportunity for stress release and self-reflection:

Stefan Tochev
Chief Executive Officer
MDPI AG

21 November 2023
769 Editorial Board Members of MDPI Journals Achieve Highly Cited Researcher Recognition in 2023


We extend our sincere congratulations to the 769 Editorial Board Members of our journals – from 40 different countries/territories – who have been recognized as Highly Cited Researchers for the year 2023 by Clarivate. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields, as indicated by Web of Science data.

Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade who stand out for their significant and broad influence in various scientific and social science domains. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 21 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.

This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.

This means that these researchers have demonstrated an incredible level of significant and broad influence in their chosen field or fields over the last decade. They represent a small fraction of the researcher population whose contributions disproportionately push the boundaries of knowledge, enhancing global well-being, sustainability, and security.

Congratulations to the scholars for their noteworthy achievement – we are honored to have them on board with our journals!


Abate, Antonio
Aguilera, Ruth V.
Ahmed, Warish
Ahn, Myung-Ju
An, Qiaoshi
Anasori, Babak
Andersson, Dan I.
Angeletti, Silvia
Annabi, Nasim
Antinori, Spinello
Ariga, Katsuhiko
Asa, Sylvia L.
Astruc, Didier
Atala, Anthony
Atanasov, Atanas G.
Balsamo, Gianpaolo
Bandodkar, Amay J.
Banks, William A.
Bao, Yan-Ping
Barba, Francisco J.
Barnes, Peter J.
Barnholtz-Sloan, Jill S.
Barrow, Colin J.
Bashir, Ali Kashif
Basit, Abdul W.
Bassetti, Matteo
Batley, Jacqueline
Battino, Maurizio
Behnood, Ali
Benediktsson, Jon Atli
Biondi, Antonio
Bjarnsholt, Thomas
Blaschke, Thomas
Blay, Jean-Yves
Blumwald, Eduardo
Blunt, John W.
Boczkaj, Grzegorz
Bogers, Marcel
Bonomo, Robert A.
Boyd, Robert W.
Boyer, Cyrille
Braeckmans, Kevin
Bragazzi, Nicola Luigi
Bu, Wenbo
Bursać Kovačević, Danijela
Bush, Ashley I.
Byrd, John C.
Cabeza, Luisa F.
Cai, Xingjuan
Cambria, Erik
Cao, Guozhong
Cao, Xingzhong
Capasso, Raffaele
Carvalho, Andre F.
Casper, Jonathan
Castellanos-Gomez, Andres
Cavalli, Giacomo
Chai, Siang-Piao
Chan, Jasper Fuk-Woo
Chan, Timothy A.
Chang, Chih-Hao
Chang, Guoqing
Chao, Dongliang
Chen, Bo
Chen, Chaoji
Chen, Fahu
Chen, Gang
Chen, Jianmin
Chen, Jun
Chen, Jun
Chen, Jun
Chen, Lidong
Chen, Lingxin
Chen, Min
Chen, Mou
Chen, Peng
Chen, Qian
Chen, Qianwang
Chen, Shaowei
Chen, Shuangming
Chen, Wei
Chen, Xiaobo
Chen, Yimin
Chen, Yu
Chen, Yulin
Chen, Zhong
Chen, Zonghai
Cheng, Gong
Cheng, Huanyu
Cheng, Laifei
Cheng, Qiang
Chew, Kit Wayne
Chiclana, Francisco
Choi, Wonyong
Choi, Young Hae
Chowdhary, Anuradha
Cichocki, Andrzej
Clevers, Hans
Coops, Nicholas C.
Cortes, Javier
Cortes, Jorge
Costanza, Robert
Creutzig, Felix
Crommie, Michael F.
Cuadrado, Antonio
Cui, Haiying
Cui, Yi
Curigliano, Giuseppe
Dai, Sheng
Dai, Shifeng
Daiber, Andreas
Davies, Michael J.
Davis, Thomas P.
Dawson, Ted M.
de la Fuente-Nunez, Cesar
Delord, Jean-Pierre
Demaria, Marco
Deng, Xiangzheng
Desneux, Nicolas
Dikic, Ivan
Dimopoulos, Meletios-Athanasios
Ding, Aijun
Ding, Jianxun
Dokmeci, Mehmet Remzi
Dolgui, Alexandre
Dong, Chung-Li
Dou, Shi Xue
Dragicevic, Tomislav
Du, Bo
Du, Qian
Du, Yonghua
Duan, Xidong
Dufresne, Alain
Dummer, Reinhard
Edwards, David
Elaissari, Abdelhamid
ElMasry, Gamal
Enjuanes, Luis
Fabbro, Doriano
Facchetti, Antonio
Fan, Junliang
Fan, Kelong
Fan, Xiulin
Fan, Zhanxi
Fang, Baizeng
Fang, Chuanglin
Fang, Yongjin
Fasano, Alessio
Feng, Liangzhu
Feng, Xuning
Fensholt, Rasmus
Ferdinandy, Péter
Fernandez-Lafuente, Roberto
Filippi, Massimo
Flavian, Carlos
Fortino, Giancarlo
Fowler, Michael
Franceschi, Claudio
Frattini, Federico
Friston, Karl J.
Fu, Gengtao
Gai, Francesco
Gaisford, Simon
Galanakis, Charis M.
Galluzzi, Lorenzo
Galvano, Fabio
Gan, Ren-You
Gao, Feng
Gao, Huijun
Gao, Huile
Gao, Peng
Gao, Wei
Garbe, Claus
Garg, Abhishek D.
Gasbarrini, Antonio
Gastaldelli, Amalia
Gautier, Emmanuel L.
Genevet, Patrice
Geng, Yong
Gerdts, Gunnar
Geschwind, Daniel H.
Ghaffari, Roozbeh
Ghamisi, Pedram
Giacobbe, Daniele Roberto
Giampieri, Francesca
Gillies, Robert J.
Godos, Justyna
Gogotsi, Yury
Golding, Nick
Gong, Jinlong
Gong, Peng
Gong, Yongji
Govindan, Kannan
Gozal, David
Grancini, Giulia
Grant, William B.
Graus, Francesc
Green, Douglas R.
Grosso, Giuseppe
Gu, Meng
Gu, Zhanjun
Guan, Cao
Gueimonde, Miguel
Gui, Guan
Guigo, Roderic
Guo, Hengyu
Guo, Jianping
Guo, Lin
Guo, Song
Guo, Yan
Guo, Zaiping
Gupta, Rangan
Gutzmer, Ralf
Haase, Dagmar
Hagger, Martin S.
Hall, C. Michael
Han, Fudong
Han, Heesup
Hanes, Justin
Hartung, Hans-Peter
He, Bao-Jie  
He, Debiao
He, Hongwen
He, Jiaqing
He, Jie
He, Jr-Hau
He, Qiong
He, Xiangming
He, Xijun
He, Zhili
Heneka, Michael T.
Herrera, Francisco
Herrera-Estrella, Luis
Herrera-Viedma, Enrique
Hetz, Claudio
Holick, Michael F.
Hong, Danfeng
Hong, Xuechuan
Hsueh, Po-Ren
Hu, Bin
Hu, Enyuan
Hu, Jin-Song
Hu, Weida
Hu, Wenbin
Hu, Xiaosong
Huang, Baibiao
Huang, Hongwei
Huang, Jianliang
Huang, Jianping
Huang, Peng
Huang, Xin
Hubacek, Klaus
Hussain, Saddam
Italiano, Antoine
Iwata, Hiroji
Jaeschke, Hartmut
Jain, Atul

Jaiswal, Amit K.
Jankovic, Joseph
Janssens, Ivan A.
Jelezko, Fedor
Jeon, Byong-Hun
Ji, Guangbin
Ji, Qiang
Ji, Wei
Ji, Xiaobo
Ji, Xiaoyuan
Jiang, Bin
Jiang, Hong
Jiang, Junjun
Jiang, Lianzhou
Jiang, Qing
Jiang, Shibo
Jiang, Yuyan
Jiang, Zhongyi
Jiao, Licheng
Jin, Shi
Jin, Zhong
Kalantar-zadeh, Kourosh
Kamal, Mohammad Amjad
Kaner, Richard B.
Kaneti, Yusuf Valentino
Kang, Zhenhui
Karagiannidis, George K.
Karniadakis, George Em
Karp, Peter D.
Kataoka, Kazunori
Katritch, Vsevolod
Kawi, Sibudjing
Kepp, Oliver
Khademhosseini, Ali
Khan, Nafees A.
Kiessling, Fabian
Kildishev, Alexander V.
Kim, Haegyeom
Kim, Jeonghun
Kim, Jin-Hoi
Kim, Jong Seung
Kim, Ki-Hyun
Kirkwood, John M.
Kivshar, Yuri
Klenk, Hans-Peter
Ko, Wen-Chien
Kong, Baohua
Kontoyiannis, Dimitrios P.
Koonin, Eugene V.
Kroemer, Guido
Kuang, Dai-Bin
Kudo, Masatoshi
Kuhn, Jens H.
Kumar, Prashant
Kumar, Sudhir
Kurths, Juergen
Kurzrock, Razelle
Kuzyakov, Yakov
Kyrpides, Nikos C.
La Vecchia, Carlo
Lai, Yuekun
Lan, Ke
Lancellotti, Patrizio
Landi, Francesco
Lavie, Carl J.
Laxminarayan, Ramanan
Lee, Chengkuo
Lee, Jechan
Lee, Jin-Wook
Lee, Pooi See
Lee, Sang Soo
Lehmann, Johannes
Lei, Yaguo
Li, Bin
Li, Chunzhong
Li, Dongsheng
Li, Feng
Li, Hai
Li, Heng
Li, Hongyi
Li, Hui
Li, Jinghong
Li, Jun
Li, Li
Li, Linlin
Li, Neng
Li, Ning
Li, Shuai
Li, Shutao
Li, Wei
Li, Wentao
Li, Xiang
Li, Xuecao
Li, Xuelong
Li, Yat
Li, Yurui
Li, Zhijun
Liang, Chao
Liang, Shuquan
Liaw, Peter K.
Lin, Jun
Lin, Yuehe
Lippi, Giuseppe
Lister, Ryan
Liu, Chengmei
Liu, Gang
Liu, Hong
Liu, Hui
Liu, Jian
Liu, Jinyan
Liu, Jun
Liu, Meilin
Liu, Pan
Liu, Wei
Liu, Xianhu
Liu, Xiaoping
Liu, Xuejun
Liu, Yang
Liu, Yu
Liu, Yuan
Lonardo, Amedeo
Long, Hualou
Long, Ying
Lu, Bingan
Lu, Junling
Lu, Lu
Lu, Nanshu
Lu, Rongxing
Lucey, Brian
Lucieer, Arko
Lugato, Emanuele
Lund, Henrik
Luo, Yangchao
Luo, Yi
Luo, Zisheng
Lv, Wei
Lyons, Timothy W.
Ma, Haile
Ma, Jianmin
Ma, Jun
Ma, Tianyi
Ma, Wei
Ma, Yanming
Madabhushi, Anant
Mahmoudi, Morteza
Mai, Liqiang
Mai, Wenjie
Makridakis, Spyros
Mandala, Mario
Mantovani, Alberto
Mao, Jianfeng
Mao, Like
Mardani, Abbas
Mathivanan, Suresh
Matyjaszewski, Krzysztof
McCabe, Matthew F.
McCauley, Darren
McClements, David Julian
Mei, Lin
Melenhorst, Jan Joseph
Melero, Ignacio
Meyerholz, David K.
Van Mierlo, Joeri
Miroshnichenko, Andrey E.
Mittler, Ron
Mu, Shichun
Mubarak, Mohammad S.
Mueller, Lukas A.
Muhammad, Khan
Mumtaz, Shahid
Munekata, Paulo Eduardo Sichetti
Nakagawa, Shinichi
Nauen, Ralf
Newman, David J.
Niaura, Raymond S.
Nidheesh, P. V.
Niu, Ben
Nussinov, Ruth
O'Connor, David
Odintsov, Sergei D.
Omri, Anis
Orsini, Nicola
Ostrikov, Kostya (Ken)
Oswald, Isabelle P.
Oudard, Stephane
Ouyang, Minggao
Ozcan, Aydogan
Pan, Anlian
Pan, Anqiang
Pan, Caofeng
Pan, Genxing
Pan, Likun
Pan, Quan-Ke
Pan, Xiaoqing
Pandolfi, Pier Paolo
Parati, Gianfranco
Pateiro, Mirian
Peng, Qiang
Peng, Qing
Peng, Shushi
Perc, Matjaz
Perlin, David S.
Perlman, Stanley
Petruzzelli, Antonio Messeni
Pitt, Bertram
Pöhlmann, Stefan
Polasky, Stephen
Pommier, Yves
Poor, H. Vincent
Potenza, Marc N.
Preat, Veronique
Prinsep, Michele R.
Pu, Kanyi
Putnik, Predrag
Qin, Yuanwei
Qiu, Jieshan
Qu, Xiaogang
Ragauskas, Arthur J.
Ramakrishna, Seeram
Ramkissoon, Haywantee
Ran, Jingrun
Rao, Zhonghao
Recio, Isidra
Ren, Jinsong
Rengel, Zed
Rho, Junsuk
Riahi, Keywan
Ribeiro-Soriano, Domingo
Richardson, Paul G.
Robert, Caroline
Rocca, Maria A.
Rodriguez-Manas, Leocadio
Rojas, Orlando J.
Rojo, Teofilo
Roubaud, David
Saad, Fred
Saad, Walid
Sadorsky, Perry
Saliba, Michael
Sander, Chris
Sangaiah, Arun Kumar
Santamouris, Mattheos
Santoro, Gabriele
Scaldaferri, Franco
Schatzberg, Alan F.
Schwab, Matthias
Schweizer, Frank
Scolyer, Richard A.
Scott, Daniel
Serruys, Patrick W.
Setzer, William N.
Shahzad, Babar
Shao, Shuai
Shao, Zongping
Shen, Guozhen
Shen, Liyin

Shen, Zexiang
Shi, Peng
Shi, Yi
Siano, Pierluigi
Simões, Manuel
Sing, Swee Leong
Singh, Vijay P.
Smagghe, Guy
Smith, Lee
Soffietti, Riccardo
Song, Houbing
Song, Jibin
Song, Yu
Sood, Anil K.
Souto, Eliana B.
Stadler, Marc
Stanley, H. Eugene
Stephanopoulos, Gregory
Sternberg, Cora N.
Stoumpos, Constantinos C.
Stunnenberg, Hendrik G.
Su, Shiliang
Sun, Baoguo
Sun, Cuixia
Sun, Fengchun
Sun, Hongqi
Sun, Jie
Sun, Lijun
Sun, Litao
Sun, Runcang
Sun, Yanjuan
Sun, Zaicheng
Sun, Zhipei
Sureda, Antoni
Svenning, Jens-Christian
Tan, Chaoliang
Tan, Weihong
Tang, Chuan-He
Tang, Chuyang
Tang, Dianping
Tang, Yongbing
Tanzi, Rudolph E.
Terpos, Evangelos
Teschendorff, Andrew E.
Tian, He
Timsit, Jean-Francois
Tiwari, Aviral Kumar
Tohge, Takayuki
Tousoulis, Dimitris
Tran, Lam-Son Phan
Tress, Wolfgang
Trivedi, Pankaj
Tsao, Rong
Tully, Mark A.
Tung, Chen-Ho
Van der Bruggen, Bart
Vandenbroucke, Roosmarijn E.
Vangronsveld, Jaco
Varsani, Arvind
Vatanen, Tommi
Verbeke, Kristin
Vermote, Eric
Verpoorte, Robert
Vieta, Eduard
Vincent, Jean-Louis
Vita, Antonio
Wan, Jiafu
Wan, Shaohua
Wanek, Wolfgang
Wang, Bin
Wang, Bo
Wang, Chao
Wang, Chuanyi
Wang, Chunsheng
Wang, Dan
Wang, Feng
Wang, Gongming
Wang, Guoxiu
Wang, Haihui
Wang, Hao
Wang, Huanqing
Wang, Huanting
Wang, Hui
Wang, Jian
Wang, Jie
Wang, Jing
Wang, John
Wang, Joseph
Wang, Lianzhou
Wang, Lihui
Wang, Meng
Wang, Peng
Wang, Pengfei
Wang, Qi
Wang, Qi
Wang, Qiang
Wang, Qilin
Wang, Qin
Wang, Qing
Wang, Shaojian
Wang, Sibo
Wang, Tao
Wang, Ying
Wang, Yong
Wang, Zhen
Wang, Zhong Lin
Wang, Zhongrui
Wang, Zifa
Wang, Zuankai
Wei, Haotong
Wei, Leyi
Wei, Zhixiang
Wei, Zhongbao
Weissleder, Ralph
Weitschies, Werner
Wen, Guanghui
Wesemael, Bas van
Willerslev, Eske
Witlox, Frank
Wu, Haijun
Wu, Hao Bin
Wu, Hui
Wu, Jun
Wu, Qinglin
Wu, Shuilin
Wu, Xiaojun
Wu, Yongzhen
Wu, Yuping
Wu, Zheng-Guang
Wu, Zhong-Shuai
Xia, Jianguo (Jeff)
Xia, Meimei
Xia, Xinhui
Xia, Yongyao
Xia, Zhiguo
Xiang, Quanjun
Xiao, Fuyuan
Xiao, Jie
Xin, Sen
Xing, Baoshan
Xing, Wei
Xiong, Rui
Xu, Hui
Xu, Li Da
Xu, Ping
Xu, Yi-Jun
Xu, Zhenjiang Zech
Yan, Chong
Yan, He
Yan, Huaicheng
Yan, Kai
Yan, Ruqiang
Yang, Bing
Yang, Chenguang
Yang, Hongshun
Yang, Hui
Yang, Jian
Yang, Jianping
Yang, Jie
Yang, Jun
Yang, Kai
Yang, Shihe
Yang, Xiaofeng
Yang, Xinsong
Yang, Yun-Gui
Yao, Yonggang
Yigitcanlar, Tan
Yin, Shen
Yin, Shou-Wei
Yin, Yulong
Yin, Zongyou
Yokoya, Naoto
Young, Allan H.
Yu, Guihua
Yu, Jun
Yu, Le
Yu, Minghao
Yu, Shu-Hong
Yu, Wei
Yu, Wenwu
Yuan, Qiangqiang
Yuan, Yifei
Yuan, Yuan
Yuen, Chau
Zeadally, Sherali
Zhai, Tianyou
Zhang, Bing
Zhang, Dengsong
Zhang, Fan
Zhang, Fusuo
Zhang, Guangyu
Zhang, Guowen
Zhang, Hengjie
Zhang, Hongjie
Zhang, Hui
Zhang, Lai-Chang
Zhang, Lefei
Zhang, Lei
Zhang, Liangpei
Zhang, Lijun
Zhang, Min
Zhang, Peng
Zhang, Qiang
Zhang, Qiaobao
Zhang, Qichun
Zhang, Shicheng
Zhang, Shujun
Zhang, Tierui
Zhang, Wei
Zhang, Weili
Zhang, Xian-Ming
Zhang, Xiaodong
Zhang, Xiaogang
Zhang, Xiaoling
Zhang, Yang
Zhang, Yaobin
Zhang, Yi
Zhang, Yi-Zhou
Zhang, Yong
Zhang, Yu Shrike
Zhang, Yue-Jun
Zhang, Yuelin
Zhang, Zheng
Zhang, Zhicheng
Zhang, Zhien
Zhao, Guochun
Zhao, Jie
Zhao, Li-Dong
Zhao, Qing
Zhao, Yi
Zheng, Hao
Zheng, Weitao
Zheng, Yufeng
Zhong, Cheng
Zhou, Jie
Zhou, Jizhong
Zhou, Kun
Zhou, Liang
Zhou, Peng
Zhou, Qi
Zhou, Wei
Zhou, Weiqi
Zhu, Chengzhou
Zhu, Hongwei
Zhu, Junfa
Zhu, Jun-Jie
Zhu, Lei
Zhu, Mingshan
Zhu, Quanxin
Zhu, Yi
Zhu, Yongfa
Zhu, Zhe
Zhuang, Xiaodong
Zou, Quan
Zou, Ruqiang
Zuo, Chao

1 November 2023
MDPI Insights: The CEO’s Letter #5 - OA Week, UK, and Strategy

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Open Access Week 2023 – the Global Drive to Open Continues

As the world's largest open-access (OA) publisher, we believe that unrestricted access to research findings is the cornerstone of transparency, efficiency, and quality control across scientific disciplines. At MDPI, we provide free, immediate access to scientific papers, empowering scientists to examine, validate, replicate, and build upon existing results. This minimizes redundancy, optimizes resources, and fosters innovative approaches.

International OA Week, held from 23 to 29 October 2023, provided a unique opportunity to link the global movement toward open sharing and open science with the progress of policy changes at the local level. Our mission, during OA Week and all the year round, is to offer educational resources highlighting the benefits of open-access publishing. The MDPI Blog is a valuable resource for information on open access and open science.

Core principles of OA publishing

Accessibility, transparency, and collaboration are core principles of OA publishing. OA aims to break down barriers that have traditionally restricted research access, ensuring that knowledge is available to all, regardless of financial situation or institutional affiliations. Our commitment to diverse pathways for OA publishing worldwide includes discounts for researchers. You can learn more about how MDPI supports scientific communities here.

One of the key strengths of OA publishing is its ability to facilitate interdisciplinary research. By removing paywalls and promoting knowledge-sharing across disciplines, OA encourages collaboration and innovation. Researchers from various fields can access and build upon each others’ work, fostering a holistic approach to addressing complex global challenges.

OA holds the potential to democratize knowledge, advance science, and drive positive societal change.

Policy driving change

Governments, institutions, and funding agencies have recognized the transformative potential of OA and have implemented policies to promote it. These policies often require publicly funded research to be made openly accessible, accelerating the growth of OA repositories and journals. Check out our spotlights on OA policies in the USEU and China

OA publishing is continuously evolving, with community-driven models and technologies shaping its future. Initiatives such as “Plan S” and “cOAlition S” promote OA publishing from the perspective of national funders, requiring grantees to publish their research openly. A new policy announced by the US administration last year mandates that, with effect from January 2026, all US federally funded research should be freely and immediately available after publication.

Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing.

For more than two decades, OA publishing has been revolutionizing academic publishing by promoting accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As OA continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change.

MDPI is proud to lead the transition to open access.

Read more:

Impactful Research

Spotlight on Smart Cities

Smart cities will serve as a cornerstone for future human development. Their implementation will help us tackle many of the significant challenges we are facing – climate change, ageing populations, waste management, public safety, travel, and so on. Recognising the importance of this multifaceted field, MDPI launched the inaugural issue of Smart Cities in 2018 to provide an advanced forum for research into smart technology and society. Here we take a look at how this journal has developed, and its impact in this exciting field.

As at 30 October, 2023, Smart Cities has published 421 papers and has an Impact Factor of 6.4. It also has a CiteScore of 8.5, and more than one quarter of its published papers – 124 – have been cited 10 times or more.

Highly cited papers in Smart Cities

Below are several highly cited papers recently published in Smart Cities. Citation metrics are current as at 31 October 2023.

1. “Introducing the “15-Minute City”: Sustainability, Resilience and Place Identity in Future Post-Pandemic Cities
Authors: Carlos Moreno, Zaheer Allam, Didier Chabaud, Catherine Gall and Florent Pratlong
Smart Cities 2021, 4(1), 93-111; https://doi.org/10.3390/smartcities4010006
Citations: Crossref (338), Scopus (366), Web of Science (270), Google Scholar (710)
The paper discusses the socio-economic impacts of the COVID-19 on cities, including increasing inequalities and rising unemployment. It introduces the concept of the "15-Minute City," a form of "chrono-urbanism," as a response to the challenges posed by the pandemic.

2. “A Review on Electric Vehicles: Technologies and Challenges
Authors: Julio A. Sanguesa, Vicente Torres-Sanz, Piedad Garrido, Francisco J. Martinez and Johann M. Marquez-Barja
Smart Cities 2021, 4(1), 372-404; https://doi.org/10.3390/smartcities4010022
Citations: Crossref (359), Scopus (363), Web of Science (268), Google Scholar (558)
This paper provides an overview of the progress in Electric Vehicles (EVs), focusing on battery technology, charging methods, and emerging research challenges. It also analyzes the global EV market and its future outlook.

3. “IoT in Smart Cities: A Survey of Technologies, Practices and Challenges
Authors: Abbas Shah Syed, Daniel Sierra-Sosa, Anup Kumar and Adel Elmaghraby
Smart Cities 2021, 4(2), 429-475; https://doi.org/10.3390/smartcities4020024
Citations: Crossref (121), Scopus (151), Web of Science (91), Google Scholar (215)
This paper gives an overview of the Internet of Things (IoT) in the context of Smart Cities, discussing the fundamental components, technologies, architectures, networking technologies, and artificial algorithms that underpin IoT-based Smart City systems.

4. “Artificial Intelligence Techniques in Smart Grid: A Survey
Authors: Olufemi A. Omitaomu and Haoran Niu
Smart Cities 2021, 4(2), 548-568; https://doi.org/10.3390/smartcities4020029
Citations: Crossref (76), Scopus (94), Web of Science (57), Google Scholar (120)
This survey paper reviews the utilization of artificial intelligence (AI) techniques in the context of the smart grid. It covers various applications of AI in load forecasting, power grid stability assessment, fault detection, and security issues in the smart grid and power systems.

5. “The Metaverse as a Virtual Form of Smart Cities: Opportunities and Challenges for Environmental, Economic, and Social Sustainability in Urban Futures
Authors: Zaheer Allam, Ayyoob Sharifi, Simon Elias Bibri, David Sydney Jones and John Krogstie
Smart Cities 2022, 5(3), 771-801; https://doi.org/10.3390/smartcities5030040
Citations: Crossref (72), Scopus (75), Web of Science (43), Google Scholar (176)
This paper discusses the concept of the Metaverse, a virtual world introduced by Meta (formerly Facebook), and its potential impact on urban life. It explores how emerging technologies such as AI, Big Data, IoT, and Digital Twins could reshape urban design and services in the context of the Metaverse.

Testimonial

“It was indeed a great and pleasant experience with MDPI regarding our recent publication. The submission process was very straightforward and less time-consuming than the norm. The review process was very fast compared to many other open access journals, which is praiseworthy. The support from the Editorial Office during the revision process was highly useful as well. We look forward to publishing with MDPI in the future, and I will most definitely recommend MDPI to my colleagues and collaborators. – Dr. Luís Rosa, University of Minho

Article in Smart Cities: Mobile Networks and Internet of Things Infrastructures to Characterize Smart Human Mobility

Inside MDPI

MDPI Manchester office, UK Visit


Allie Shi (Editorial Director, MDPI), Stefan Tochev (CEO, MDPI), Jamie Anderson (Manchester Office Manager, MDPI), Michael O’Sullivan (Senior Scientific Officer, MDPI), Hushneara Akhtar, and Becky Castellon (IOAP Team Lead, MDPI), dining out in Manchester, UK.

In October, I visited MDPI’s new office in Manchester. During the visit, I connected with our English Editing (EE) managers, Scientific Officer, members of the Editorial team, the Marketing team, and IOAP Team Lead.

Our Manchester office focuses primarily on EE services and provides local support for the UK market. Additionally, we regularly visit Editorial Board members and participate in local conferences.

I would like to thank Jamie Anderson, Manchester Office Manager, and her team, for their deep commitment to our Manchester staff and to MDPI’s impact on the UK market.

The UK by numbers

The UK is a hub for the world’s top universities, making it a key market for MDPI and the publishing world in general. It is home to two of the top-five-ranked universities globally, 11 in the top 100, and 15 in the top 200.

As a result, the UK plays a key role in MDPI’s global market. As at October 2023, it ranks as the seventh-largest contributor to the total number of papers published by MDPI. We have 3,500 Editorial Board members affiliated with UK institutions, including 34 serving as Editors-in-Chief (EiCs). Our commitment to collaboration with institutions is evident in the UK, where we have successfully established some 60 Institutional Open Access Program (IOAP) agreements with esteemed institutions, such as the University of Oxford, the University of Cambridge, Imperial College London, the University of Edinburgh, and more.

According to InCites Dataset + ESCI for the period 2018–2022, as at October 2023, nearly 65% of UK papers are now published as OA. Just over 10% of total OA publications are by UK authors. UK papers are known for their high quality, with an average of 11 citations per paper. Furthermore, 2.16% of UK papers are in the top 1% of cited papers, and 14.61% are in the top 10% of cited papers, showcasing their impact.

We are currently hiring EEs in various locations worldwide.

English Editing at MDPI

Our English Editing (EE) department consists of two main branches, Quality Control and Learning and Development, reflecting our priorities. We are continuously enhancing the quality of our English Editing services and have raised the relevant standards, which now extend to company-wide communications. English editors participate in international interviews, conduct English assessments, and provide colleagues with presentations on ways to improve their use of written and spoken English.

While expanding, the EE department has proactively refocused its efforts on the quality of our work and how the English Editing department can benefit the company more broadly. We currently have approximately 140 full-time English Editors based across five offices worldwide, supplemented by over 700 freelance English editors.

Our Manchester office serves as the hub for the EE Department, with EE Managers situated there, except for Kurtis Jackson, who serves as the Head of EE and is located in our Basel office. Manchester EEs play a critical role in establishing and developing EE teams in our other offices, overseeing management and recruitment. The EE department plays a vital role in MDPI’s operations, as it is the department that touches every published paper. If this work interests you, I encourage you to explore our available EE positions, whether you are seeking full-time or freelance opportunities.

Testimonials

“MDPI provides an excellent service compared to any other previously used services. It delivers fast and high-quality results but at an affordable price.” – Ardha Apriyanto, University of Potsdam

“In my role as a professor, I consider that MDPI Author Services offer an excellent quality in the editing of Western academic writing while maintaining the required standards of clarity, precision and rigor. Additionally, delivery times are fast compared to other available services.” – Jesus Insuasti, University of Nariño

Read more:

Coming Together for Science

STM and Frankfurt Book Fair

Attending STM

MDPI has been a proud sponsor of the STM Conference for several years. The STM Conference is a dynamic event featuring interactive sessions, expert panellists, idea-sharing, and ample networking opportunities. On 16 October, the event kicked off with arrival drinks, sponsored by MDPI, followed by a welcoming dinner, providing a great chance to connect and network with industry professionals. The following day was filled with speakers, sessions, and further opportunities to connect. STM exemplifies the collaborative spirit of the scientific community, with session topics including achieving open, visible, and impactful research at scale; maintaining research integrity in a rapidly changing world; and exploring the impact of ever-evolving technology in the scholarly community.

Meeting with Web of Science

On a personal note, one of the highlights of STM was a candid and productive conversation with Nandita Quaderi, Editor-in-Chief and SVP at Web of Science. During our discussion, we talked about MDPI, Web of Science, the IJERPH delisting, and ways of moving forward. This open conversation aimed at fostering better collaboration for the future.

“We discussed ways to improve our communication and collaboration.”

I appreciated our frank discussion and felt that Nandita wholeheartedly supports open access. She also expressed her appreciation for the monthly CEO Letter, which she sees as a way to add personality to the MDPI brand and provide insight into the great work we do at MDPI. While we highlighted the positives, we also discussed ways to improve our communication and collaboration moving forward. This meeting alone made the trip worthwhile, and I hope Nandita doesn’t mind my sharing that she found our chat to be “the most honest and constructive discussion” she’s had with someone from MDPI in recent years.

75th Frankfurt Book Fair


Jelena Milojevic (Book Editor, MDPI), Jovana Dubajic (Book Editor, MDPI), Evan Escamilla (Project Manager, MDPI), Laura Wagner (Head of Books, MDPI), and Jenny Knowles (Commissioning Editor, MDPI), at the Frankfurt Book Fair in Frankfurt am Main, Germany.

For the 75th time, the Frankfurter Buchmesse opened its doors in October to celebrate exciting stories and their authors. If you haven’t yet had the chance to visit the Frankfurt Book Fair, I highly recommend it. It’s the largest book fair in the world, attracting thousands of visitors from around the globe. This is the place to gain valuable industry insights from top-class publishing professionals, connect with publishers directly, and learn about the latest trends in publishing.

MDPI Books

Our Books team was also present at the Frankfurt Book Fair, networking and learning from various panels. Did you know that our MDPI Books department publishes OA Books?

The book publishing program includes monographs, book series, edited books and reprints of special issues and topical collections, among other book types.

If you have a book proposal you would like to discuss, please feel free to contact our Books team to understand the benefits and methods of publishing your next book with the OA model.

Closing Thoughts

MDPI Strategy Meeting

As the newly appointed CEO, this is my first year leading the MDPI Senior Management Strategy session. I saw it as an opportunity to explore what MDPI has the potential to become in the next five years. Guided by the vision of its founder and President, Dr. Shu-kun Lin, the company has accomplished remarkable feats over the past 27 years and currently holds the position as the world’s third-largest academic publisher, following Springer Nature and Elsevier.

Our primary objective is to build upon the milestones of the past decades and consolidate MDPI’s position as well-established publishing brand. The two-day meeting emphasized the importance of communicating MDPI’s values more actively via its brand and adopting a straightforward yet impactful approach to managing MDPI as a mature academic publisher.

“Our primary objective is to consolidate MDPI’s position as well-established publishing brand”

As the world’s number one open-access publisher, MDPI has long been a game-changer in the scholarly community, serving millions of authors. The challenge in being a trailblazer is the need to continuously improve and at the same time explore the next blue-ocean strategy, while also maintaining the smooth operation of the business. Our collection model, featuring guest-curated thematic topics in the form of Special Issues, has disrupted the industry. Other publishers closely study us and attempt to replicate our models. The future of this collection model is something we are actively addressing – while, of course, looking ahead to what comes next!

Stefan Tochev
Chief Executive Officer
MDPI AG

19 October 2023
Open Access Week 2023 – the Global Drive to Open Continues


MDPI has been a strong proponent of the open access publishing model right from the beginning. As one of the pioneering fully open access publishers, we firmly believe that unrestricted access to research findings forms the foundation for better transparency, efficiency, and quality control across all scientific disciplines.

In December 2022, we reached a significant milestone by surpassing one million articles published. That is one million articles freely available to all, to circulate and build upon!

Offering free and immediate access to scientific papers empowers scientists to examine, validate, replicate, and expand upon existing results. This not only helps prevent redundancy and optimizes how resources are used but also paves the way for innovative new approaches.

The International Open Access Week takes place from 23 to 29 October 2023, providing a unique opportunity to connect the global movement towards open sharing and open science with the progress of policy transformations at the local level.

Our goal, during Open Access Week as well as throughout the year, is to offer resources for educating people about the benefits of open access publishing. The MDPI Blog offers a wealth of information around open access and open science.

Promoting the values of accessibility, transparency, and collaboration

Open access publishing embodies the fundamental values of democratizing knowledge and fostering global accessibility. It aims to break down barriers that have traditionally limited access to scholarly work, ensuring that knowledge is available to all, regardless of their financial or institutional affiliations. 

Discounts are part of our commitment to ensuring there are diverse pathways to Open Access publishing for researchers worldwide. MDPI supports scientific communities in several different ways. 

One of the key strengths of open access publishing lies in its ability to facilitate interdisciplinary research. By removing paywalls and promoting the sharing of knowledge across disciplines, OA encourages collaboration and innovation. Researchers from diverse fields can access and build upon each other's work, fostering a holistic approach to addressing complex global challenges. 

Funders' policies are getting aligned with open science

Governments, institutions, and funding agencies have recognized the transformative potential of open access and have implemented policies to promote it. These policies often mandate that publicly funded research should be made openly accessible. Such initiatives have accelerated the growth of open access repositories and journals, reinforcing the commitment to open access principles. Check our spotlights on OA policies in the USEU and China

Open access publishing is continually evolving, with innovative and community-driven models and technologies shaping its future. Initiatives like "Plan S" and "cOAlition S" promote the adoption of OA publishing from the national funders’ perspective by requiring grantees to publish their research openly. A new policy announced by the US administration last year requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. 

Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing. 

For more than twenty years, open access scholarly publishing has been revolutionizing academia by promoting the values of accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As open access continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change. 

MDPI is proud to be a leader in the transition to open access.

2 October 2023
MDPI Insights: The CEO’s Letter #4 - MDPI Presence in China

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Open Access in China

It is Saturday, 23 September, and I have just returned from an unforgettable 12-day trip to China, visiting our main offices in Beijing and Wuhan. In the wake of a packed and very enjoyable agenda of internal and external meetings, I would like to use this edition of the CEO Letter to showcase how MDPI supports the scholarly community in China.

Coincidentally, Jack McKenna, Communications Associate from MDPI’s corporate content team, has just released a blog article discussing China’s open access (OA) policy. It is a timely read, providing a concise overview of the development of the OA movement in China and reflecting on its future. I shall draw some content from Jack’s piece and use this edition of the CEO Letter to highlight the various ways in which MDPI is involved in this market. And it would be remiss of me not to include some pictures and highlights from my travels!

Open Access Policy in China

As per Jack’s post, in 2020, China became the world’s leading producer of research articles. Today, China is experiencing a “substantial growth rate in OA [Open Access] publication”. This growth is supported by the State’s commitment to research & development and its policy “requiring the promotion of open science”.

Over the past two decades, there have been gradual developments in China’s OA framework, with repositories and platforms being developed in a consistent manner. Currently, key institutions across China – including the National Science Library, the National Science and Technology Library, and the Natural Science Foundation of China – support OA. The State aims to establish consistent policies across government agencies – a framework for a more encompassing embrace of OA across institutions.

In China, the number of subscription-only articles decreased by nearly 30% over the 10-year period of 2011–2021, while gold OA increased by 22%. Between 2017 and 2020 alone, China published 800,921 academic papers in an OA format.

In 2023, as the leading publisher of academic research, China is pursuing “self-reliance”. Therefore, the State will be establishing consistent policies across government agencies, including those related to OA. Additionally, it will want to ensure that Chinese people can access the research that is supported by Chinese funding and produced by Chinese academics. For this reason, “Open Access is a matter of priority in China”.

MDPI Offices in China

 While the history of MDPI begins in Basel, Switzerland, the story of MDPI’s founder is very much rooted in China. Dr. Shu-kun Lin, Founder and President of MDPI, graduated with a BSc from Wuhan University in 1982. He also studied physical chemistry at the Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (1982–1986; MSc in 1985), and at the University of Louisville, USA (1987–1989). Dr. Lin completed his doctorate in organic chemistry at the Swiss Federal Institute of Technology (ETH-Zürich) in 1992.


Stefan Tochev (CEO, MDPI) at MDPI’s Wuhan office.

In 2002, MDPI’s Basel headquarters moved to Matthäusstrasse 11, 4052 Basel, and Dr. Lin opened an editorial office in Qingdao, China, which launched the journal Marine Drugs in the following year. Below is a list of MDPI’s current offices in China and their respective dates of inauguration:

  • 2008: Beijing (Tongzhou, Haidian)
  • 2013: Wuhan (Hankou, Guanggu)
  • 2019: Tianjin
  • 2021: Dalian
  • 2021: Nanjing

Our Strength is in Our People

With over 6,000 MDPI staff, across 20 offices in 11 countries, MDPI is able to offer authors responsive and efficient round-the-clock support, enabling a rapid publication process.

In my experience, stakeholders are genuinely surprised when they realize the extent of our global operations. My response is to reiterate that our people are our strength. This is why we have fast and efficient processes and top-notch responsiveness. Our global presence ensures that your manuscript is constantly attended to, rather than sitting on someone’s desk. We prioritize our authors’ needs and act quickly to move things through the various stages of publication. MDPI is built on speed, convenience, and competence, which I believe are core pillars for success in any industry. We continually strive to improve our systems and processes on the basis of these core strengths. We literally have over 6,000 staff worldwide dedicated to serving your needs. It’s not magic: it’s people; it’s real.

Impactful Research

MDPI Awards

To support the academic community, and especially young researchers, and also to enhance communication among scientists, MDPI journals offer various awards in specific fields. We serve the scientific community by funding research to facilitate the development of sustainable global solutions through our annual World Sustainability Award and Emerging Sustainability Leader Award.

In 2022, MDPI made awards totalling over US$1 million in recognition and support of researchers worldwide.

Across our journal catalogue, we have granted over 2,000 awards to recognize and support researchers from all disciplines. Since 2016, these awards have served as a source of recognition, acknowledging the impact of research by heightening the influence of talented individuals. The award types mainly include the Young Investigator Award, the Best PhD Thesis Award, the Best Paper Award, and the Outstanding Reviewer Award.

To learn more about MDPI Awards and to find out which are currently available, please click here.

MDPI Awards to Scholars from China

Since 2021, there have been 23 Best Paper Awards granted to authors affiliated with Chinese institutions, identifying their papers as having high-quality scientific impact. A total of 45 Chinese scholars have received awards such as the Young Investigator Award, the Best PhD Thesis Award, the Outstanding Reviewer Award, and the Tu Youyou Award, among others. Prizes for these awards include MDPI grants for paid publications, totalling over CHF 70,000 for scholars affiliated with Chinese institutions.

MDPI’s Tu Youyou Award


Prof. Tu Youyou (left), Dr. Shu-Kun Lin (President, MDPI).

In 2015, Professor Tu Youyou was awarded the Nobel Prize in Physiology or Medicine “for her discoveries concerning a novel therapy against Malaria.” In order to commemorate Professor Tu’s contributions to human health and to promote the passion and spirit conveyed by her experiences, MDPI in 2016 established the ‘Tu Youyou Award’, which runs biennially to recognize outstanding scholars dedicated to the research of natural products and medicinal chemistry.

The 2022 Tu Youyou Award was granted to Prof. Dr. Xiaoguang Lei of Peking University. Click here to access the interview with the winner.

2015 Nobel Prize for Medicine Awarded to Professor Youyou Tu

Professor Tu’s work was celebrated in a Special Issue from Molecules on the occasion of her 80th birthday. The Special Issue: 'Artemisinin (Qinghaosu): Commemorative Issue in Honor of Professor Youyou Tu on the Occasion of her 80th Anniversary” was created five years before she won the Nobel Prize, highlighting the visibility MDPI provides researchers and their work.

Highly Cited Articles by Chinese Scholars Published in MDPI

Click here to access the most cited MDPI papers published by scholars affiliated with Chinese institutions. This list presents the most influential research from the more than 287,000 MDPI papers published by Chinese scholars. With over 9 million total citations, I encourage you to maximize your visibility and impact by publishing with MDPI, the number one most cited open access publisher.

Read more:

Inside MDPI

Stefan Tochev (CEO, MDPI) with the Beijing Marketing team.

Marketing Department in China

During my visit to our offices in Beijing and Wuhan, I had the opportunity to meet with, and to present to, our local marketing teams. These teams are responsible for various journal-related and corporate promotional activities, including newsletters, conferences, seminars, author training, journal awards, content creation, digital marketing, and social media.

I was pleased by the ambition and curiosity of our marketing colleagues. They showed a strong desire to collaborate and acquire knowledge and tactics to effectively market and promote MDPI-journal-related activities. I presented some of the principles and objectives that we apply in the Corporate Marketing and Communications department, and used the opportunity to strengthen our collaborative communications across offices.

Stefan Tochev (CEO, MDPI) with the Wuhan Marketing team.

Coming Together for Science

Collaborations, Scholarships and Meetings

MDPI maintains partnerships with nearly 190 learned societies and over 800 institutions and consortia, helping to facilitate the transition to OA publishing. Our commitment to working with institutions is evident in China, where we have successfully established over 35 Institutional Open Access Programs (IOAP) with esteemed institutions such as the Tsinghua University, Huazhong University of Science and Technology, and Shanghai Jiao Tong University.

Our institutional partnerships, waiver programs, and article processing cost discounts create diverse pathways to OA publishing for researchers worldwide.

Scholarships in China

Since 2021, several MDPI journals (Sensors, Photonics, Coatings, Materials, Energies, and Journal of Fungi) have funded full scholarships for four Master’s and five Ph.D. projects in China. These scholarships align with Tianjin University, Wuhan University of Technology, Central South University, the Chinese Academy of Sciences, and the China University of Petroleum (Beijing).

Meeting with the Society of Chinese University Journals (CUJS)


Prof. Tieming Zhang (President of CUJS, centre) and MDPI colleagues at CUJS office.

I am pleased to have participated in some highly productive meetings during my visit to China, including one with the Society of Chinese University Journals (CUJS). The meeting involved Prof. Tieming Zhang (President of CUJS), Assoc. Prof. Xin Zhang (Vice President and Secretary General), and Dr. Fei Gao (Executive Member of CUJS). Alongside my colleagues Dr. Guoshi Liu, Dr. Giulia Stefenelli, and Anita Sun, I represented MDPI and held an open discussion to address any questions regarding OA and MDPI.

We discussed several methods for collaboration, including a workshop on the future of peer review, MDPI sponsoring a funding grant for early-career researchers, and transitioning journals from diamond to gold OA. I am thankful for the opportunity to have met our colleagues at CUJS in person and feel very confident about our future collaborations in support of OA publishing in China.

MDPI hosts free academic seminars, author training sessions, and academic conferences as part of its commitment to enrich and support the scholarly community. CUJS often stages academic events (e.g., conferences, editor training, and editor competitions), and I believe there are great opportunities for CUJS and MDPI to collaborate accordingly.

Meeting with National Science Library, Chinese Academy of Sciences (NSLC)


Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Officers, MDPI), Anita Sun (PR Manager, MDPI) and Dr. Guoshi Liu (Managing Director, MDPI) at the National Science Library, Chinese Academy of Sciences.

We also visited the NSLC Director, Xiwen Liu, and colleagues Ying Jin, Zhesi Shen, and Sichao Tong. Following our introductions, we gave a presentation on the history and editorial process at MDPI, discussing specific details related to MDPI’s business and data. We highlighted the status of our  IOAP collaborations in China and the makeup of our author base, specifically in China, and drew attention to the fact that MDPI has published research by authors from every country in the world. We then discussed the design indicators, calculation methods and implementation purposes of the ‘Early Warning Journal List’ and how we can have open communication to provide any data regarding MDPI journals. I am pleased to report that we reached a consensus on future communications, and am grateful to NSLC for hosting us in their offices.

In-person meetings with stakeholders provide an invaluable opportunity to communicate what MDPI is about and the various ways in which we serve the scholarly community. While digital marketing and online communication are essential, they are no replacement for the understanding and trust that come about through in-person interactions.

The Numbers

As at September 2023, China holds the largest position in MDPI’s global market, ranking as the largest contributor to the total number of papers published by MDPI.

At this point in time, there were more than 847,000 China mainland scholars who have published with MDPI, 51 of whom are Section-Editors-in-Chief (SEiC) of MDPI journals, with seven serving as Editors-in-Chief (EiCs) for journals such as Air, Big Data and Cognitive Computing, Blockchains, Future, Nanoenergy Advances, and Targets.

Our growth and presence in China are a true testament to the service we provide to the scholarly community, and to the relationships we foster through collaborative activities. We look forward to continuing to support the growth of the scholarly community in China, providing a valuable and trusted experience with MDPI.

Closing Thoughts

Final Reflections on our MDPI Offices in Beijing and Wuhan


Stefan Tochev (CEO, MDPI), Dr. Constanze Schelhorn (Indexing Manager, MDPI), Jiale Shang (Admin, Tongzhou, MDPI) at Beijing Capital International Airport, Beijing.

I spent approximately two weeks visiting some of our offices in China, and the first word that comes to mind when describing my experience is ‘hospitality.’ My colleagues and I were met with enthusiasm and delight at the airport by the Tongzhou Admin team (thank you, Jiale Shang, and thank you, Eric Wang, for keeping us organized on this trip!) and were taken care of with great attention. From hotels to transportation, dinners, and meetings, our stay was catered for perfectly.

Perhaps this is where MDPI’s focus on customers and service originates. At our core, we are a service company that provides a publishing platform for its authors. It’s therefore no surprise that authors consistently rate their experience with MDPI very highly.

95% of submitting authors rate their overall experience with the MDPI publication process as Excellent or Good (Springer Nature report 90%).

91% of submitting authors rate their overall experience with the MDPI peer review process as Excellent or Good.

Speed/Efficiency and Editorial Relationship are two key reasons underlying this high satisfaction score. ‘Editorial Relationship’ can be further explored, but in the past month, the most commonly noted aspects were the professionalism, kindness, availability, communicativeness, and personalized assistance provided by our editorial staff throughout the process. These attributes are at the core of our work across all our offices and continents.

Hospitality and Service

Just as our Chinese colleagues strove to keep us engaged by showing us the city sights (thank you, Thea Pan, and Jason Wu from the Wuhan Marketing team!) and sharing a variety of wonderful meals, our editorial staff are committed to serving our authors throughout their publishing journey. Our aim is to place the author at the centre of everything we do, eager to welcome our ‘guests’ and provide them with a pleasant publishing experience.

I asked my colleague Francis Wu (Senior Publisher, Wuhan office) where this hospitality originates. He responded that it is part of Chinese culture. I reflected long and deep on this answer. China is a vast country, and when visitors arrive, hosts want to ensure they feel welcomed and taken care of in order to maximize their time and visit. I can’t think of a better analogy for how I would want our authors to feel when they visit MDPI for their publishing needs. A company culture that prioritizes service, something that goes beyond products and productivity, and focuses on the overall experience. Over 6,000 people, across all MDPI offices, are ready, willing and able to go the extra mile for their colleagues and their customers. This is something I am truly proud of.

Stefan Tochev
Chief Executive Officer
MDPI AG

27 September 2023
Meet Us at the 27th International Conference on Miniaturized Systems for Chemistry and Life Sciences (µTAS 2023), 15–19 October 2023, Katowice, Poland


MDPI will attend the 27th International Conference on Miniaturized Systems for Chemistry and Life Sciences (µTAS 2023). µTAS 2023 continues an international conference series that is the premier forum for reporting research results in microfluidics, microfabrication, nanotechnology, integration, materials and surfaces, analysis and synthesis, and detection technologies for the life sciences and chemistry. The conference offers plenary and invited talks, expansive poster sessions, networking forums, and an array of industry exhibitions, as well as numerous contributed oral and poster presentations selected from submitted abstracts.

The conference anticipates over 1000 scientists, trainees, and industry professionals from around the globe will once again share advances regarding integrated microsystems and nanotechnology for chemistry and life sciences in person.

The following MDPI journals will be represented:

If you plan on attending this conference, please feel free to stop by our booth #17 and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://microtas2023.org/.

22 September 2023
Meet Us at the 45th Annual Meeting of Japanese Society of Biomaterials, 6–7 November 2023, Kobe, Japan


The 45th Annual Meeting of Japanese Society of Biomaterials will be held from 6 to 7 November 2023 at the Kobe International Conference Center (Kobe, Hyogo, Japan). The conference focuses on the current technological advancement and development of biomaterials, as well as cutting-edge materials to solve the various problems with which modern society is confronted. The conference invites all researchers in the life science, engineering, medical device, and other industries to join.

The following MDPI journals will be represented at the conference:

  • Bioengineering;
  • Gels;
  • JFB;
  • Polymers.

If you are planning to attend this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following link: https://lynx-dent.jp/jsb45/.

18 September 2023
Meet Us at the 16th IFToMM World Congress (WC2023), 5–10 November 2023, Tokyo, Japan


MDPI will be attending the 16th IFToMM World Congress (WC2023), which will be held from 5 to 10 November 2023 in Tokyo, Japan.

The organizing committee of the 16th World Congress of the International Federation for the Promotion of Mechanism and Machine Science is very pleased to welcome you to Tokyo.

The IFToMM World Congress is held every 4 years and is the largest congress on mechanism and machine science. It provides an opportunity for researchers, scholars and students with interests in the theory and use of mechanisms and machines for sharing new ideas and experiences and discussing future developments.

The following MDPI journals will be represented:

  • Machines;
  • Lubricants;
  • Bioengineering;
  • Robotics;
  • Vibration;
  • Inventions;
  • Symmetry;
  • Designs;
  • JMMP;
  • AI.

If you plan to attend this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference and our booth, please visit the following link: http://wc2023.jc-iftomm.org/.

6 September 2023
Recap of Awards Granted to Scholars in 2022


MDPI is committed to supporting the academic community, nurturing talent and advancing science. Awards are an important part of the research landscape and play a vital role in helping academics gain recognition, especially young researchers as they embark on new research avenues.

In 2022, our journals presented a total number of 394 Awards, including Travel Awards, Young Investigator Awards, Best PhD Thesis Awards, Best Paper Awards, and Outstanding Reviewer Awards, with several winners announced for some of the awards. The total prize sum amounted to just under 580,000 Swiss francs (CHF), or approximately 650,000 US dollars. Overall, more than 720 scholars were awarded.

The majority of the awards were dedicated to young researchers in relatively early stages of their careers. This encompassed 66 of the afore-mentioned Travel Awards, 60 Young Investigator Awards, supporting research projects and conference attendance, as well as 51 Best PhD Thesis Awards. Additionally, 113 Best Paper Awards were given by our journals. The selection committees were entrusted with identifying the most impactful and novel research and review articles published in their journal within a given year.

MDPI will continue its support and recognition for the academic community moving forward, sponsoring new awards across disciplines. To learn more about all the awardees and their research projects in your field of study, please visit the following pages:

To explore more MDPI awards, please click here.

5 September 2023
Meet Us at the 16th China Pharmaceutical Preparations Conference, 15–17 September 2023, Changsha, China


The upcoming conference is the 16th so far, and it has become an important conference in the field of pharmaceutical research in China. The theme of this formulation conference is "New Technologies, New Opportunities, and New Challenges" which will be held in Changsha, China. Experts from various fields and directions in pharmacy at home and abroad will be invited to conduct exchanges and discussions on theoretical research, technology applications, policies, and regulations on pharmaceutical formulations. In addition to the main venue, the conference also has a basic pharmacy forum (targeted drug delivery strategy, controlled release strategy), industrial pharmacy forum, International Controlled Release Association China Branch Forum, external preparations forum, improved new drugs and clinical research forum, medicinal excipients and pharmaceutical packaging materials forum, preparation R&D services and equipment forum, young pharmaceutical workers forum, graduate student forum, and other sub-venues.

Pharmaceutics (ISSN: 1999-4923) is a peer-reviewed, open access journal on the science and technology of pharmaceutics and biopharmaceutics, and it is published monthly online by MDPI. Pharmaceutics will participate in this event as an exhibitor together with seven other MDPI journals.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us at our booth #A39. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information, please feel free to contact the Pharmaceutics Editorial Office at [email protected].

1 September 2023
Meet Us at the Tissue Engineering and Regenerative Medicine International Society (TERMIS–AP) Conference, 16–19 October 2023, Hong Kong, China


MDPI will attend the Tissue Engineering and Regenerative Medicine International Society (TERMIS-AP) conference, which will be held from 16 to 19 October 2023 at the Hong Kong Science Park, Hong Kong, China. The mission of TERMIS–AP is to provide a platform for the generation and dissemination of knowledge and interactions across a range of expertise for the advancement of basic, translational, and clinical research.

The conference will comprise various topics that provide comprehensive coverage of diverse issues in current tissue engineering and regenerative medicine under the main theme of “New Chapter of Future Regenerative Medicine”.

The following MDPI journals will be represented:

If you plan on attending this conference, please feel free to stop by our booth #09 and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://ap2023.termis.org/.

30 August 2023
MDPI Insights: The CEO’s Letter #3 - Sustainability and Co-opetition

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Our Commitment to Sustainability

As a pioneer in academic open access publishing since 1996, MDPI has always been dedicated to facilitating scientific exchange across all disciplines. Our approach to open science is guided by principles such as Open Access (OA), Timeliness and Efficiency, Simplicity, High-Quality Service, Flexibility, and a commitment to Sustainability. This commitment involves preserving published papers for the long term and supporting the future of science through partnerships, sponsorships, and awards.

In this edition of the CEO Letter, I will delve into MDPI’s various sustainability initiatives. As a leader in OA publishing, we are able to provide the public with a significant amount of environment-related content at no cost.

MDPI and the Sustainable Development Goals (SDGs)

In 2020, the SDG Publishers Compact was launched to accelerate implementation of the SDGs by promoting content that informs, develops, and inspires action. MDPI joined this initiative in 2021 and subsequently launched the MDPI SDG Hub in 2022, offering free access to recent research within the scope of each of the 17 SDGs. We also support authors from underrepresented communities by waiving publication charges for selected SDG-related papers. Detailed sustainability practices and supported publications are available in the report under each Goal page.

“More than 80% of MDPI articles and reviews published in 2022 relate to the Sustainable Development Goals.” [source: InCites, Accessed on 21.08.2023]

As at August 2023, MDPI boasts 14 journals dedicated to sustainability-related topics. Our first journal in this area, Sustainability, has published over 29,000 articles on the SDGs, accumulating over 240,000 citations (source: InCites, as at 1 January 2023). These journals serve as vital platforms for researchers to share insights and address environmental challenges. In addition:

MDPI journals specializing in sustainability-related topics:

  • 2009: Sustainability
  • 2012: Resources
  • 2013: Climate
  • 2014: Environments
  • 2016: Recycling
  • 2019: Clean Technologies
  • 2020: Sustainable Chemistry
  • 2021: Wind, Biomass, Conservation, Pollutants, Solar
  • 2022: Waste, Microplastics

Read more:

Impactful Research

Highly Cited Articles in Sustainability

In 2022, content published in Sustainability and indexed in Journal Citation Reports (JCR) received nearly 190,000 citations. This highlights the fact that Sustainability publishes highly cited research articles related to environmental sciences and SDG-related topics such as climate action.

We are pleased to share that Sustainability received a 2022 CiteScore of 5.8, marking a 16% increase from the 2021 metric. Specifically, the CiteScore positions Sustainability as follows: Q1 (27 out of 163) in the “Environmental Science (miscellaneous)” category, and Q1 (101 out of 779) in the “Geography Planning and Development” category. For additional journal statistics, please visit here.

“Sustainability received a 2022 CiteScore of 5.8”

While MDPI journals such as Climate and Atmosphere have a distinct focus on atmosphere pollution and its impact on climate processes, journals like Sustainability, Environments, Water, Remote Sensing, and IJERPH publish content related to climate change. These journals have published over 32,300 articles related to SDG 13: Climate Action.

Highly Cited Papers in Sustainability

Below are several highly cited papers published in Sustainability over the past three years. Citation metrics are current as at 15 August 2023.

1. “A Global Assessment: Can Renewable Energy Replace Fossil Fuels by 2050?
Authors: Jerry L. Holechek, Hatim M. E. Geli, Mohammed N. Sawalhah, and Raul Valdez
Sustainability 2022, 14(8), 4792; https://doi.org/10.3390/su14084792
Citations: Crossref (97), Scopus (91), Web of Science (82), Google Scholar (125)

This paper addresses one of the most significant challenges of climate change – achieving Net Zero Carbon by 2050. The meta-analysis suggests that while difficult, this transition is possible through the concerted application of pathways, lifestyle changes, and global cooperation.

2. “Anxiety and the Ecological Crisis: An Analysis of Eco-Anxiety and Climate Anxiety
Author: Panu Pihkala
Sustainability 2020, 12(19), 7836; https://doi.org/10.3390/su12197836
Citations: Crossref (144), Scopus (121), Web of Science (159), Google Scholar (382)

This paper has received substantial media attention, including coverage by The Guardian, BBC, Vice, and CNBC. An interview with Dr. Panu Pihkala, a leading interdisciplinary researcher on the topic, can be found on MDPI’s podcast: Insight Faster, Episode 1.

3. “Impact of Climate Change on Agriculture and Its Mitigation Strategies: A Review
Authors: Gurdeep Singh Malhi, Manpreet Kaur, and Prashant Kaushik
Sustainability 2021, 13(3), 1318; https://doi.org/10.3390/su13031318
Citations: Crossref (207), Scopus (221), Web of Science (186), Google Scholar (355)

This paper reviews literature on climate change, addressing its causes, future projections, impact on agriculture, including plant physiology, growth, productivity, pest infestation, and the economic implications of mitigation strategies.

4. Impacts of Plastic Pollution on Ecosystem Services, Sustainable Development Goals, and Need to Focus on Circular Economy and Policy Interventions
Authors: Rakesh Kumar, Anurag Verma, Arkajyoti Shome, Rama Sinha, Srishti Sinha, Prakash Kumar Jha, Ritesh Kumar, Pawan Kumar, Shubham, Shreyas Das, Prabhakar Sharma, and P. V. Vara Prasad
Sustainability 2021, 13(17), 9963; https://doi.org/10.3390/su13179963
Citations: Crossref (134), Scopus (136), Web of Science (113), Google Scholar (184)

This review aims to assess the adverse effects of plastic pollution on ecosystems, link the management of plastic with the SDGs, and propose policy measures using transdisciplinary approaches. Empowering communities to reduce plastic use is crucial. Addressing global plastic pollution is a priority.

Sustainability is an international, cross-disciplinary, open access journal that explores environmental, cultural, economic, and social sustainability of human beings. It provides a forward-looking platform for research on sustainability and sustainable development, and is published semi-monthly online by MDPI. Sustainability is affiliated with The Canadian Urban Transit Research & Innovation Consortium (CUTRIC) and The International Council for Research and Innovation in Building and Construction (CIB).

Read more:

Inside MDPI

President of Ireland Authors Editorial in MDPI Journal Sustainability

It’s a very special occasion when the president of a country takes the initiative to write an editorial for a journal. Michael D. Higgins, President of the Republic of Ireland, has contributed his insights to a forthcoming Special Issue in Sustainability:

This Special Issue, focusing on “making sustainable development happen” at grassroots levels, allows for perspectives from, and on, the major world faiths, exploring how challenges have been conceptualised and addressed, in addition to case studies of faith-based sustainability initiatives in practice.

The experience of faith institutions and communities in translating theological and moral commitments to sustainable development into action is now a topic we must examine with urgency; one on which I am so glad this Special Issue focuses.

As President of Ireland, I very much support this Special Issue of Sustainability. It is my great hope that the contents of the papers contained herein will assist in making sustainable development happen at grassroots levels across the world so that we can cooperate together, people of faith and of none, to ensure a just, inclusive and sustainable future for all on our fragile planet.

Read the completed editorial here:

Special Issue “Faith and Sustainable Development: Exploring Practice, Progress and Challenges among Faith Communities and Institutions”: Foreword by the President of Ireland
Author: Michael D. Higgins
Sustainability 2023, 15(12), 9683; https://doi.org/10.3390/su15129683

Coming Together for Science

The World Sustainability Forum 2023

The World Sustainability Forum (WSF) is a biennial MDPI event focused on sustainability. WSF 2023 marks the tenth anniversary of the conference series, taking place on 14 September. For the first time, the event will be hosted as a 24-hour conference across three locations – Singapore, Basel in Switzerland, and Toronto in Canada – alongside virtual streaming.

This unique format allows us to span three time zones, providing live coverage of critical sustainability-related topics throughout the day:

  • The Singapore Hub, chaired by Professor Horn Mun Cheah and Associate Professor Renee Tan, will explore “Sustainability for Social and Community Impact”.
  • The Basel Hub, chaired by Prof. Dr. Anet Režek Jambrak and Dr. Lela Mélon, will delve into “Sustainability in the industry, and at university and corporate settings”.
  • The Toronto Hub, led by Dr. Umberto Berardi, will discuss “The Sustainable Built Environment”.

MDPI Sustainability Foundation: Recognizing Excellence in Sustainability Research

The MDPI Sustainability Foundation supports researchers through two sustainability-focused awards:

  1. The World Sustainability Award, amounting to USD 100,000, is given to senior researchers.
  2. The Emerging Sustainability Leader Award, valued at USD 20,000, sponsored by the journal Sustainability, is presented to early-career researchers.

The winners of the Sustainability Foundation will be formally awarded during the WSF2023 on 14 September. Interviews with the award winners and finalists are available below.

2023 World Sustainability Award Winners

  1. Professor Michael R. Templeton
  2. Professor Tom Lyon
  3. Dr Krithi K. Karanth

Interviews with 2023 Emerging Sustainability Leader Award Finalists

  • Dr. Bahareh Kamranzad
  • Dr. Youjin Kim
  • Dr. Julia Lohmann

As a hybrid event, WSF23 provides scholars with the option to attend in person at one of the conference sites or, for a more sustainable approach, virtually. All sessions will be recorded and archived for future access. Registration is open until 3 September 2023, with in-person and virtual tickets available here.

Read more:

Closing Thoughts

“Co-opetition”: Collaboration Plus Healthy Competition – A Visit to Elsevier

I firmly believe in fostering collaboration and at the same time promoting healthy competition within the academic publishing industry. The market offers ample room for publishers and related companies to provide valuable services and products that enrich the academic community. While MDPI is recognized for its efficient and streamlined processes –thanks to our over 6,000 colleagues, in-house tools, and initiatives that support the author journey – our ethos has always involved learning from and collaborating with other organizations.

MDPI’s Interaction with Elsevier

In January 2023, I had a brief conversation with Judy Verses, President of Global Academic and Government Markets at Elsevier, following her participation in a panel discussion at the Academic Publishers Europe event in Berlin. One of the highlights for me was Judy’s insight into the impact of research, particularly her emphasis on the role of collaboration, including policy and showing the impact of research to influence on funding decisions.

“Such collaborations drive forward-looking strategies to elevate our support for the scholarly community”

Judy and I resumed our discussion in August, when I visited Elsevier's office to review current projects, such as our recent agreement with Science Direct and the continued indexing of MDPI journals in Scopus (indexing database owned by Elsevier). We also explored possible opportunities for the future, including a potential collaboration to expand MDPI’s Scilit data infrastructure. This endeavour aims to aggregate and provide access to scholarly metadata encompassing journal articles, conference papers, books, preprints, and more. While these discussions are ongoing, the underlying principle remains that such collaborations drive forward-looking strategies to elevate our services and support for the scholarly community.

It was great that Judy and I acknowledged the merits of 'co-opetition,' a concept based of the belief that fostering cooperation alongside healthy competition can lead to shared advancements for both individual companies and the industry at large.

‘Fully OA’ Organizations Dedicated to Open Access

MDPI proudly aligns with the ‘Fully OA’ group, a collaborative initiative comprising nine organizations dedicated to Open Access. Our monthly meetings, including an OASPA representative, serve as platforms to share non-confidential information, resources, and projects. These gatherings also facilitate discussions on topics relevant to fully OA organizations. Occasionally, joint actions spring from these interactions, such as collaborative blog posts on pertinent subjects and joint statements, such as a recent response to the House Appropriations Committee.

This display of cooperation among competing entities forms a strategic alliance focused on nurturing the best interests of the OA publishing model.

As I wrap up this third edition of the CEO Letter, I encourage you to seize opportunities for collaboration and contribute to advancing our shared academic culture. As the African proverb has it, “If you want to go fast, go alone; if you want to go far, go together.”

Stefan Tochev
Chief Executive Officer
MDPI AG

18 August 2023
Meet Us at the 2023 China Biomaterials Conference, 12–15 October 2023, Chongqing, China


Conference: 2023 China Biomaterials Conference (CSBM2023)
Date: 12–15 October 2023
Booth: #B4

MDPI journals will be attending the 2023 China Biomaterials Conference (CSBM2023) as an exhibitor. This meeting will be held in Chongqing, China, from 12 to 15 October 2023.

The theme of the conference is “Innovative Biomaterials to Protect People's Health”, focusing on the frontiers of biomaterials science, technological innovation, achievement transformation, regulatory science, etc., to discuss and share the latest developments in the current field of biomaterials.

The following MDPI journals will be represented:

  • IJMS;
  • JFB;
  • Bioengineering;
  • Biomimetics;
  • Marine Drugs;
  • Polymers;
  • Nanomaterials;
  • Biomedicines;
  • Micromachines;
  • Pharmaceutics;
  • Electrochem.

If you plan on attending this conference, please feel free to stop by our booth (#B4) and speak with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit http://2023.csbm.org.cn/index.php/index/index/index.html.

16 August 2023
Bioengineering | Hot Papers in the Field of Organ-on-a-Chip

One of the groundbreaking advancements in modern technology is the field of organ-on-a-chip in the realm of bioengineering. This innovative technique, by emulating the structure and functionality of human organs, presents unprecedented opportunities in areas such as drug screening, disease research, and personalized medicine. Organ-on-a-chip is a miniature biologically based microchip that enables biological experiments within a simulated microenvironment of human organs. Through the precise manipulation of cellular interactions, biomaterials, and fluids, organ-on-a-chip can mimic the physiological functions and pathological processes of human organs, providing a more reliable tool for disease research and drug development. In this context, we are pleased to feature some recently published papers centered around the topic of organ-on-a-chip in Bioengineering (ISSN: 2306-5354). These publications encompass various organs and disease domains. These articles showcase the potential of organ-on-a-chip in disease modeling, drug screening, and personalized medicine, while also exploring its value in biological research and medical applications.

1. “A Review of Biomaterials and Scaffold Fabrication for Organ-on-a-Chip (OOAC) Systems”
by Luana A. Osório, Elisabete Silva and Ruth E. Mackay
Bioengineering 2021, 8(8), 113; https://doi.org/10.3390/bioengineering8080113
Available online: https://www.mdpi.com/2306-5354/8/8/113

2. “Versatile Vessel-on-a-Chip Platform for Studying Key Features of Blood Vascular Tumors”
by Marina Llenas, Roberto Paoli, Natalia Feiner-Gracia, Lorenzo Albertazzi, Josep Samitier and David Caballero
Bioengineering 2021, 8(6), 81; https://doi.org/10.3390/bioengineering8060081
Available online: https://www.mdpi.com/2306-5354/8/6/81

3. “Multi-Compartment Lymph-Node-on-a-Chip Enables Measurement of Immune Cell Motility in Response to Drugs”
by Nicholas Hallfors, Aya Shanti, Jiranuwat Sapudom, Jeremy Teo, Georg Petroianu, SungMun Lee, Lourdes Planelles and Cesare Stefanini
Bioengineering 2021, 8(2), 19; https://doi.org/10.3390/bioengineering8020019
Available online: https://www.mdpi.com/2306-5354/8/2/19

4. “Organ-On-A-Chip Database Revealed—Achieving the Human Avatar in Silicon”
by Lincao Jiang, Qiwei Li, Weicheng Liang, Xuan Du, Yi Yang, Zilin Zhang, Lili Xu, Jing Zhang, Jian Li, Zaozao Chen et al.
Bioengineering 2022, 9(11), 685; https://doi.org/10.3390/bioengineering9110685
Available online: https://www.mdpi.com/2306-5354/9/11/685

5. “Organ on Chip Technology to Model Cancer Growth and Metastasis”
by Giorgia Imparato, Francesco Urciuolo and Paolo Antonio Netti
Bioengineering 2022, 9(1), 28; https://doi.org/10.3390/bioengineering9010028
Available online: https://www.mdpi.com/2306-5354/9/1/28

6. “Application of Micro-Engineered Kidney, Liver, and Respiratory System Models to Accelerate Preclinical Drug Testing and Development”
by Hanieh Gholizadeh, Shaokoon Cheng, Agisilaos Kourmatzis, Hanwen Xing, Daniela Traini, Paul M. Young and Hui Xin Ong
Bioengineering 2022, 9(4), 150; https://doi.org/10.3390/bioengineering9040150
Available online: https://www.mdpi.com/2306-5354/9/4/150

7. “A Biomimetic Electrospun Membrane Supports the Differentiation and Maturation of Kidney Epithelium from Human Stem Cells”
by Xingrui Mou, Jessica Shah, Rohan Bhattacharya, Titilola D. Kalejaiye, Bowen Sun, Po-Chun Hsu and Samira Musah
Bioengineering 2022, 9(5), 188; https://doi.org/10.3390/bioengineering9050188
Available online: https://www.mdpi.com/2306-5354/9/5/188

8. “Recent Advances in Drug Delivery System Fabricated by Microfluidics for Disease Therapy”
by Fuhao Jia, Yanbing Gao and Hai Wang
Bioengineering 2022, 9(11), 625; https://doi.org/10.3390/bioengineering9110625
Available online: https://www.mdpi.com/2306-5354/9/11/625

9. “A Bioprinted Heart-on-a-Chip with Human Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Evaluation”
by Alan Faulkner-Jones, Victor Zamora, Maria P. Hortigon-Vinagre, Wenxing Wang, Marcus Ardron, Godfrey L. Smith and Wenmiao Shu
Bioengineering 2022, 9(1), 32; https://doi.org/10.3390/bioengineering9010032
Available online: https://www.mdpi.com/2306-5354/9/1/32

10. “Organs-on-Chips Platforms Are Everywhere: A Zoom on Biomedical Investigation”
by Mohamed Zommiti, Nathalie Connil, Ali Tahrioui, Anne Groboillot, Corinne Barbey, Yoan Konto-Ghiorghi, Olivier Lesouhaitier, Sylvie Chevalier and Marc G. J. Feuilloley
Bioengineering 2022, 9(11), 646; https://doi.org/10.3390/bioengineering9110646
Available online: https://www.mdpi.com/2306-5354/9/11/646

16 August 2023
MDPI’s 2022 Young Investigator Awards in Engineering—Winners Announced


MDPI’s Young Investigator Awards recognize promising junior researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2022 in the engineering category. The winners were selected by the journals’ Award Evaluation Committee.

We warmly congratulate the following young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.

Actuators:

  • Yi Zhang, University of Electronic Science and Technology, China

Batteries:

  • Lin Ma, University of North Carolina at Charlotte, USA

Biosensors:

  • Stefano Cinti, University of Naples Federico II, Italy

Buildings:

  • Umberto Berardi, Toronto Metropolitan University, Canada
  • Benedetto Nastasi, Sapienza University of Rome, Italy

JMSE:

  • Do Kyun Kim, Seoul National University, Republic of Korea

Machines:

  • Fernando Bento, University of Beira Interior, Portugal
  • Goshtasp Cheraghian, Humboldt University of Berlin, Germany
  • Roman Mykhailyshyn, The University of Texas at Austin, USA

Micromachines:

  • Pingan Zhu, City University of Hong Kong, China

Processes:

  • Viknesh Andiappan, the Swinburne University of Technology Sarawak Campus, Malaysia

Sensors:

  • Wenzhuo Wu, Purdue University, USA

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

16 August 2023
MDPI’s 2022 Travel Awards in Engineering—Winners Announced


We are proud to recognize the winners of MDPI’s 2022 Travel Awards in the engineering category for their outstanding presentations.

MDPI journals regularly offer travel awards to encourage junior scientists to present their latest research at academic conferences in specific fields, which helps to increase their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to warmly congratulate the winners of the 2022 Travel Awards and wish them the greatest success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Biosensors:

  • Dmitry Kireev, University of Texas at Austin, USA

Buildings:

  • Danilo D’Angela, University of Naples Federico II, Italy

JMMP:

  • Jungsub Kim, Texas A&M University, USA

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

16 August 2023
MDPI’s 2022 Outstanding Reviewer Awards in Engineering—Winners Announced


In order to acknowledge our reviewers, who demonstrate diligence, professionalism, and timeliness when generously dedicating their time to reviewing papers, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer review process.

We are proud to recognize the winners for the year 2022 in the engineering category for their outstanding contributions by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all of the winners on their achievements. MDPI will continue to provide support and recognition to the academic community.

Actuators:

  • Chongjing Cao, Shenzhen Institute of Advanced Technology (SIAT), China

Applied Sciences:

  • Roman Mykhailyshyn, University of Texas at Austin, USA
  • Chiranjibi Sitaula, Monash University, Australia
  • Davide Forcellini, 1University of Auckland, New Zealand; 2University of San Marino, San Marino
  • Giuseppe Ciaburro, Università degli Studi della Campania Luigi Vanvitelli, Italy
  • Yang Song, Norwegian University of Science and Technology, Norway
  • Xiaoming Liu, Beijing Institute of Technology, China

Biosensors:

  • Carlos Torres-Torres, Instituto Politécnico Nacional, Mexico

Buildings:

  • Paolo Blecich, University of Rijeka, Croatia
  • Łukasz Ścislo, Cracow University of Technology, Poland

Fluids:

  • Giorgio Sonnino, Université Libre de Bruxelles (ULB), Belgium
  • Luiz Antonio Alcântara Pereira, Federal University of Itajubá (UNIFEI), Brazil

JMSE:

  • Cagatay Iris, University of Liverpool, United Kingdom
  • Chiemela Victor Amaechi, Lancaster University, United Kingdom
  • Denis Istrati, University of Nevada, USA
  • Mai The Vu, Sejong University, Korea
  • Mina Tadros, University of Lisbon, Portugal

Machines:

  • Chao Fu, Northwestern Polytechnical University, China
  • Eduardo Suárez, Universidade de Vigo, Spain
  • Jordi-Roger Riba, Universitat Politècnica de Catalunya, Spain

Processes:

  • Catalin Ianasi, Institute of Chemistry “Coriolan Dragulescu”, Romania
  • Daniel Ferrández, Polytechnic University of Madrid, Spain
  • Kamil Krzysztof Roman, Institute of Technology and Life Sciences in Warsaw, Poland
  • Marcin Dębowski, University of Warmia and Mazury in Olsztyn, Poland
  • Mariusz Szymanek, University of Life Sciences in Lublin, Poland

Sensors:

  • Agustin L. Herrera-May, Universidad Veracruzana, Mexico
  • Chiachung Chen, National Chung Hsing University, Taiwan
  • Jae-Myung Ryu, Kumoh National Institute of Technology, Republic of Korea
  • Sebastian Głowiński, Koszalin Technical University, Poland
  • Wei Zhou, University of Waterloo, Canada

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

16 August 2023
MDPI’s 2022 Best PhD Thesis Awards in Engineering—Winners Announced


MDPI’s Best PhD Thesis Awards are presented to recognize the young scholars who are judged to have completed the most outstanding PhD thesis in their field of research and to encourage them to continue their excellent work and further contributions to their field.

We would like to warmly congratulate the winners of the 2022 Best PhD Thesis Awards and wish them success with their future research endeavors. MDPI will continue to enhance communication among scientists.

JMSE:

  • “Mathematical Modelling of Wave-Induced Motions and Loads on Moored Offshore Structures”
    by Changqing Jiang, University of Duisburg-Essen, Germany

Machines:

  • “Experimental Characterization of Frictional Hysteresis for Nonlinear Dynamic Analysis of Jointed Structures”
    by Alfredo Fantetti, Imperial College London, UK

Processes:

  • “Sustainable Cultivation of Microalgae Biomass for Bioenergy Production”
    by Angela Paul Peter, Xiamen University Malaysia, Malaysia

Sensors:

  • “Studying Protein Function with Fluorescent Nanoantennas”
    by Scott G. Harroun, Université de Montréal, Canada

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

16 August 2023
MDPI’s Best Paper Awards in Engineering—Winners in 2022 Announced


The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected reviews and research papers through a rigorous judging process based on criteria such as scientific merit, overall impact, and the quality of presentation of the papers published in the journal.

We are honored to present the winners announced for the year 2022 in the engineering category, who were selected from extensive competition, and congratulate the authors for their outstanding scientific publications. MDPI will continue to provide support and recognition to the academic community.

Actuators:

Applied Sciences:

Buildings:

Fluids:

JMSE:

Lubricants:

Micromachines:

Processes:

Sensors:

WEVJ:

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here

15 August 2023
Meet Us at the 37th International Specialised Symposium on Yeasts (ISSY37), 27 November–1 December 2023, Adelaide, Australia


Conference: 37th International Specialised Symposium on Yeasts—ISSY37
Date: 27 November–1 December 2023
Location: Adelaide, Australia

MDPI will be attending ISSY37 as an exhibitor, and we welcome researchers from different backgrounds to visit and share their latest ideas with us.

The theme for ISSY37 is “Yeast Biotech 2.0: New Yeast, Knowledge and Applications”. The meeting will bring together leading researchers, biotech executives, suppliers, government and early career researchers interested in fundamental and applied investigations of yeast. The planned themes will likely include:

  • Biodiversity and new yeast;
  • Yeast-derived food and beverages;
  • Yeast cell factories;
  • Yeast in plant-based foods and meat/dairy alternatives;
  • Synthetic genomes, organelles and communities;
  • Designer yeast;
  • Bioenergy;
  • Biomedicine;
  • Biosafety.

The following MDPI journals will be represented:

If you are planning to attend this conference, please do not hesitate to contact us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://issy2023.com.au/.

10 August 2023
Meet Us at the 7th International Conference of Bionic Engineering, 12–15 October 2023, Wuhan, China


Conference
: The 7th International Conference of Bionic Engineering—ICBE2023
Date: 12–15 October 2023
Location: Wuhan, China

MDPI will be attending ICBE2023 as an exhibitor, and we welcome researchers from different backgrounds to visit and share their latest ideas with us. 

Biomimetic science and engineering is a rapidly developing interdisciplinary field that closely relates to biology, chemistry, physics, materials science, mechanical engineering, medicine and other disciplines. The 7th International Conference of Bionic Engineering and the International Youth Conference of Bionic Science and Engineering 2023 (ICBE and IYCBSE 2023) will not only offer a unique platform to exchange information and ideas, and to initiate collaborations between international bionic scholars, but will also create an opportunity to promote the transformation of bionic technologies and to address future challenges for biomimetic science and engineering.

Organized by Wuhan University, Hubei University and Jilin University, the ICBE and IYCBSE 2023 will be conducted in an online/offline (Wuhan, China) hybrid mode.

The theme of ICBE and IYCBSE 2023 is “human, nature, harmony”, including but not limited to the following topics:

  • Biological systems and biodiversity;
  • Bioinspired functional structures and surfaces;
  • Biomaterials and bioinspired materials;
  • Bionic machinery;
  • Biomechanics and rehabilitation engineering;
  • Biosensors and signal processing;
  • Robotics, motion systems and artificial intelligence;
  • Nature-inspired energy system;
  • Biofabrication and bioinspired manufacturing;
  • Sustainable and environmentally friendly novel technologies;
  • Industrial applications of bionics;
  • Other fields related to bionics. 

The following MDPI journals will be represented:

If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.icbe2022.net/En/Default.

27 July 2023
MDPI Insights: The CEO’s Letter #2 - Open Peer-Review and IJERPH

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Open Peer Review Reports

Continuing the topic of openness from my inaugural monthly CEO letter, in these Opening Thoughts, I highlight the growth and importance of open peer-review reports at MDPI. Open peer reports align with the principles of open science, making the publishing process more transparent and facilitating rigorous peer review.

MDPI journals operate an open peer-review option by default, allowing authors to publish review reports and author responses (often referred to as open reports) together with the published paper. Publishing the reviewer reports and author responses together with the article provides greater transparency and trust for readers, as this allows them to track the editorial decision-making process. Open peer-review also encourages reviewers and editors to provide high-quality comments, as these will be made public if the article is accepted for publication.

Start and Growth of Open Peer Review at MDPI

The MDPI journal Life was a pioneer in offering this opportunity to its authors in 2014. The first MDPI article with peer-review reports openly published was a review by the Nobel Laureate Werner Arber, in which the review reports were published as supplementary material. By 2018, open peer-review was available across all MDPI journals. As such, MDPI authors have embraced the open peer-review model, providing a steady increase in the number of MDPI articles. As of 2023, approximately one-third (34.0%) of MDPI articles were published with open review reports.

As at July 2023, the percentage of MDPI articles published with open peer review has increased to 36.2% of the total papers published in 2023 so far, indicating ongoing growth in adoption.

Open peer review continues to play a critical role in the assessment of the peer-review process in Life. For further insights, please see the recent editorial by Dr. Pabulo Henrique Rampelotto, the former Editor-in-Chief of Life, who spearheaded the implementation of the open peer-review process.

Benefits of Open Peer Review

The benefits of open peer review include increased transparency, trust and constructive feedback. To promote open communication further and increase the robustness of the peer-review process, we encourage reviewers to sign their reports so that their name appears on the review report (this process is referred to as open identity). The default option is for reviewers to remain anonymous; however, by signing the reports, reviewers receive direct credit for their contribution to the peer-review process and show their commitment towards open science.

As the leading open access publisher, MDPI remains committed to promoting open peer-review and encourages authors to choose this approach. Our goal is to provide a rigorous and transparent peer-review process that benefits the scientific community, and we believe that open peer-review is a vital step in fostering openness and collaboration in scientific communication.

Impactful Research

MDPI Papers Cited in the News – IJERPH edition

Every month, our corporate marketing team compiles data from Altmetrics to create a list of MDPI papers that have been cited in the news. This list continues to grow as renowned news outlets regularly reference research published by MDPI in their articles.

During 2022, a total of 111,965 MDPI research papers were mentioned in prominent news outlets such as National Geographic, The Washington Post, Forbes, The Guardian, the BBC, CNN, Time, and Harvard Business Review.

Highly Cited Journal Publications

IJERPH, known for publishing impactful research, received the most news mentions among all MDPI journals in 2022, based on Altmetrics data:

  • International Journal of Environmental Research and Public Health: 3509 mentions
  • Nutrients: 2698 mentions
  • International Journal of Molecular Sciences: 1701 mentions
  • Journal of Clinical Medicine: 1131 mentions
  • Viruses: 1111 mentions

These numbers show the recognition and impact of the articles published in IJERPH. For a more detailed view of the journal’s most cited and viewed papers, you can visit here. In total, IJERPH has garnered over 28,000 mentions in prominent news outlets, and as at July 2023, an impressive count of over 17,000 papers cited 10 times or more. These figures highlight the impactful contribution of IJERPH publications to the scientific community.

Example of Recent Mentions

During May and June 2023, a noteworthy selection of articles from IJERPH was cited in news articles, including:

The Washington Post: “Bringing nature inside can improve your health. Here’s how to do it.”
IJERPH paper:Physiological Benefits of Viewing Nature: A Systematic Review of Indoor Experiments

Harvard Business Review: “How to Take Better Breaks at Work, According to Research
IJERPH paper:Canine-Assisted Therapy Improves Well-Being in Nurses

National Geographic: “Lyme disease is spreading fast—but a vaccine may be on the way
IJERPH paper:Range Expansion of Tick Disease Vectors in North America: Implications for Spread of Tick-Borne Disease

Inside MDPI

MDPI Develops an Artificial Intelligence Tool to Enhance the Peer-Review Process

At MDPI, we believe that rigorous peer-review is the corner-stone of high-quality academic publishing. We are grateful to the scholars who generously dedicate their time to peer-review articles submitted to MDPI journals. Their contributions are invaluable to the advancement of science.

Peer-review is a critical part of the publication process, ensuring that MDPI upholds the highest quality standards for the papers we publish. Every manuscript submitted to our journals undergoes a comprehensive peer-review process conducted by subject-matter experts.

To further enhance our peer-review process, our Data Analytics team has developed an Artificial Intelligence (AI) tool designed to support the selection of reviewers. This proprietary tool utilizes Natural Language Processing (NLP), a specially designed AI language model, to extract information from the title and abstract of submitted papers. It then searches our database for similar manuscripts and suggests potential reviewers based on this analysis. Integrated with MDPI's submission system (SuSy), the AI tool cross-references the suggested candidates with our reviewer database to verify their invitation status and availability.

The goal of this tool is to provide better targeted peer-review invitations, reducing the number of emails sent for each paper and increasing the efficiency of our editorial staff.

In the near future, our Data Analytics team plans to deploy similar AI projects to improve other critical aspects of our services, offering an enhanced experience to our authors and readers.

Click here to learn about MDPI’s review process, including procedures, responsibilities, and benefits.

Read more:

Coming Together for Science

The Future of IJERPH

On 5 July 2023, Prof. Dr. Paul B. Tchounwou, the founding Editor-in-Chief of IJERPH, along with five Section Editors in Chief (Prof. Dr. Germán Vicente-Rodríguez, Prof. Dr. Karl Goodkin, Prof. Dr. William A. Toscano, Prof. Dr. Jimmy T. Efird, and Prof. Dr. William Douglas Evans), gathered in Basel to discuss the future of the journal. The meeting provided an opportunity to address the recent decision by The Web of Science to delist IJERPH due to the journal failing the Content Relevance criterion, and propose best strategies that will ensure high scientific rigor as well as a clear scope and aim of IJERPH, going forward.

While the delisting is disappointing for IJERPH, as well as for our authors, academic editors, and the entire scientific community supporting our journal, we see it as an opportunity to reflect and prepare for the future direction of the journal.

Since its launch in 2004, IJERPH’s vision and mission have evolved to be more complete and comprehensive in engaging scientific communities. In light of this, we will refresh the journal’s aims and scope, ensuring they align with the organic expansion of IJERPH. Additionally, we will restructure the journal sections into broader categories, encouraging collaborative research and transdisciplinary approaches for authors. This is designed to foster collaboration and knowledge exchange among diverse fields, contributing to a holistic understanding of health promotion and disease prevention. We are confident that these next steps will enhance the scientific strength and societal impact of our journal.

Journal Achievements

In addition to the productive discussions, we took the time to celebrate some of the remarkable achievements of IJERPH, which I highlight below:

  • Founded by Prof. Dr. Paul B. Tchounwou in 2004
  • Indexed in PubMed in 2008
  • Received its first Impact Factor in 2012
  • Published its 5000th paper in 2017
  • Over 60,000 papers published as at June 30, 2023
  • 131,628,173 paper views in 2018–2022
  • Over 28,000 mentions in prominent news outlets
  • 17,000 papers cited 10 times or more as at June 30, 2023
  • No.1 journal in the 2022 Google Scholar Metrics in the category of Public Health
  • Awarded several editions of Young Investigator Awards, Travel Awards, and Outstanding Reviewer Awards since 2018.

These achievements showcase the journal’s significant contributions to the field and its impact on global health. We are proud of the exceptional work accomplished by the IJERPH team and look forward to building upon this success in the years to come.

Closing Thoughts

MDPI’s Impact in Spain

During the past month, I had the opportunity to visit our new office building in Barcelona, where I met with our local colleagues to discuss the ways we serve the scholarly community, particularly in Spain. The multi-functional office plays a vital role in supporting various business needs, including editorial, design, conference management, data analytics, journal relationship management, publishing partnerships, and collaborations with societies.

Spain holds a significant position in MDPI’s global market, ranking as the fourth-largest contributor to the total number of papers published by MDPI as at July 2023, ranking next to Italy, the USA, and China, with Germany completing the top five.

The Numbers

Out of the 1,680,000 total MDPI articles published as at 25 July, almost 80,000 articles are contributed by Spanish authors, representing nearly 40,000 unique authors affiliated with Spanish institutions. Remarkably, over 6,300 of these authors hold editorial board member (EBM) positions within MDPI journals, with 30 of them serving as Editors-in-Chief (EiCs).

Our commitment to working with institutions is very evident in Spain, where we have successfully established over 40 Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Barcelona, the Autonomous University of Barcelona, Pompeu Fabra University, the University of Navarre, and Complutense University of Madrid.

Over the past five years, we have successfully organized eight in-person conferences in Barcelona, attracting over 1,150 registrations, with two forthcoming events scheduled for 2024. Barcelona's excellent connectivity to international airports makes it easily accessible to participants from around the world. Its welcoming atmosphere provides us with the perfect environment for knowledge-sharing, networking, and contributing to the local economy.

Our growth and presence in Spain are a true testament to the incredible service we provide to the scholarly community and the relationships we foster through responsive and collaborative communication. We look forward to continuing to support Spanish scholars, providing them a valuable and trusted experience with MDPI, the leader in open access publishing.

Testimonials

I close this letter as I did in the first edition, by sharing testimonials from our stakeholders. Here are a few IJERPH testimonials from a Spanish guest editor and an author:

Guest Editor
“I want to thank the kindness, attention and professionalism of the MDPI team throughout the editorial process of the Special Issue. I believe that it is a very professional and quality editorial process.”
- Professor Víctor Arufe-Giráldez, University of A Coruña
Special Issue in International Journal of Environmental Research and Public Health: Physical Activity in Childhood and Adolescence
Special Issue in International Journal of Environmental Research and Public Health: Physical Education: Present and Future
__
Author
“I want to thank the rigor of the revisions made to the manuscripts to improve their quality, the support to the authors for the editor assignment system they have and the follow-up they carry out, for the speed in answering and in carrying out the entire process of the revision, and for doing all this at an affordable price.”
- Dr. María Paz García-Caro, University of Granada
Article in International Journal of Environmental Research and Public Health: Factors Associated with Suicide Attempts and Suicides in the General Population of Andalusia (Spain)

Stefan Tochev
Chief Executive Officer
MDPI AG

14 July 2023
Meet Us at 2023 BMES Annual Meeting, 11–14 October 2023, Seattle, USA


A range of MDPI journals will be attending the 2023 BMES Annual Meeting as exhibitors. This meeting will be held in Seattle, USA, from 11 to 14 October 2023.

The BMES Annual Meeting will gather participants for networking, education, and continued growth in the biomedical engineering field. It is a premiere event centered around topics and discussions specific to our community. The theme of this year’s meeting is focused on the convergence of three pillars essential to our field’s success: science, technology, and social transformation.

The conference's vision is to center the perspective that the future of biomedical engineering requires and the curious evaluation of complex scientific challenges, while candidly considering intersectionality and social factors. Through creative programming, it will ensure that these three pillars are interwoven into all aspects of the meeting.

The following MDPI journals will be represented:

  • Bioengineering;
  • Biomedicines;
  • Biomimetics;
  • Cancers;
  • CIMB;
  • Diseases;
  • Micromachines;
  • Biosensors.

If you are attending this conference, please feel free to start a conversation with us at our booth at #931. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://www.bmes.org/annualmeeting.

11 July 2023
MDPI’s Newly Launched Journals in June 2023

With the first issue released in June 2023, five new MDPI journals disseminating multi-disciplinary science are due to launch, which will cover the subjects of medicine & pharmacology, biology and physical sciences.

The newly launched journals will be overseen by professional Editorial Board Members and Editors to ensure an accurate and rapid publication, rigorous peer review and broad visibility.

Please feel free to browse and discover more about the new journals below.

Journal Founding Editor-in-Chief Journal topics (selected)
Prof. Dr. Jun Ma, Peking University, China| Editorial | view inaugural issue growth and development;
diet and nutrients; school health promotion policies and practices; child health and care; adolescent health and wellbeing | view journal scope | submit an article
Prof. Dr. Bernd Rehm, Griffith University, Australia | Editorial | view inaugural issue DNA and gene synthesis; synthetic transcription factors; protein engineering; viral engineering; metabolic engineering | view journal scope | submit an article
Prof. Dr. Varsha Gandhi, University of Texas MD Anderson Cancer Center, USA | Editorial | view inaugural issue lymphatics; cancers associated with lymphocytes and lymphoblasts; lymphatic tissues; lymphoma; lymphoid leukemia | view journal scope | submit an article
Dr. Bradley Turner, University of Melbourne, Australia | Editorial | view inaugural issue multiple sclerosis; amyotrophic lateral sclerosis; primary lateral sclerosis; atherosclerosis; systemic sclerosis | view journal scope | submit an article
Prof. Dr. Clemens Burda, Case Western Reserve University, USA | Editorial | view inaugural issue Gamma ray, X-ray, and UV–Vis spectroscopies; NIR/mid-infrared/Raman spectroscopy; microwave and THz spectroscopy; high-resolution gas-phase atomic, molecular, and cluster spectroscopy; MS, NMR, and EPR spectroscopy | view journal scope | submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to submit an application to the New Journal Committee ([email protected]) if you would like to create more new journals.

3 July 2023
MDPI Insights: The CEO's Letter #1 - Open Access and Impactful Research

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

The Future is Open, and MDPI is Leading the Way

I strongly believe in a future that embraces openness, where open source, open information, and open access (OA) take center stage. This belief that led me to join MDPI in 2020, and I am honored to have recently been appointed as Chief Executive Officer (CEO). In this capacity, and operating in close liaison with Dr. Lin and MDPI’s senior management, I shall work to build on Dr. Lin’s achievements of the past quarter-century. In this role, I will focus on communication initiatives to promote MDPI's remarkable work and continue to build our company as a trusted leader in OA publishing. For over two decades, MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020. This trajectory is deeply rooted in our history and reflects our unwavering commitment and vision for an open future.

1 Million Published Articles

2023 began with a remarkable achievement for MDPI, as we became the first OA publisher to reach the milestone of 1 million published articles. This represents 2.7 million unique authors who have trusted us with their work, or about a third of all researchers worldwide. As the world's most cited OA publisher, we are proud in sharing these significant milestones.

Our mission remains unchanged: to make science open and accessible to all. We understand the importance of knowledge access, empowering researchers to stay at the forefront of a rapidly changing world. Our diverse range of journals covers a wide spectrum of disciplines, offering cutting-edge insights, trusted tools, and crucial knowledge to address global challenges.

Liberating Science

As the world’s leading OA publisher, MDPI is actively liberating science. We are committed to eliminating the frustrations researchers and the general public face when accessing information, ensuring it is not locked behind paywalls. We firmly believe that everyone has a right to information, and our commitment to open access publishing drives our work.

In this inaugural edition of Insights: The CEO's Letter, I draw inspiration from the upcoming 20th anniversary of the Berlin Declaration on Open Access. Its stated mission reminds us that true impact is achieved when knowledge is widely and readily available to society:

"Our mission of disseminating knowledge is only half complete if the information is not made widely and readily available to society”

Impactful Research

MDPI Publishes Impactful Research: Recognized by Leading Indexing Databases

MDPI journals are indexed in every single top database in the world.

As of June 2023, we have 214 journals indexed within Web of Science, 223 indexed within Scopus, 87 indexed within PubMed and PMC, and 17 indexed within MEDLINE, and these numbers increase every month. We constantly strive to expand the coverage of our journals within leading multi-disciplinary and scope-specific databases, resulting in an incredibly broad range of journals that are indexed within a variety of databases. MDPI has active relationships with approximately 65 well-known databases around the world, and we continue to expand our portfolio every year so that your work can be found, cited, and referenced with ease.

Continued Growth of MDPI Journals

The 2022 Scopus and Web of Science journal citation metrics were officially released in June, and I am pleased to report that 31 MDPI journals received their first CiteScore, taking the total number of journals with a CiteScore to 216. The number of MDPI journals receiving an Impact Factor (IF) also continues to grow with 111 receiving their first, by being covered in the ESCI, bringing our total number of journals with an IF to 208 of which 41 journals received an IF above 4.0. Looking at 2022 CiteScores in the Scopus database, 80% of MDPI journals have a score that ranks them in Q1 or Q2 in at least one subject category.

Publishing impactful science would not be possible without all of our authors, editors and reviewers. Thank you for your contribution and continued support! Together we share the latest scientific insights faster and ensure that your work is accessible to all.

Read more

Interview with Indexing Manager—Constanze Shelhorn

Inside MDPI

Preprints.org: Clarivate adds the Preprint Citation Index to the Web of Science

At MDPI, we are dedicated to driving the advancement of science. Through our initiative, Preprints.org, researchers can publish their work and gain valuable feedback from the broader research community, ensuring rapid progress in their respective fields. This is particularly crucial during times of health and climate challenges, where timely dissemination of findings is essential.

Increased Visibility for Preprints

I am pleased to share that Clarivate recognizes the significance of preprints and has taken a crucial step to enhance their visibility. Clarivate has added the Preprint Citation Index to the Web of Science, encompassing preprints published not only on Preprints.org but also on other reputable repositories.

Looking ahead, the future of preprints appears promising, bolstered by the recent indexing announcement from the Web of Science. As a result, preprints will receive increased visibility, serving as a valuable resource for staying informed about the latest research developments.

Read more

What are Preprints?
The Pros and Cons of Preprints
Preprints and COVID-19
Preprints—The Future of Open Access Publishing?

Coming Together for Science

The First International Conference on Antioxidants: Sources, Methods, Health Benefits and Industrial Applications

In this edition of ‘Coming Together for Science,’ I am pleased to highlight the First International Conference on Antioxidants organized by our conference team in the beautiful city of Barcelona, Spain. The conference attracted over 130 attendees, who engaged in 42 talks, and 89 poster presentations spread across several sessions.

Working Together

Under the leadership of Prof. Dr. Alessandra Napolitano (Department of Chemical Sciences, University of Naples ‘Federico II’, Naples, Italy) and Prof. Dr. Rosa M. Lamuela Raventos (Department of Nutrition, Food Sciences and Gastronomy, University of Barcelona, Spain) as chairs, and supported by the committee members, 10 invited keynote speakers, poster presenters, and all the attendees, this dedicated group of academics came together to discuss the natural sources, methodologies, health benefits, and industrial applications of antioxidants.

Especially noteworthy is the positive feedback received from attendees, with 94% rating the overall organization of the conference as good or excellent. I particularly love the picture above, capturing the gathering of some of the participants. You can browse through more photos in the event gallery located here.

Managing Events With Sciforum

If you are considering hosting your own academic event, I highly recommend checking out Sciforum, MDPI's event management platform. Sciforum simplifies the entire process, making it easy to host your own event by allowing you to focus on what really matters: Science!

Read more

Sciforum: forthcoming events
Spotlight on Antioxidants

Closing Thoughts

Stefan Tochev, Dr. Shu-Kun Lin, Dr. Eric O. Freed, Peter Roth, Wynne Wang, Allison Yang

Viruses and Editorial Quality: Acknowledging the Dedication of our Viruses Journal Team

During a June meeting with Dr. Eric O. Freed, the founding and current Editor-in-Chief of our journal Viruses, I was reminded of the exceptional dedication of our editorial board. Meeting with Eric is a pleasure, as he has a strong commitment and clear vision for the journal. Over the course of two days, we gained a deep understanding of the journal’s expectations and focus on strategic growth, editorial board representation, and engagement.

I am pleased to share that Viruses holds a CiteScore of 7.1 (an increase of 7.57% versus the 2021 metric) and an Impact Factor of 4.7. You can view the journal statistics here. Viruses publishes highly cited papers, and is indexed in renowned databases such as Scopus, SCIE (Web of Science), PubMed, and others, and maintains affiliations with prestigious societies. Moreover, the Viruses team has recently announced an exciting upcoming event titled ‘Viruses 2024 – A World of Viruses,’ scheduled to take place in Barcelona, Spain, from 14–16 February 2024.

Testimonials

If you notice my enthusiasm regarding our editorial service, it’s because the surveys and testimonials we receive speak volumes about the experiences of our authors, reviewers, and guest editors who collaborate with MDPI. The purpose of these letters is to highlight the exceptional work that we do and the experiences we create for the scholars – thus, let me end with this testimonial from an author:

“It was a great pleasure to publish in Viruses Special Issue [Emerging Viruses in Aquaculture]. The submission process was easy. Guest editors were very helpful and provided all the guidance and support as needed. The handling of the manuscript by the Editorial Team was very fast, efficient, and professional. The reviewer’s comments were insightful, and the publication processes were remarkably rapid.”
Ms. Magdalena Stachnik, Państwowy Instytut Weterynaryjny | PIWet

Article in Viruses: Emerging Viral Pathogens in Sturgeon Aquaculture in Poland: Focus on Herpesviruses and Mimivirus Detection

Stefan Tochev
Chief Executive Officer
MDPI AG

28 June 2023
2022 Impact Factors for MDPI Journals

The 2022 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

We are thrilled to announce that 90% of our ranked MDPI journals, specifically 86 out of 96 (captured in the table below), are performing above average in Q1 or Q2. This year, Clarivate has expanded its Impact Factor (IF) awards to include journals in the Emerging Sources Citation Index (ESCI) and the Arts and Humanities Citation Index (AHCI), providing greater transparency for the full set of journals indexed in the Web of Science Core Collection. As a result, 111 of MDPI journals have received their first IF in 2023, with 37 journals surpassing an IF of 3.0. In total, 208 MDPI journals have been honored with an IF.

Clarivate explains that by "expanding the coverage but holding to highly selective standards, the [Impact Factor] is now a reliable indicator of trustworthiness, as well as a measure of scholarly impact, at the journal level."

Please visit our blog post where we discuss the release of the latest citation metrics with our Indexing Manager, Dr. Constanze Schelhorn, to find out what's different this time around and how to make use of different metrics available.

Journal Impact Factor Rank Quartile Category
Vaccines 7.8 Q1 Immunology
Medicine, Research & Experimental
Antioxidants 7.0 Q1 Food Science & Technology
Biochemistry & Molecular Biology
Chemistry, Medicinal
Cells 6.0 Q2 Cell Biology
Nutrients 5.9 Q1 Nutrition & Dietetics
International Journal of Molecular Sciences 5.6 Q1 Biochemistry & Molecular Biology
Q2 Chemistry, Multidisciplinary
Journal of Theoretical and Applied Electronic Commerce Research 5.6 Q2 Business
Biomolecules 5.5 Q1 Biochemistry & Molecular Biology
Biosensors 5.4 Q1 Chemistry, Analytical
Instruments & Instrumentation
Q2 Nanoscience & Nanotechnology
Fractal and Fractional 5.4 Q1 Mathematics, Interdisciplinary Applications
Marine Drugs 5.4 Q1 Chemistry, Medicinal
Pharmacology & Pharmacy
Pharmaceutics 5.4 Q1 Pharmacology & Pharmacy
Nanomaterials 5.3 Q1 Physics, Applied
Q2 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Nanoscience & Nanotechnology
Cancers 5.2 Q2 Oncology
Foods 5.2 Q1 Food Science & Technology
Polymers 5.0 Q1 Polymer Science
Remote Sensing 5.0 Q1 Geosciences, Multidisciplinary
Q2 Remote Sensing
Imaging Science & Photographic Technology
Environmental Sciences
Antibiotics 4.8 Q1 Pharmacology & Pharmacy
Q2 Infectious Diseases
Drones 4.8 Q2 Remote Sensing
Journal of Functional Biomaterials 4.8 Q2 Engineering, Biomedical
Materials Science, Biomaterials
Biomedicines 4.7 Q1 Pharmacology & Pharmacy
Q2 Biochemistry & Molecular Biology
Medicine, Research & Experimental
Journal of Fungi 4.7 Q2 Mycology
Microbiology
Viruses 4.7 Q2 Virology
Bioengineering 4.6 Q2 Engineering, Biomedical
Gels 4.6 Q1 Polymer Science
Molecules 4.6 Q2 Chemistry, Multidisciplinary
Biochemistry & Molecular Biology
Pharmaceuticals 4.6 Q2 Pharmacology & Pharmacy
Chemistry, Medicinal
Toxics 4.6 Q1 Toxicology
Q2 Environmental Sciences
Biomimetics 4.5 Q1 Engineering, Multidisciplinary
Q2 Materials Science, Biomaterials
Microorganisms 4.5 Q2 Microbiology
Plants 4.5 Q1 Plant Sciences
Biology 4.2 Q2 Biology
Chemosensors 4.2 Q2 Instruments & Instrumentation
Chemistry, Analytical
Electrochemistry
Membranes 4.2 Q2 Engineering, Chemical
Materials Science, Multidisciplinary
Chemistry, Physical
Polymer Science
Toxins 4.2 Q1 Toxicology
Q2 Food Science & Technology
Metabolites 4.2 Q2 Biochemistry & Molecular Biology
Batteries 4.0 Q2 Electrochemistry
Materials Science, Multidisciplinary
Q3 Energy & Fuels
Catalysts 3.9 Q2 Chemistry, Physical
Journal of Clinical Medicine 3.9 Q2 Medicine, General & Internal
Land 3.9 Q2 Environmental Studies
Sensors 3.9 Q2 Instruments & Instrumentation
Chemistry, Analytical
Engineering, Electrical & Electronic
Sustainability 3.9 Q2 Environmental Sciences (SCIE)
Environmental Studies (SSCI)
Q3 Green & Sustainable Science & Technology (SCIE)
Green & Sustainable Science & Technology (SSCI)
Buildings 3.8 Q2 Construction & Building Technology
Engineering, Civil
Agronomy 3.7 Q1 Agronomy
Q2 Plant Sciences
Fermentation 3.7 Q2 Biotechnology & Applied Microbiology
Pathogens 3.7 Q2 Microbiology
Agriculture 3.6 Q1 Agronomy
Diagnostics 3.6 Q2 Medicine, General & Internal
Genes 3.5 Q2 Genetics & Heredity
Journal of Intelligence 3.5 Q2 Psychology, Multidisciplinary
Lubricants 3.5 Q2 Engineering, Mechanical
Processes 3.5 Q2 Engineering, Chemical
Coatings 3.4 Q2 Materials Science, Coatings & Films
Physics, Applied
Q3 Materials Science, Multidisciplinary
ISPRS International Journal of Geo-Information 3.4 Q2 Geography, Physical
Q3 Computer Science, Information Systems
Remote Sensing
Materials 3.4 Q2 Metallurgy & Metallurgical Engineering
Physics, Applied
Physics, Condensed Matter
Q3 Materials Science, Multidisciplinary
Chemistry, Physical
Micromachines 3.4 Q2 Instruments & Instrumentation
Physics, Applied
Chemistry, Analytical
Q3 Nanoscience & Nanotechnology
Water 3.4 Q2 Water Resources
Environmental Sciences
Brain Sciences 3.3 Q3 Neurosciences
Energies 3.2 Q3 Energy & Fuels
Fire 3.2 Q1 Forestry
Q2 Ecology
Life 3.2 Q2 Biology
Current Issues in Molecular Biology 3.1 Q3 Biochemistry & Molecular Biology
Horticulturae 3.1 Q1 Horticulture
Animals 3.0 Q1 Agriculture, Dairy & Animal Science
Veterinary Sciences
Insects 3.0 Q1 Entomology
Atmosphere 2.9 Q3 Meteorology & Atmospheric Sciences
Environmental Sciences
Electronics 2.9 Q2 Engineering, Electrical & Electronic
Physics, Applied
Q3 Computer Science, Information Systems
Forests 2.9 Q1 Forestry
Inorganics 2.9 Q2 Chemistry, Inorganic & Nuclear
Journal of Marine Science and Engineering 2.9 Q1 Engineering, Marine
Q2 Oceanography
Engineering, Ocean
Metals 2.9 Q2 Metallurgy & Metallurgical Engineering
Q3 Materials Science, Multidisciplinary
Tropical Medicine and Infectious Disease 2.9 Q2 Tropical Medicine
Parasitology
Q3 Infectious Diseases
Universe 2.9 Q2 Astronomy & Astrophysics
Physics, Particles & Fields
Healthcare 2.8 Q2 Health Policy & Services (SSCI)
Q3 Health Care Sciences & Services (SCIE)
Applied Sciences 2.7 Q2 Engineering, Multidisciplinary
Physics, Applied
Q3 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Crystals 2.7 Q2 Crystallography
Q3 Materials Science, Multidisciplinary
Entropy 2.7 Q2 Physics, Multidisciplinary
Magnetochemistry 2.7 Q2 Chemistry, Inorganic & Nuclear
Q3 Chemistry, Physical
Materials Science, Multidisciplinary
Symmetry 2.7 Q2 Multidisciplinary Sciences
Actuators 2.6 Q2 Instruments & Instrumentation
Engineering, Mechanical
Aerospace 2.6 Q1 Engineering, Aerospace
Behavioral Sciences 2.6 Q2 Psychology, Multidisciplinary
Current Oncology 2.6 Q3 Oncology
Machines 2.6 Q2 Engineering, Mechanical
Q3 Engineering, Electrical & Electronic
Medicina 2.6 Q3 Medicine, General & Internal
Separations 2.6 Q3 Chemistry, Analytical
Minerals 2.5 Q2 Mining & Mineral Processing
Mineralogy
Geochemistry & Geophysics
Children 2.4 Q2 Pediatrics
Diversity 2.4 Q2 Biodiversity Conservation
Q3 Ecology
Journal of Cardiovascular Development and Disease 2.4 Q3 Cardiac & Cardiovascular Systems
Mathematics 2.4 Q1 Mathematics
Photonics 2.4 Q3 Optics
Veterinary Sciences 2.4 Q1 Veterinary Sciences
Fishes 2.3 Q2 Marine & Freshwater Biology
Fisheries
Axioms 2.0 Q2 Mathematics, Applied
Systems 1.9 Q2 Social Sciences, Interdisciplinary
Tomography 1.9 Q3 Radiology, Nuclear Medicine & Medical Imaging


Note: The Journal of Personalized Medicine's Impact Factor was omitted in the original release and will be assigned separately. Please find the data on the journal webpage in due course.

Source: 2022 Journal Impact Factors, Journal Citation Reports TM (Clarivate, 2023)

 

27 June 2023
Bioengineering | A Commemorative Issue in Honor of Professor Alexander Friedenstein’s Outstanding Achievements

We are proud to announce a Special Issue of Bioengineering (ISSN: 2306-5354) “A Tribute to Professor Alexander Friedenstein and His Outstanding Achievements in the Area of Stromal Stem Cells”, devoted to the pioneering work of Professor Alexander Friedenstein and his ground-breaking discoveries in stromal stem cells. Prof. Friedenstein is rightly credited with the discovery of mesenchymal stem cells (MSCs), having defined them as stroma-resident cells that fulfill the main criteria attributed to stem cells, making them highly important in the field of regenerative medicine. Single-cell-derived clones of stromal progenitors have been shown to have an intrinsic ability to form bone, cartilage, and connective tissues in vivo, paving the way for a range of cell therapies and tissue engineering developments.

As we approach the centenary of Professor Friedenstein’s birth in 2024, we pay tribute to his outstanding achievements in this field through a Special Issue edited by Dr. Elena A. Jones, Dr. Dimitrios Kouroupis, and Dr. Rodrigo Somoza. The Issue will include original research articles and reviews that celebrate his legacy, exploring issues such as how we can best isolate and culture MSCs, enhance their desired functions, and control their differentiation or trophic activity through their microenvironment. We also consider the benefits and limitations of MSCs versus MSC-derived extracellular vesicles for therapeutics, and how we can effectively isolate MSCs-derived extracellular vesicles and reinforce their therapeutic signatures.

Professor Alexander Friedenstein’s groundbreaking work on stromal stem cells has opened up new frontiers in regenerative medicine and continues to inspire research into new applications in the field.

We invite submissions that celebrate his incredible legacy and honor his memory. You can click here to go to the submission form.

14 June 2023
Meet Us at the 2023 Chinese Biophysics Congress, 19–23 July 2023, Changsha, China
 


Conference:
2023 Chinese Biophysics Congress
Date: 19–23 July 2023
Place: Changsha, China

MDPI will be attending the 2023 Chinese Biophysics Congress, which will be held from 19 to 23 July 2023 in Changsha, China.

The Chinese Biophysics Congress is the largest and most developed academic event in the field of biophysics in China. Prof. Tao Xu, the chairman of the Chinese Society of Biophysics, will be the chair of the organizing committee. The main theme is Biophysics and Human Health, focusing on the latest research progress and development trend of biophysics and related research fields.

The following MDPI journals will be represented:

  • IJMS;
  • Biophysica;
  • Biomedicines;
  • Physics;
  • CIMB;
  • Bioengineering;
  • Biomolecules.

Please do not hesitate to reach out ([email protected]) if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have. For more information about the conference, please visit the following website: https://www.bsc.org.cn/2023/.

25 May 2023
Bioengineering | Hot Papers in 3D Bioprinting

Three-dimensional bioprinting is an evolving technology that is used for biomedical research and healthcare. It involves the creation of three-dimensional structures using living cells and biomaterials with the help of a bio-printer. Three-dimensional bioprinting can be used to create complex living tissue structures, such as organs, bones, and skin, which can be used for transplantation and other clinical applications. This technology has become popular in recent years, as it offers a promising solution to organ shortages and could help improve patients’ outcomes. In this context, we are pleased to feature some recently published papers on 3D bioprinting in Bioengineering (ISSN: 2306-5354), which provide valuable insights into this exciting field.

1. “3D Printed Nanocellulose Scaffolds as a Cancer Cell Culture Model System”
by Jennifer Rosendahl, Andreas Svanström, Mattias Berglin, Sarunas Petronis, Yalda Bogestål, Patrik Stenlund, Simon Standoft, Anders Ståhlberg, Göran Landberg, Gary Chinga-Carrasco et al.
Bioengineering 2021, 8(7), 97; https://doi.org/10.3390/bioengineering8070097
Available online: https://www.mdpi.com/2306-5354/8/7/97

2. “Bioprinting Scaffolds for Vascular Tissues and Tissue Vascularization”
by Peter Viktor Hauser, Hsiao-Min Chang, Masaki Nishikawa, Hiroshi Kimura, Norimoto Yanagawa, and Morgan Hamon
Bioengineering 2021, 8(11), 178; https://doi.org/10.3390/bioengineering8110178
Available online: https://www.mdpi.com/2306-5354/8/11/178

3. “Biofabrication Strategies for Musculoskeletal Disorders: Evolution towards Clinical Applications”
by Saman Naghieh, Gabriella Lindberg, Maryam Tamaddon and Chaozong Liu
Bioengineering 2021, 8(9), 123; https://doi.org/10.3390/bioengineering8090123
Available online: https://www.mdpi.com/2306-5354/8/9/123

4. “Recapitulating the Angiogenic Switch in a Hydrogel-Based 3D In Vitro Tumor-Stroma Model”
by Claudia Kuehlbach, Sabine Hensler, and Margareta M. Mueller
Bioengineering 2021, 8(11), 186; https://doi.org/10.3390/bioengineering8110186
Available online: https://www.mdpi.com/2306-5354/8/11/186

5. “Natural Biomaterials and Their Use as Bioinks for Printing Tissues”
by Claire Benwood, Josie Chrenek, Rebecca L. Kirsch, Nadia Z. Masri, Hannah Richards, Kyra Teetzen and Stephanie M. Willerth
Bioengineering 2021, 8(2), 27; https://doi.org/10.3390/bioengineering8020027
Available online: https://www.mdpi.com/2306-5354/8/2/27

6. “Protein-Based 3D Biofabrication of Biomaterials”
by Mahta Mirzaei, Oseweuba Valentine Okoro, Lei Nie, Denise Freitas Siqueira Petri and Amin Shavandi
Bioengineering 2021, 8(4), 48; https://doi.org/10.3390/bioengineering8040048
Available online: https://www.mdpi.com/2306-5354/8/4/48

7. “The Importance of Mimicking Dermal-Epidermal Junction for Skin Tissue Engineering: A Review”
by Mina Aleemardani, Michael Zivojin Trikić, Nicola Helen Green and Frederik Claeyssens
Bioengineering 2021, 8(11), 148; https://doi.org/10.3390/bioengineering8110148
Available online: https://www.mdpi.com/2306-5354/8/11/148

8. “Advantages of Additive Manufacturing for Biomedical Applications of Polyhydroxyalkanoates”
by Alberto Giubilini, Federica Bondioli, Massimo Messori, Gustav Nyström and Gilberto Siqueira
Bioengineering 2021, 8(2), 29; https://doi.org/10.3390/bioengineering8020029
Available online: https://www.mdpi.com/2306-5354/8/2/29

9. “3D Printing of Thermoresponsive Hydrogel Laden with an Antimicrobial Agent towards Wound Healing Applications”
by Martyna Nizioł, Justyna Paleczny, Adam Junka, Amin Shavandi, Anna Dawiec-Liśniewska and Daria Podstawczyk
Bioengineering 2021, 8(6), 79; https://doi.org/10.3390/bioengineering8060079
Available online: https://www.mdpi.com/2306-5354/8/6/79

10. “Translational Application of 3D Bioprinting for Cartilage Tissue Engineering”
by Sophie McGivern, Halima Boutouil, Ghayadah Al-Kharusi, Suzanne Little, Nicholas J. Dunne and Tanya J. Levingstone
Bioengineering 2021, 8(10), 144; https://doi.org/10.3390/bioengineering8100144
Available online: https://www.mdpi.com/2306-5354/8/10/144

18 May 2023
Bioengineering Webinar | Bioengineered Systems: Implants and Devices for Orthopaedic Applications, Held on 20 April 2023

On 20 April 2023, MDPI hosted a webinar for a Special Issue titled “Bioengineered Systems: Implants and Devices for Orthopaedic Applications”. The webinar featured the Special Issue’s Guest Editors, Dr. David E. Anderson, Dr. Madhu S. Dhar and Dr. Dustin L. Crouch. All speakers were from the University of Tennessee, Knoxville, USA, and this multidisciplinary team represented expertise in implant interfaces, regenerative medicine, tissue engineering and biomedical engineering. The Guest Editors/Speakers discussed how technological advances in orthopaedic research are accelerating in multiple areas, including endoprosthetics, tissue regeneration, and biotherapies.

Thank you for attending and we also wish to thank the Bioengineering team and MDPI for organizing and hosting this webinar.

You can watch the recorded webinar at the following link: https://youtu.be/wtoXrPe5fzc.

Please note that this webinar is associated with a Special Issue in the Bioengineering (ISSN: 2306-5354) journal: “Bioengineered Systems: Implants and Devices for Orthopaedic Applications”. The deadline is 31 May 2023.

Webinar Chair and Keynote Speakers:

  • Dr. David E. Anderson, College of Veterinary Medicine, University of Tennessee, Knoxville, TN, USA;
  • Dr. Madhu S. Dhar, Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, TN, USA;
  • Dr. Dustin L. Crouch, Department of Mechanical, Aerospace & Biomedical Engineering, College of Engineering, University of Tennessee, Knoxville, TN, USA.

12 April 2023
Bioengineering Webinar | Bioengineered Systems: Implants and Devices for Orthopaedic Applications, 20 April 2023


We look forward to providing this exciting webinar related to our Bioengineering (ISSN: 2306-5354) Special Issue, "Bioengineered Systems: Implants and Devices for Orthopaedic Applications". The topic is broad and highly interdisciplinary, so it should be of interest to many, both researchers and practitioners. There has been and much progress and innovation in this area, with the promise to improve healthcare for a wide range of orthopaedic and other clinical problems.

The Guest Editors of this Special Issue invite you to participate in this webinar. Following the presentations, there will be a question-and-answer session. We look forward to a lively and interactive exchange of ideas.
We hope to see you soon!

Date: 20 April 2023 at 2:00 p.m. CEST | 8:00 a.m. EDT | 8:00 p.m. CST Asia
Webinar ID: 852 1064 4327

Register now for free!

Program

Speaker/Presentation

Time in CEST

Dr. David E. Anderson (Chair)
Chair Introduction

 2:00–2:05 p.m.

Dr. David E. Anderson
Tissue Engineering Approach to Implant–Tissue Interfaces

 2:05–2:20 p.m.

Dr. Madhu S. Dhar
Bioengineered Systems to Control Cell Fate

 2:20–2:35 p.m.

Dr. Dustin L. Crouch
Bioengineered Artificial Limbs for Direct Interface with Musculoskeletal Tissues

 2:35–2:50 p.m.

Q&A

 2:50–3:05 p.m.

Dr. David E. Anderson (Chair)
Closing of Webinar

 3:05–3:15 p.m.

After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Unable to attend? Register anyway and we will let you know when the recording is available to watch.

Webinar Chair and Keynote Speakers:

  • Dr. David E. Anderson, College of Veterinary Medicine, University of Tennessee, Knoxville, TN, USA
  • Dr. Madhu S. Dhar, Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, TN, USA
  • Dr. Dustin L. Crouch, Department of Mechanical, Aerospace & Biomedical Engineering, College of Engineering, University of Tennessee, Knoxville, TN, USA

Relevant Special Issue:
Bioengineered Systems: Implants and Devices for Orthopaedic Applications
Guest Editors: Dr. David Edgar Anderson, Dr. Madhu S. Dhar and Dr. Dustin Crouch
Deadline for manuscript submissions: 31 May 2023

Relevant feature papers:
“Role of Implantable Drug Delivery Devices with Dual Platform Capabilities in the Prevention and Treatment of Bacterial Osteomyelitis”
Bioengineering 2022, 9(2), 65; doi:10.3390/bioengineering9020065

“Effects on Tissue Integration of Collagen Scaffolds Used for Local Delivery of Gentamicin in a Rat Mandible Defect Model”
Bioengineering 2022, 9(7), 275; doi:10.3390/bioengineering9070275

“Feasibility of Implanting a Foot–Ankle Endoprosthesis within Skin in a Rabbit Model of Transtibial Amputation”
Bioengineering 2022, 9(8), 348; doi:10.3390/bioengineering9080348

11 April 2023
Bioengineering | High-Quality Special Issues


The Special Issues below have been selected as high-quality Special Issues for 2022 by the Editorial Office of Bioengineering (ISSN: 2306-5354). We hope that they provide insights and references for scholars in related fields.

1. “Convergence of Science and Engineering: A Promising Window toward Improving the Public Health”
Edited by Ali Zarrabi
Webpage: https://www.mdpi.com/journal/bioengineering/special_issues/convergence_sci_eng
Viewed by 16,316 | Cited by 16

2. “Feature Papers in Nanotechnology Applications in Bioengineering”
Edited by Gou-Jen Wang
Webpage: https://www.mdpi.com/journal/bioengineering/special_issues/Nanotechnology_Application_Bioengineering
Viewed by 13121 | Cited by 8

3. “Artificial Intelligence Based Computer-Aided Diagnosis”
Edited by Jijiang Yang and Jianqiang Li
Webpage: https://www.mdpi.com/journal/bioengineering/special_issues/AI_computer_aided_diagnosis
Viewed by 14195 | Cited by 26

4. “Recent Advances of Medical Devices”
Edited by Robert M. DiBlasi and Crescenzio Gallo
Webpage: https://www.mdpi.com/journal/bioengineering/special_issues/Medical_Devices_bioengineering
Viewed by 13650 | Cited by 12

5. “Bioprinting of Tissue-Engineered Scaffolds: Design Strategies & Printability of Smart Biomaterials”
Edited by Chaozong Liu, Saman Naghieh and Gabriella Lindberg
Webpage: https://www.mdpi.com/journal/bioengineering/special_issues/tissue-engineered_scaffolds
Viewed by 19194 | Cited by 45

If you are an active researcher in the field and are passionate about participating in editorial work, please do not hesitate to contact the Bioengineering Editorial Office ([email protected])

31 March 2023
Interview with Prof. Dr. Tri Indah Winarni—Author of Papers Published in Bioengineering

We had the pleasure of speaking with Prof. Dr. Tri Indah Winarni, author of two papers published in Bioengineering (ISSN: 2306-5354). We discussed the recent research trends in the field, and her personal career development.

Prof. Dr. Tri Indah Winarni's articles published in Bioengineering:

  1. Effect of Short-Term Deep-Pressure Portable Seat on Behavioral and Biological Stress in Children with Autism Spectrum Disorders: A Pilot Study
  2. Physiological Effect of Deep Pressure in Reducing Anxiety of Children with ASD during Traveling: A Public Transportation Setting

The following is an interview with Prof. Dr. Tri Indah Winarni:

1. Congratulations on your published papers. Can you provide a background about yourself and what your research areas are?
I am a Professor at Universitas Diponegoro from the Department of Anatomy, Faculty of Medicine. My research area is autism spectrum disorders, including fragile X syndrome, and five years ago we established the Undip Biomechanical Engineering Research Center (UBM-RC). Since then, we have explored more research areas to establish deep pressure therapy to help with anxiety.

2. What are the current cutting-edge research topics in your field of interest?
Providing handy and effective deep pressure therapy for children with autism spectrum disorders.

3. What made you decide to publish an article in Bioengineering?
Bioengineering is a reputable journal, more open for researchers worldwide, giving the chance to publish important findings. The publishing experience was nice, helpful, with thorough peer review, and fast (sometimes too fast, but it is good for students). Moreover, the Open Access model helps to increase the citation rate. The Open Access model is great, but also not for students, because it was very expensive to publish a paper.

4. What do you hope that readers will get from your papers?
They will get appropriate information for their research and scientific contributions, and it is also useful for patients/parents, who can get more updated information.

We are thankful for Prof. Dr. Tri Indah Winarni's time and support for the Bioengineering journal.

Prof. Dr. Tri Indah Winarni's contact information:
Email: [email protected]

13 March 2023
Interview with Rodolfo Reda—Author of a Published Paper in Bioengineering

We had the pleasure of speaking with Rodolfo Reda, one of the authors of the published paper “An Update on Nickel–Titanium Rotary Instruments in Endodontics: Mechanical Characteristics, Testing and Future Perspective—An Overview” in Bioengineering (ISSN: 2306-5354). We discussed the recent research trends in the field and his personal career development.

Name: Rodolfo Reda
Email: [email protected]
Article title: “An Update on Nickel–Titanium Rotary Instruments in Endodontics: Mechanical Characteristics, Testing and Future Perspective—An Overview”

 

 

 

 

 

1. Congratulations on your published paper. Can you please provide background about yourself and what your research areas are?
Thanks for the opportunity. I am a DDS and currently a Ph.D. student at Sapienza University of Rome, Italy, where I graduated. I concentrated my research activity on Ni-Ti alloys and the characteristics of Ni-Ti rotary files used in endodontics. I approached the world of stem cell studies in the laboratory, studying their reactions as a function of the different reagents to which they were subjected. Subsequently, my passion for biochemical and molecular alterations led me to analyze the tissue conditions around dental implants to determine how they affect the implant-supported prostheses features.

2. What are the current cutting-edge research topics in your field of interest?
I believe that the challenge for the future is to reduce the invasiveness of our clinical procedures. To do this, it is necessary to fully understand the biochemical/molecular alterations that lead to the predisposing conditions of the disease or its initial stages in order to be able to prevent it or at least cure it in advance.

3. What made you decide to publish an article in Bioengineering? Why did you choose Bioengineering?
The rapid growth that the journal has had is a symptom of the great attention from the editors. In fact, I can confirm this considering the number of articles they have published and the success they have achieved. I chose this journal because it was the most suitable for the type of article I intended to submit.

4. How was your experience publishing with Bioengineering?
Very simple and quick. The journal’s management is effective, allowing it to reduce the time between the various phases of the peer-review—it is a system that works well.

5. Was it important to you that the journal is Open Access?
I believe that scientific culture should be as freely accessible as possible. The possibility of Open Access publishing favors the dissemination of scientific knowledge.

6. How do you think Open Access impacts authors?
Some are frightened away by the costs of managing such a system. However, it should not be intimidating because it is possible for them to achieve excellent results, often with important help from the journal when they exploit an excellent article or study.

7. What do you hope that readers will get from your paper?
Curiosity. I believe that the most important thing a scientific article can achieve is to stimulate the reader’s curiosity, enticing other clinicians to research in this same area, perhaps with a few more new ideas.

We are thankful for Rodolfo Reda's time and support for Bioengineering

13 March 2023
Interview with Dr. Anthony Atala—Editorial Board Member of Bioengineering

We had the pleasure of speaking with Dr. Anthony Atala, Editorial Board Member of Bioengineering (ISSN: 2306-5354), to discuss the recent trends in the field and his personal career developments.

Anthony Atala, M.D., is the G. Link Professor and Director of the Wake Forest Institute for Regenerative Medicine and the W. Boyce Professor and Chair of the Department of Urology at Wake Forest University, USA. His work focuses on growing human cells, tissues, and organs. Sixteen technological applications developed in Dr. Atala's laboratory have been employed clinically in human patients.

Dr. Atala was elected to the Institute of Medicine of the National Academies of Sciences (now the National Academy of Medicine), to the National Academy of Inventors as a Charter Fellow, and to the American Institute for Medical and Biological Engineering. Dr. Atala is a recipient of the US Congress funded Christopher Columbus Foundation Award, bestowed on a living American who is currently pursuing a discovery that will significantly affect society; the World Technology Award in Health and Medicine, for achieving significant and lasting progress; the Edison Science/Medical Award; the Fast Company World Changing Ideas Award; the R&D Innovator of the Year Award; the Smithsonian Ingenuity Award; and the 2022 Jacobson Innovation Award of the American College of Surgeons for his pioneering work in regenerative medicine.

Dr. Atala’s work was listed twice in Time Magazine’s top ten medical breakthroughs of the year, and as one of five discoveries that will change the future of organ transplantation. In 2019, Dr. Atala’s work was ranked by the Project Management Institute as one of the top ten most impactful biotech projects of the past 50 years. Dr. Atala was named by Scientific American as one of the world’s most influential people in biotechnology, by U.S. News & World Report as one of fourteen pioneers of medical progress in the 21st century, by Life Sciences Intellectual Property Review as one of fifty key influencers in the life sciences intellectual property arena, and by Nature Biotechnology as one of the top ten translational researchers in the world.

Dr. Atala has led or served on several national professional and government committees, including the National Institutes of Health work group on Cells and Developmental Biology, the National Institutes of Health Bioengineering Consortium, and the National Cancer Institute’s Advisory Board. He was a Founder of the Tissue Engineering Society, the Regenerative Medicine Society, the Regenerative Medicine Foundation, the Alliance for Regenerative Medicine, the Regenerative Medicine Development Organization, the Regenerative Medicine Manufacturing Society, and the Regenerative Medicine Manufacturing Consortium.

Dr. Atala works with several journals in a variety of capacities, including as Editor-in-Chief of Stem Cells Translational Medicine, Therapeutic Advances in Urology, and BioPrinting. He is the editor of 25 books, has published more than 800 journal articles, and has applied for or received over 250 national and international patents.

We hope you enjoy the interview.

1. What are your research areas?
Our work focuses on growing human cells, tissues, and organs for human transplantation. We are working on developing replacement organs and tissues, as well as healing cell therapies, for more than 40 different areas of the body. Projects range from blood vessels and kidneys to cell therapies for lung disease and hemophilia. We are pursuing multiple strategies, including 3D printing, to move our projects forward to meet our ultimate goal—making patients better. We are also working extensively in using regenerative medicine approaches for body-on-a-chip systems for drug development and microphysological modeling.

2. What are the latest developments in your research field?
To envision the next transformational steps for the field, we can look at current technologies for the 3D printing of cartilage, bone and skin constructs which can serve as benchmarks for progress. As we understand the factors that have contributed to their success, and as we anticipate advances overall in the bioprinting of materials and cells, current limitations can hopefully be overcome in the short term. The continued development of materials for 3D printing, cell sourcing, tissue structure and biomechanical properties, should have a significant impact on moving the field forward.

3. Can you briefly share your career development story? For example, what cases have influenced you the most?
As I initially pursued medicine, I never even considered research. In fact, I had to be talked into doing a research fellowship after I finished my medical training. Yet once I started on that path, I realized I didn’t want to turn back. Research has been an important part of my career and life ever since. The Wake Forest Institute for Regenerative Medicine research teams are driven by its mission—to improve patients’ lives through regenerative medicine. The goal is to create replacement tissues and organs for patients. It is estimated that every 30 seconds, a patient dies from a disease that could be treated with tissue replacement. There are simply not enough donor tissues and organs to meet the demand. Regenerative medicine offers the hope of engineering replacement organs in the lab to help solve this shortage. Because these organs would be made with a patient’s own cells, there would be no issues with rejection.

4. Do you have any advice you would like to share with young students and early career researchers?
I think it’s important not to put limitations on yourself and your thinking. My advice is always to be receptive to new opportunities and change and to seek advice and input from people who can help when you have a decision to make that can change your life’s trajectory.

5. What do you think of the development of Open Access in publishing?
I am generally in favor of Open Access. Both the scientific community and the general public benefit when publications are widely available. Another consideration is of course financial. Publication fees are often used as an alternative to reader charges, and that can have downsides; for example, bias against less well-funded researchers.

We are thankful for Dr. Atala's time and for his continued support of Bioengineering.

Dr. Anthony Atala’s contact information:
Email: [email protected]

13 March 2023
Interview with Prof. Dr. Ali Zarrabi—Editorial Board Member of Bioengineering

We had the pleasure of speaking with Prof. Dr. Ali Zarrabi, an Editorial Board Member of Bioengineering (ISSN: 2306-5354), to discuss the recent research trends in the field and his personal career developments. We hope you enjoy the interview.

1. What are your research areas?
My research area is translational nano-bioengineering. It is a multi-disciplinary research field with the mission of performing cutting-edge fundamental and applied research, rooted firmly in nano- and bio-engineering, leading to the development of novel diagnostic/treatment methods for a range of diseases and conditions. Translation is the process of turning laboratory studies into results that directly benefit the health of individuals and the public. It will cover the entire range of basic science and pre-clinical discoveries in diagnostics and therapeutics.

2. What are the latest developments in your research field?
We have developed several bioengineered nano-composites for drug delivery, disease/biomarker diagnosis, tissue engineering (repair or replacement), and wound healing applications. In my research group, the young researchers will be given the opportunity to conduct collaborative research with other groups of highly diverse backgrounds and expertise. Our research spans many areas, including cancer, aging, pharmacology and toxicology, drug delivery, infection, and nutrition.

3. Can you briefly share your career development story? For example, what cases have influenced you the most?
Having seen the influence of interdisciplinary research on the health of society, I decided to become a part of this success story, even with a tiny contribution. I have continuously tried hard in the hopes of conquering the peak and planning for the next.

4. Do you have any valuable suggestions that you would like to share with young students and early career researchers?
Young students should not be discouraged if they do not reach their desired results immediately. They must keep going and try hard to find the way to go.
About the early career researchers, do not underestimate the following:
1. Group work;
2. The miracle of working with undergraduates.
The current student generation has numerous unmet capabilities that you could discover.

5. What do you think of the development of Open Access in publishing?
In my opinion, it is more than necessary to make the results of research available to the public. Especially now that the science development rate is higher than at any time in history, we should keep our findings open to contribute to universal development. Otherwise, our findings will be out of date soon after we publish them in a non-open manner.

We are thankful for Prof. Dr. Zarrabi's time and support of Bioengineering.

Prof. Dr. Zarrabi's contact information:
Email: [email protected]

13 March 2023
MDPI’s Newly Launched Journals in December 2022

As a leading open access publisher, MDPI provides scholars with a high-quality and rich academic exchange platform by continuously expanding into new and exciting research areas.

In December 2022, MDPI launched five new journals, covering multiple subjects such as life sciences, biology, medicine and pharmacology, social sciences and humanities. These new journals are being edited by established scholars across the world.

Journal

Founding Editor-in-Chief

Journal Topics (Selected)

Prof. Dr. Fabio Gresta, University of Messina, Italy| Editorial | view inaugural issue

grass/forage/turf production; grassland management; pasture monitoring; grazing and livestock; grass agro-ecosystems| view journal scope | submit an article

Prof. Dr. Christos G. Athanassiou, University of Thessaly, Greece| Editorial | view inaugural issue

pesticides; fungicides; herbicides; fertilizers; soil conditioners| view journal scope | submit an article

Prof. Dr. Stephen H. Safe, Texas A&M University, USA| Editorial | view inaugural issue

receptor structure; receptor function; receptor signaling; receptor expression and regulation; receptor interactions with drugs| view journal scope | submit an article

Dr. Jean Jacques Vanden Eynde, University of Mons-UMONS, Belgium| Editorial | view inaugural issue

drug discovery; medicinal chemistry; preclinical and clinical research; marketed drugs; intellectual property and regulatory affairs| view journal scope | submit an article

Prof. Dr. Heather Kanuka, University of Alberta, Canada| Editorial | view inaugural issue

higher education; tertiary education; policy and practice in higher education; educational leadership in higher education; educational administration and management in higher education| view journal scope | submit an article

If you are interested in creating more open access journals with us to publish cutting-edge research, please send your journal proposal application to [email protected].

7 March 2023
Displaying Co-Authors’ Email Addresses on the Webpage of Published Papers

MDPI is pleased to announce that we now display the co-authors’ email addresses in addition to the corresponding author’s email address on the webpage of published papers, protected by Captcha. For more information about this change, please visit the journal’s instructions for authors page. 

We believe this change will facilitate academic discussions and advance our cause of open science and research. The corresponding authors are responsible for communicating with their co-authors and indicating in our system (https://susy.mdpi.com/) if co-authors would prefer for their email addresses not to be displayed.

6 March 2023
Bioengineering | Interview with Prof. Dr. Fergal J. O'Brien

We had the pleasure of speaking with Prof. Dr. Fergal J. O'Brien, Editorial Board Member of Bioengineering (ISSN: 2306-5354). Prof. Dr. O'Brien is working as Professor of bioengineering and regenerative medicine and is the Head of the Tissue Engineering Research Group which is based in the Royal College of Surgeons in Ireland. He is also part of the leadership team of the Advanced Materials and Bioengineering Research Centre and is Deputy Vice Chancellor for Research and Innovation at RCSI.

We hope you enjoy the interview!

6 March 2023
Interview with Prof. Dr. Stephanie Willerth—Author of a Published Paper in Bioengineering

We had the pleasure of speaking with Prof. Dr. Stephanie Willerth, author of the published paper “Natural Biomaterials and Their Use as Bioinks for Printing Tissues” in Bioengineering (ISSN: 2306-5354). We discussed the recent research trends in the field and her personal career developments.

1. Congratulations on your published paper. Can you please tell us a bit about yourself and what your research areas are?
I am a Full Professor and the Canada Research Chair at the University of Victoria where I hold dual appointments in the Department of Mechanical Engineering and the Division of Medical Sciences. I also hold an affiliate appointment with the School of Biomedical Engineering at the University of British Columbia. I run a research group that investigates how to engineer neural tissue from induced pluripotent stem cells (iPSCs) using a variety of methods, including 3D bioprinting and cellular reprogramming. My research group has developed many types of biomaterial scaffolds for promoting the differentiation of iPSCs into neural cell types for tissue engineering applications, such as screening the toxicity of drugs, learning about how tissues form during development, and replacing dysfunctional tissues. I also founded the spin-off company Axolotl Biosciences, with the goal of bioprinting neural tissues that are easily accessible to scientists and engineers from a range of backgrounds.

2. What are the current cutting-edge research topics in your field of interest?
The field of 3D bioprinting is evolving at a rapid rate. It has been interesting to see the new bioprinters being developed along with recent advances in bioinks that allow for the generation of tissues similar to those found in the human body. The use of 3D bioprinting for clinical applications is also another hot area of research and discussion.

3. What made you decide to publish an article in Bioengineering? Why did you choose Bioengineering?
We were invited to submit by one of my colleagues—Dr. Houman Savoji. One of the advantages of submitting to journals such as Bioengineering is that you get quick and high-quality reviews, and there is a quick turnaround in your paper being published after it has been accepted.

4. How was your experience publishing with Bioengineering?
It was great—the process, including submission and responding to reviews, was quick and easy.

5. Was it important to you that the journal is Open Access?
Yes, we receive significant support from a variety of funding agencies, including the Natural Science and Engineering Research Council, the Canadian Institutes of Health Research, the Michael Smith Health Research B.C., the Pacific Parkinson’s Research Institute, the Canada Research Chairs program, and the New Frontiers in Research Fund, and these organizations are funded by taxpayers and donors. I think it is important that anyone can read the results of the research being conducted using such funding.

6. How do you think Open Access impacts authors?
Our Open Access papers tend to be more widely read by diverse audiences, which helps ensure that our work is read by relevant audiences.

7. What do you hope that readers will receive from your paper?
The review does an excellent job of discussing the advantages and disadvantages of the different types of naturally derived biomaterials when used as bioinks for generating tissue models. The team who wrote the paper is an outstanding collection of women scientists and engineers. The first author—Claire Benwood—successfully defended her master’s degree last fall and will start working in the biotechnology industry this spring.

We are thankful for Prof. Dr. Willerth's time and support for the Bioengineering journal.

Prof. Dr. Stephanie Willerth’s contact information:
Email: [email protected]

16 February 2023
Increasing Visibility for Preprints.org – Clarivate adds the Preprint Citation Index to the Web of Science

On 9 February 2023, Clarivate, a global leader in providing trusted insights and analytics, added the Preprint Citation Index to the Web of Science platform, streamlining the research process by allowing researchers to locate and link to preprints alongside other trusted content in the database.

The Preprint Citation Index will act as a bridge to connect cutting-edge preprints with peer-reviewed journal articles published within the Web of Science Core Collection. Alerts can be easily set to monitor new research across several repositories and authors will also be able to include preprints on their Web of Science Research Profile to more accurately display their various research outputs.

As of its launch, the Preprint Citation Index will provide nearly two million preprints from various repositories, including MDPI’s own Preprints.org.

MDPI's Preprints Platform – Preprints.org

To advance Open Science and the fast dissemination of research, MDPI offers researchers a free multidisciplinary preprint platform. Preprints.org accepts submissions from all research areas and offers authors high visibility, permanent archiving, article-level Metrics and immediately citable content by assigning a Digital Object Identifier (DOI) to all preprints.

During submission to any MDPI journal, authors have the option to share their research as a preprint. After an initial screening, the manuscript is available online in 48 hours or less. Once online, preprints can be downloaded, shared, commented on, and cited, providing authors maximum visibility.

We invite you to join the ranks of the over 100k researchers using Preprints.org and share your research.

For more information, please visit Preprints.org.

14 February 2023
Meet Us at the 11th National Conference on Bioinformatics and Systems Biology, 25–27 February 2023, Guangzhou, China


Conference
: 11th National Conference on Bioinformatics and Systems Biology
Date: 25–27 February 2023
Place: Guangzhou, China

MDPI will be attending the 11th National Conference on Bioinformatics and Systems Biology (CCBSB2023) as the exhibitor. The National Academic Conference on Bioinformatics and Systems Biology has been successfully held for ten sessions since its first session in 1998. It is a national event with the highest academic level and the greatest influence in the field of bioinformatics research in China. The theme of the conference is "The Latest Frontier Research of Bioinformatics and Systems Biology and Their Applications", and the topics cover translational informatics and data sharing security, biomedical data mining and computing, genome informatics, artificial intelligence and life sciences, group bioinformatics and integrated biology, non-coding RNA and RNA informatics, network biology, major disease omics informatics, biological macromolecular structure prediction and simulation, bioinformatics algorithm research, biological data resources, bioinformatics and drugs discovery, computational synthetic biology, agricultural and forestry informatics and other bioinformatics, and other frontier directions.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://ccbsb2022.casconf.cn/.

13 February 2023
Dr. Andrea Cataldo Appointed Section Editor-in-Chief of Section “Biomedical Engineering and Biomaterials” in Bioengineering

We are pleased to announce that Dr. Andrea Cataldo has been appointed Section Editor-in-Chief of the Section “Biomedical Engineering and Biomaterials” in Bioengineering (IF: 5.046, ISSN: 2306-5354).

Dr. Andrea Cataldo received his materials engineering degree from the University of Salento, Lecce, Italy, in 1998, and a Ph.D. in information engineering in 2003 from the same University. From 2005 to 2013, he was a Researcher in the area of electric and electronic measurements and, currently, he is an Associate Professor. He is a lecturer in the courses “Instrumentation and Measurement Lab”, “Measurements” and “Principles of Bioengineering” and he is the supervisor of a research group at the Department of Engineering for Innovation, the director of the “measurement Lab” and the founder and technical supervisor of the spin-off MoniTech. His main research interests include measurement and sensing techniques, monitoring systems, sensors, dielectric characterization and non-destructive tests of materials. He has been involved in leading various research projects supported by public and private bodies. He has co-authored over 200 publications in international journals, book chapters, and international and national conferences, along with three books, and he holds four patents.

The following is a short Q&A with Dr. Andrea Cataldo, who shared his vision for the journal with us as well as his views on the research area and Open Access publishing:

1. What appealed to you about the journal that made you want to take the role as its Section Editor-in-Chief?
The journal, although relatively new, thanks to an Open Access policy, a rigorous method of selection and revision of the works and, most importantly, a very high speed of the management of the editorial process, has significantly attracted many researchers and scientists working in the field of bioengineering. Another key reason for its strong attractiveness undoubtedly lies in the tremendous scientific and technological impact that the biomedical engineering, bioengineering and biomaterials sectors are currently experiencing.

2. What is your vision for the Section?
“Biomedical Engineering and Biomaterials” is a multidisciplinary Section collecting the current status, recent progress, and future perspectives in the context of bioengineering science, biomaterials and biomedical engineering.

The Section welcomes innovative contributions covering key aspects of bioengineering, medical diagnosis, biosensors, devices and biomedical instrumentation including design, characterization and application-focused research with a focus on innovative applications involving machine learning and AI.

3. What does the future of this field of research look like?
Tremendous progress has been made in terms of innovative contributions and practical applications of bioengineering, medical diagnosis, biosensors, devices and biomedical instrumentation, including design-, characterization- and application-focused research. In particular, similarly to the enormous impact that enabling technologies 4.0 have entailed in many application fields, the introduction of such paradigms is also leading to an epochal technological transition in bioengineering.

On such a basis, the future of this research field seems particularly oriented to the practical application of advanced experimental tools based on machine learning and AI for medical diagnostics, smart sensing and bio-monitoring, predictive modeling, individualized surgery and computational modeling of biological systems.

4. What do you think of the development of Open Access in the publishing field?
As previously mentioned, I believe that the Open Access policy is key to success and an innovative strategy to guarantee a wide diffusion of scientific research without barriers and to anyone. However, without a rigorous and accurate review procedure and adequate scientific coordination, these positive factors can easily become a disadvantage. From my personal experience, I can say that the Bioengineering journal combines these two factors very well, effectively allowing the simultaneous achievement of an excellent qualitative and informative impact in the sectors of interest. It should also be added that the discount and/or free-of-charge mechanism for publication fees, for example for young researchers, to those who act as reviewers or who contribute to Special Issues or feature papers, also give the opportunity for submission to research groups who may not possess many financial resources.

We warmly welcome Dr. Andrea Cataldo as the new Section Editor-in-Chief and we look forward to him leading Bioengineering to reach many more milestones.

8 February 2023
Interview with Prof. Dr. Giovanni Improta—Editorial Board Member of Bioengineering

We had the pleasure of speaking with Prof. Dr. Giovanni Improta, Editorial Board Member of Bioengineering (ISSN: 2306-5354), to discuss the recent research trends in the field and his personal career developments. We hope you enjoy the interview.

Name: Prof. Dr. Giovanni Improta
Email: [email protected]
Research interests: public health; health technology assessment; Lean Six Sigma; bioengineering; clinical decision making; modeling and simulation of healthcare processes; management of healthcare organizations; biomedical signal processing and analysis; quality improvement in healthcare; modeling and analysis of biomedical data; machine learning and data mining for healthcare

Prof. Dr. Giovanni Improta is a researcher of electronics and informatics bioengineering at the Department of Public Health of the School of Medicine and Surgery of the University of Naples "Federico II" (Naples, Italy), where he teaches the course "Healthcare Organization Models" in the master’s degree program in biomedical engineering at the Department of Electrical Engineering and Information Technology of the School of Polytechnic and Basic Sciences of the aforementioned university. Additionally, he teaches the course "Toxicology and Industrial Hygiene" in the master's degree program in chemical engineering at the Department of Chemical Materials and Industrial Production Engineering of the same university.

He has an M.Sc. in both management engineering and biomedical engineering. He also has a master’s degree in finance, administration and management control, and three Ph.D. degrees: a Ph.D. in economics and management of health organizations, achieved in 2011 at the University of Naples "Federico II" with a thesis titled "The HTA (Health Technology Assessment) for the management of biomedical equipment of a Hospital Company: reallocation, donation to developing countries, conception and design of a virtual community"; a Ph.D. in bioengineering, achieved in 2014 at the University of Bologna "Alma Mater Studiorum" with a thesis titled "Symbolic Dynamics Analysis: a new methodology for fetal heart rate variability analysis"; and a Ph.D. in products and industrial processes engineering, achieved in 2017 at the University of Naples "Federico II", with a thesis titled "Dynamic Analytic Hierarchy Process: a new approach to technology assessment to support healthcare processes". He was a research fellow at the Department of Public Health of the University of Naples "Federico II" from 2010 to 2017, where he had the opportunity to participate in national and international research projects and to collaborate with companies operating in the public health and biomedical sector.

His research activities are focused on the management and optimization of health processes through the implementation of management strategies and the development of simulation models and multi-criteria decision systems as well as the analysis, processing, and management of biomedical data and signals by means of statistical approaches and machine learning algorithms. He participated in several national and international conferences, he was involved in different national and international research projects, and he is the author of more than 125 Scopus-indexed scientific publications in both peer-reviewed journals and international conference proceedings. The topics he addresses include clinical decision-making systems, Lean and Six Sigma in healthcare, health technology assessment, and biomedical data analysis. He is also the inventor of two patents on innovative solutions to improve patients’ monitoring and well-being. Moreover, he is the editor, guest editor, and reviewer for different international peer-reviewed journals.

The following is an interview with Prof. Dr. Giovanni Improta:

1. What are your research areas?
My main research activities are focused on the management and optimization of health processes through the implementation of management strategies and the development of simulation models and decision support systems as well as the analysis, processing, and management of biomedical data and signals by means of statistical approaches and machine learning algorithms. Within healthcare management and biomedical data analysis, I mostly contribute to the development of modeling tools, machine learning approaches, and statistical analysis to support clinical decision-making, the application of Lean and Six Sigma approaches to improve and optimize care processes and healthcare quality, and the use of simulation and mathematical models for health technology assessment. In this regard, I had the opportunity to contribute to these topics by authoring more than 120 Scopus-indexed scientific publications in both peer-reviewed journals and international conference proceedings.

2. What are the latest developments in your research field?
In my opinion, the main and most interesting developments regard the advancements of digitalization in the public health sector. Indeed, digital technologies have successfully transformed most sectors, with a major impact on healthcare, where massive investments in digital health technologies are bringing radical transformation to healthcare services. In this scenario, one of the main challenges is the integration of such digital technologies into assistance processes/pathways and clinical practice. The advantages that the introduction of novel biomedical engineering solutions in the public health sector can bring range from the improvement of patient‒clinician communication to the efficient design of new diagnostic‒care‒assistance pathways to the optimization of health services. Among the most innovative digital tools in the field of healthcare, the use of artificial intelligence (AI) plays a fundamental role to help clinicians in making better decisions, in more effectively managing patient data, and, not least, in creating personalized care plans. The use of artificial intelligence to support clinical decisions, in particular, is the subject of a recent patent on the development of an intelligent system for the management of polypathological patients, conceived and developed at the Department of Public Health of the “Federico II” University, to which I contributed as the inventor.

3. Can you briefly share your career development story? For example, what cases have influenced you the most?
My career has been focused on improving myself both from the personal and professional perspective. I have always tried to pursue my career’s objectives with perseverance and enthusiasm. My interest in the healthcare sector and the field of biomedical engineering is the main motivation that has boosted my career advancements and encouraged me to invest in my education and grow as a researcher in the bioengineering field. Besides my main education goals (two M.Sc. degrees and three Ph.D. degrees achieved from 2005 to 2017), I have carried out research activities at the Department of Public Health of the University of Naples "Federico II" as a research fellow from 2010 to 2017 and as a senior researcher from 2017 on, also achieving the National Academic Qualification as Associate Professor in the sector 09/G2—Bioengineering.

4. Do you have any valuable suggestions you would like to share with young students and early career researchers?
I would encourage young students and early career researchers to always invest in their education and professional growth as this is one of the most powerful tools to make their value emerge and to effectively pursue their goals. In addition, as research and innovation change and advance very fast, whatever their background is, I would warmly recommend young students to make efforts in understanding their real and profound motivation as it will always provide them with the strength and necessary determination to deal with new research topics and to face new technological, social, and health challenges.

5. What do you think of the development of Open Access in publishing?
I strongly believe in sharing and spreading research advancements with the scientific community. Therefore, I fully support and absolutely agree with Open Access in publishing as a means to foster innovation and as an incentive to learn from the most valuable and outstanding scientific approaches and outcomes in order to bring further improvements by building on solid shared knowledge.

We are thankful for Prof. Dr. Improta's time and support for Bioengineering.

28 January 2023
Interview with Prof. Dr. Anthony Guiseppi-Elie—Founding Editor-in-Chief of Bioengineering

We had the pleasure of speaking with Prof. Dr. Anthony Guiseppi-Elie, Editor-in-Chief of Bioengineering (ISSN: 2306-5354), to discuss the recent research trends in the field and his personal career development.

Name: Prof. Dr. Anthony Guiseppi-Elie
Email: [email protected]

Persistence and perseverance, vim and verve.

Prof. Dr. Anthony Guiseppi-Elie is a Chief Academic Officer and serves as Vice President of Academic Affairs and Workforce Development at Tri-Country Technical College, USA. He was the Founding Dean of the College of Engineering, Vice President of Industry Relations, and University Distinguished Professor at Anderson University, South Carolina. He is the former Associate Dean of Engineering Innovation in Engineering Medicine (ENMED) at Texas A&M University (TAMU) and Houston Methodist Hospital (HMH), where he was the TEES Professor of Engineering, Professor of Biomedical Engineering, and Professor of Electrical and Computer Engineering. At Houston Methodist Hospital, he was a Full Affiliate Member of the Houston Methodist Research Institute and a Professor of Biomedical Engineering at the Department of Cardiovascular Sciences and Engineering. Previously, he was Department Head of Biomedical Engineering and Director of the TEES Division of Biomedical Engineering at TAMU and directed the Bioelectronics, Biosensors and Biochips (C3B®) Laboratories as a member of the joint EnMed Faculty Regenerative Engineering Working Group. He is the Founder, President, and Scientific Director of ABTECH Scientific, Inc., a near-patient biomedical diagnostics company, and has been associated with three start-up companies.

He holds an Sc.D. in materials science and engineering from MIT, an M.Sc. in chemical engineering (corrosion science and engineering) from the University of Manchester Institute of Science and Technology (UMIST) and a B.Sc. (First Class Honors) with majors in analytical chemistry, biochemistry, and applied chemistry from the University of the West Indies (UWI). He spent 15 years in both intrapreneurial and entrepreneurial industrial research and product development at companies such as WR Grace & Co, Molecular Electronics Corporation and ABTECH Scientific, Inc., before becoming a full Professor of Chemical and Life Science Engineering (1998) and Professor of Emergency Medicine (2000) at Virginia Commonwealth University/Medical College of Virginia. In 2006, he joined Clemson University as the Dow Chemical Professor with appointments in Chemical and Biomolecular Engineering, Bioengineering, and Electrical and Computer Engineering. In 2015, he joined TAMU and in 2020 joined Anderson University.

As a founding professor of the department of Chemical and Life Sciences Engineering, Prof. Dr. Anthony Guiseppi-Elie was instrumental in establishing the School of Engineering at VCU, serving as the first full professor of Chemical and Life Sciences Engineering, center director, and as a member of the Dean’s Cabinet (Dean Dr. Henry McGee). As a full professor at the Department of Emergency Medicine in the Medical College of Virginia (MCV-VCU), Prof. Dr. Guiseppi-Elie played a key role in recruiting the first class and led the development of an innovative curriculum at the interface of chemical engineering and the life sciences. At Clemson University, he held appointments at the departments of Chemical and Biomolecular Engineering, Bioengineering, and Electrical and Computer Engineering. At Clemson, Prof. Dr. Guiseppi-Elie developed the Biomolecular Concentration, which included courses in biomolecular engineering, bionanotechnology, and biosensors and bioelectronics that served all three departments. At Texas A&M, he served as a founding member of the Working Group on Engineering-Medicine (ENMED) that worked over four years to develop a partnership with Houston Methodist Hospital and realize a program of study leading to the simultaneous earned MS in Engineering Innovation and the MD, both earned in four years of study.

Prof. Dr. Guiseppi-Elie is a 2015–2010 Fulbright Specialist Award recipient in bioengineering at the University of Tucumán, Tucumán, Argentina, the 2017 Visiting Distinguished Professor of Interdisciplinary Science and Engineering at Wrocław University in Poland, the 2014–2015 Visiting Distinguished Professor of Industrial Bioelectronics at l'Ecole des mines d'Alès, France, the 2013 Avis Professor in Pharmaceutics at the University of Tennessee, a 2012–2013 IEEE-EMBS Distinguished Lecturer, and a 2012 Microsystems Distinguished Lecturer at the University of Maryland. Prof. Dr. Guiseppi-Elie is a Fellow of the American Institute of Medical and Biological Engineering (AIMBE Fellow-2006), a Fellow of the Royal Society of Chemistry (FRSC-2014), A Fellow of the Institute of Electrical and Electronic Engineers (FIEEE-2016), a Lifetime Member of AIChE, and holds memberships in AAAS, ACS, MRS, AAPS, and BMES. He has previously served as Vice Chair, Co-Chair, and Secretary Treasurer of the AIMBE Industry Council and was the 2017–2018 Chair of the AIMBE College of Fellows. He is a graduate of the Academic Leadership Academy at Penn State University and serves on the External Advisory Board of the Biomedical Engineering Department at the University of Florida, the Board of Directors of STEAM-E, and The Council for Frontiers of Knowledge (The CFK) (Uganda).

Among Prof. Dr. Guiseppi-Elie’s many national and international appointments are as a member of the National Science Foundation’s (NSF) sub-committee on “Mathematical and Physical Sciences and the Living World” (2020), an appointed member of the International Panel on “Science for Technological Innovation (sfTI)” of the National Science Challenge, New Zealand (2018–2020), an appointed member of the NSF-Lead US Delegation to a Joint USA-Russia Workshop on “Emerging Trends in Bioelectronics” Electrical, Communications and Cyber System Division and the Office of International Science and Engineering (2011), an appointed member of the National Academies Panel on “Electronics and Electrical Engineering” (2009) of the US National Research Council (2009), and an appointed member of the International Panel for “Review of Programme for Research in Third Level Institutions” of the Higher Education Authority (HEA) of Ireland.

Prof. Dr. Guiseppi-Elie has taught technical innovation, entrepreneurship, biomolecular and cellular engineering, biosensors and bioelectronics, biological transport phenomena, and nanobiotechnology. His research interests are engineered bioanalytical microsystems in the service of human health and medicine. This includes bionanotechnology, microfabrication, and 3D printing of bio- and electro-responsive hydrogels, BioMEMS, physiology-on-a-chip, ABIO-BIO interfaces, and interfacing of biology and engineering at the molecular, cellular and tissue length scales. He has published over 225 archival scientific papers (8731 citations, h-index = 48), 33 book or proceedings chapters, holds 8 USA and foreign patents, and has given in excess of 200 invited lectures/colloquia. He is the founding Editor-in-Chief of Bioengineering (IF = 5.046). He was named among the top 1000 Black life scientists in the USA (2020) and the top 2% of scientists worldwide (2021).

We wish to congratulate Prof. Dr. Anthony Guiseppi-Elie for being listed among the top 2% of scientists worldwide. We hope you enjoy the interview!

1. What are your research areas?
My research interests are in the fundamentals: engineering development and clinical deployment of engineered bioanalytical microsystems in the service of human health and medicine. These are measurement devices and systems intended to engender greater control in clinical decision-making, and they employ a wide range of enabling technologies, including carbonaceous nanomaterials in bionanotechnology to support direct electron transfer and biosensor development, microlithographic fabrication of implantable biochip substrates to enable multiplexed biosensing of biomarkers in hemorrhagic trauma, 3D printing of bioactive and electro-responsive hydrogels as biorecognition hosting elements in biosensors, BioMEMS, vascular physiology-on-a-chip, ABIO-BIO interfaces to support neurostimulation, and the interfacing of biology and engineering at the molecular, cellular, and tissue-length scales. Among the areas to which I have made major contributions are enzymes, antibodies, and genosensors that employ electrochemical transduction. Another area of interest has been the development of biologically responsive polymers based on the synthesis of co-polymers fashioned from inherently conductive polymers such as Poly(3,4-ethylenedioxythiophene) (PEDOT) and polypyrrole with highly hydratable monomers such 2-Hydroxyethyl Methacrylate (2-HEMA) and 2-Hydroxypropyl Methacrylate (2-HPMA) and functionalized polypeptides to yield bioactive, electroconductive hydrogels. Such materials may be fashioned into responsive hydrogels that host a drug payload for sustained bio-erodible release and/or electro-stimulated burst release. Most recently, we have become interested in electromics, which is the control of gene expression under the influence of exogenously applied electric fields.

2. What are the latest developments in your research field?
The latest developments in the field of biosensors are found in multiplexed and multimodal biosensors. Multiplexed biosensors use the same principle of transduction but seek a plurality of analytes using a multiplicity of biological recognition elements immobilized on different regions of the complex transducer. Multimodal biosensors may target the same analyte but may use two or more modes of transduction. An equally important development is the use of post-processing to achieve data fusion with other sources of related bioanalytical data or with clinical expert data. The use of data fusion algorithms to achieve classification or stratification is exampled by the use of AI to fuse multi-modal biophysical and biochemical data to achieve stratification of allografts for transplantation.

Another important development is the use of electric fields to influence the expression of genes within cells and tissues. While electrobiology has been around for a very long time and molecular bioelectricity has provided important insight into electrophysiology, the application of controlled electric fields to support neo-vascularization or tissue innervation in regenerative engineering promises to be an important theme for the future.

3. Can you share your career development story? For example, what cases have influenced you the most?
The landmark discovery that some organic polymers may be inherently conductive, possessing electrical conductivities and other properties similar to that of metals, was irresistibly fascinating [H. Shirakawa, E. J. Louis, A. G. MacDiarmid, C. K. Chiang, A. J. Heeger, Synthesis of electrically conducting organic polymers: halogen derivatives of polyacetylene, (CH)x, Journal of the Chemical Society, Chemical Communications, 578–580]. This, and the subsequent works that became the substance of the 2000 Nobel Prize in Chemistry, came on the heels of Lehninger’s electron-transport chain of molecular bioenergetics, in which I had become immersed as an undergraduate biochemistry student. I spent my early career exploring the connections between these two streams, which led to: Guiseppi-Elie US Patent 5,312,762 5/1994 (https://patents.google.com/patent/US5312762A/en?oq=5312762) and Guiseppi-Elie et al. Nanotechnology, 2002, 13(5), 559 (https://iopscience.iop.org/article/10.1088/0957-4484/13/5/303). A second source of influence has been the textbook by Alan J. Grodzinsky—Fields, Forces, and Flows in Biological Systems, ISBN 9780367864354. I have taught from and been inspired by the holistic treatment across multiple length scales found in this textbook.

4. Do you have any valuable suggestions you would like to share with young students and early career researchers?
We are each birthed into an ecosystem of ideas and approaches to the emergence of new ideas in that ecosystem. The faster we can shed the trappings of our own and embrace those of others—for example, through travel, through forays into other disciplines, or immersive associations with other cultures, or collaborations—the faster we can mature in our humanity and in our inquiry. Stick with it, but not indefinitely. Be prepared to tack left or right, taking with you lessons learned. Collaborate extensively, recognizing that with each collaboration, you must sacrifice some of yourself so that the collaboration as a whole is better than the sum of each person taken separately. Be prepared to fail; it is an equally valid condition. Dwell on your failures, but do not become paralyzed by them; they are far more informative than your successes.

5. What do you think of the development of Open Access in publishing?
I am an advocate for Open Access publishing. Open Access publishing broadens participation in the knowledge enterprises through access and availability, and so engenders greater citizen engagement with qualified knowledge sources. I joined MDPI with a proposal to establish Bioengineering in early 2013 (ISSN (electronic): 2306-5354; Publisher: MDPI AG), not long after the publishing house was founded as Multidisciplinary Digital Publishing Institute by Dr. Shu-Kun Lin in 2010. Gold OA publishing allows peer-reviewed journal works to be accessed via the journal’s or publisher’s website. Having been in the Open Access publishing space for almost 10 years, I see that Open Access publishing continues to approach maturity, but also continues to receive some scrutiny and criticism for being a double-edged sword in both perception and practice. Open Access publishing may not yet be fully “out of the woods”, even though this model is now adopted by several major traditional scientific publishing houses, for select or new journals. This model may still be vulnerable while on the path to full maturity. Open Access journals that have benefitted from highly disciplined, deeply engaged academic editorial leadership have reaped the benefits of high Impact Factors. For example, MDPI is home to 10 journals with IF ≥ 5.000 (Clarivate, Journal Citation Reports). It is important that we continue to maintain quality and integrity while democratizing knowledge. Financial self-sufficiency and sustainability continue to be a source of concern in the Open Access space. However, subscribing to the tenets of COPE ensures a culture of publication integrity. Sustained and productive consultative relationships among publishers and Editors-in-Chief, Associate Editors, and Editorial Board Members who are credible content experts will ensure a secure future for Open Access publishing, one that balances the security of the new financial model with the aspirations of equity and integrity in scientific publishing.

text

The Founding Editor-in-Chief next to our booth at BMES 2022 in San Antonio, TX, USA

We are thankful for Prof. Dr. Anthony Guiseppi-Elie’s time and his ongoing support of Bioengineering.

20 January 2023
Interview with Dr. David Caballero—Author of a Published Paper in Bioengineering

Name: Dr. David Caballero
Email: [email protected]
Article title: “Versatile Vessel-on-a-Chip Platform for Studying Key Features of Blood Vascular Tumors

We had the pleasure of speaking with Dr. David Caballero, author of the recently published paper “Versatile Vessel-on-a-Chip Platform for Studying Key Features of Blood Vascular Tumors” in Bioengineering (ISSN: 2306-5354). We discussed the recent research trends in the field and his personal career developments.

We hope you enjoy the interview.

1. Congratulations on your published paper. Can you provide a background about yourself and what your research areas are?
I am an experienced biophysicist with an M.Sc. and Ph.D. in nanoscience from the University of Barcelona, Spain. Currently, I am an assistant researcher at the 3B´s Research Group at the University of Minho, Portugal, a world-known institute in the field of tissue engineering. Since very early on, particularly during my postdoctoral periods at ISIS/IGBMC—Université de Strasbourg (France) and at IBEC (Spain)—and now at 3B´s, I have been very passionate about applying the concepts and principles of fundamental physics to biological problems. My experiments are typically very multidisciplinary and combine microfabrication, tissue engineering, cell biology, and biophysics. The aim is to engineer realistic in vitro environments from which we can extract useful data that can be used to improve our understanding of the mechanisms involved in the onset and progression of pathologies. For example, one of my current research interests is recreating the dynamic properties of the native habitat of cells using organ-on-a-chip technology to evaluate how mechanical forces contribute to the pathophysiology of cancer. Indeed, this research field has attracted much attention from biomedical researchers and a lot of effort is currently being invested in the mechanobiology of cancer. In my case, I am interested in understanding how cancer cells migrate through confined spaces, such as vascular walls or dense matrices, and how they respond to external forces, particularly fluid flow, boosting their invasion capability. We hope that our discoveries can improve our current knowledge in the pathophysiology of the disease and eventually contribute to developing better therapies. Altogether, the combination of (bio)physics and nanotechnology in the biological field is an exciting field of research in which we will continue to see exciting results in the coming years.

2. What made you decide to publish an article in Bioengineering?
One of the most important decisions before and after writing an article is where to submit it. Indeed, there are a bunch of excellent multi-disciplinary journals in which my research could be published. A distinctive feature of Bioengineering though is the strong offer in Special Issues. After receiving the invitation from the editor, we realized that our work perfectly fit within the proposed topic and, therefore, the publication of our article would receive higher attention boosting the impact and interest in our work. After evaluation of the pros and cons of different journals, we decided to submit our article to Bioengineering. We cannot forget the big progression of Bioengineering during the last years, making this journal a very good option for publishing work in the field of tissue engineering, regenerative medicine, biophysics, or similar fields.

3. How was your experience publishing with Bioengineering?
I was indeed surprised, not only about the speed of the peer-reviewing process, but also about its quality. Typically, the time between the submission and publication of an article is very long, being in some cases several months. Sometimes this timeframe is too long, which may jeopardize the novelty of the work or a grant application, or both. Despite the speed of the peer-reviewing, I had two tough rounds of revisions. This contributed to improving the quality of the manuscript and, as a result, increased the interest in the article by the scientific community.

4. Was it important to you that the journal is Open Access?
Nowadays, publishing in Open Access is mandatory for most national and European funding schemes. However, most of the journals have very expensive APCs, which many research groups cannot afford. There is the possibility of publishing in “green” Open Access, but, in certain cases, this option dilutes the spirit of granting easy access to the articles. Publishing in “gold” Open Access at a moderate cost allows the scientific community to have full access to the published manuscripts directly on the journal website without the need to navigate inside University repositories. Overall, this has definitely contributed to our paper reaching a larger audience.

5. What do you hope that readers will get from your paper?
After reading the paper, it will be understood better how the structural and hydrodynamic complexity of vascular tumors can be reproduced and analyzed through microfluidics technology and biophysical analysis. This type of tumor displays aberrant – tortuous – vessel architectures and highly perturbed blood flows and, therefore, in vitro organ-on-a-chip platforms capable of recapitulating these distinctive features are highly demanded by the biomedical community. The readers will realize how vascular tumors perturb blood hemodynamics, particularly through the massive formation of thrombus and blood hemorrhage, two of the main events that we reproduce within the chip. Overall, our work establishes the technological basis of a versatile microfluidic platform, that we denote tumor vessel-on-a-chip, capable of reproducing the distinctive structural and dynamic traits occurring in vascular tumors. Note finally that our system may be utilized for investigating other dynamic events characteristic of vascular-related diseases or for the screening of novel pharmacological formulations targeting thrombi formation and blood hemorrhage, among other applications.

We are thankful for Dr. Caballero's time and support of the journal Bioengineering.

9 January 2023
Welcoming New Section Editors-in-Chief of Bioengineering

We are pleased to announce that Dr. Gary Chinga Carrasco, Dr. Andrea Cataldo, Prof. Dr. Franz Konstantin Fuss, and Dr. Elena A. Jones have been appointed respective Section Editors-in-Chief of the Sections “Nanotechnology Applications in Bioengineering”, “Biomedical Engineering and Biomaterials”, “Biosignal Processing”, and “Regenerative Engineering” in Bioengineering (ISSN: 2306-5354). We look forward to their contribution to the continued success of the journal.

Name: Dr. Gary Chinga Carrasco
Affiliation: Lead Scientist, Biopolymers and Biocomposites, Trondheim, Norway
Interests: biomaterials; hydrogels; 3D bioprinting; biocomposites; bio-applications

Name: Dr. Andrea Cataldo
Affiliation: Department of Innovation Engineering (DII), University of Salento, Via Monteroni, 73100 Lecce, Italy
Interests: sensors; wearable devices; biomedical detection; monitoring and instrumentation; biomedical signal processing; dielectric spectroscopy; microwave diagnostics; biomedical measurements

Name: Prof. Dr. Franz Konstantin Fuss
Affiliations:
1. Chair of Biomechanics, Faculty of Engineering Science, University of Bayreuth, 95447 Bayreuth, Germany
2. Division of Biomechanics, Department of Biomechatronic Systems, Fraunhofer Institute of Manufacturing Engineering and Automation IPA, 70569 Stuttgart, Germany
Interests: bioengineering; sports engineering; sports technology; implant engineering; biomechanics; smart equipment; wearable electronics; sensors; signal processing; non-linear engineering

Name: Dr. Elena A. Jones
Affiliation: Leeds Institute of Molecular Medicine, School of Medicine, University of Leeds, Leeds LS2 9JT, UK
Interests: mesenchymal stem cells/multipotential stromal cells (MSCs); bone regeneration; cartilage regeneration; osteoarthritis; regenerative medicine; regenerative orthopedics; MSC senescence

For more detailed information, please visit the following link: https://www.mdpi.com/journal/bioengineering/sections.

Bioengineering Editorial Office

22 December 2022
Special Issue Mentor Program

We are pleased to announce the launch of a new initiative—the MDPI Special Issue Mentor Program.

This program will enable early career researchers (who must hold a Ph.D. in a related field) to experience editing a Special Issue in MDPI journals, under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to gain editorial experience, and to cultivate their ability to edit scientific research.

The mentee’s responsibilities include:

  • Proposing a Special Issue title and assisting the mentor in preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Issue;
  • Writing a brief promotion plan for the Special Issue;
  • Preparing a list of scholars who may be interested in the Issue and personally e-mailing invitations on behalf of Guest Editors;
  • Writing an editorial for the online Special Issue together with the mentor.

The mentor’s responsibilities include:

  • Conducting a final check before the Special Issue is published online;
  • Performing editorial control of the Special Issue and quality control of the publications, both of which must be carried out in a timely manner;
  • Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
  • Organizing video calls with young scholars and the Editorial Office regularly to discuss problems and improvement suggestions for the Special Issue;
  • Making and submitting decisions regarding submissions with the assistance of mentees.

Certificates and awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and early career researchers.

If you are interested in this opportunity, please send your Special Issue proposal to the Editorial Office of a journal you choose, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail. The full list of MDPI journals is as follows: https://www.mdpi.com/about/journals.

In addition to the new Special Issue Mentor Program, we will continue to welcome all Special Issue proposals focusing on hot research topics.

22 December 2022
Interview with Dr. Ngan F. Huang—Editorial Board Member of Bioengineering

Name: Dr. Ngan F. Huang
Email: [email protected]
Editorial Board Member of Bioengineering

We had the pleasure of speaking with Dr. Ngan F. Huang, Editorial Board Member of Bioengineering (ISSN: 2306-5354), to discuss the recent research trends in the field and her personal career developments. We hope you enjoy the interview.

Dr. Ngan F. Huang is an Associate Professor in the Department of Cardiothoracic Surgery and Courtesy Associate Professor of Chemical Engineering at Stanford University. She holds a co-terminous appointment as Principal Investigator at the VA Palo Alto Health Care System. Dr. Huang completed her BS in chemical engineering at the Massachusetts Institute of Technology, followed by a Ph.D. in bioengineering at the University of California Berkeley and the University of California San Francisco Joint Program in bioengineering. Prior to joining the faculty, she was a postdoctoral scholar in cardiovascular medicine at Stanford University. Her laboratory investigates the interactions between stem cells and the extracellular matrix microenvironment for engineering tissues to treat cardiovascular and musculoskeletal diseases.

Dr. Huang has authored over 90 publications and patents in journals such as Nat Med, PNAS, and Nano Lett. Her research is funded by the NIH, the NSF, the Department of Defense, the Department of Veteran Affairs, and the American Heart Association.

The following is an interview with Dr. Ngan F. Huang:

1. What are your research areas?
My laboratory aims to understand the biochemical and mechanical interactions between extracellular matrix (ECM) proteins and stem cells that regulate cardiovascular differentiation, survival, and angiogenesis, with the goal of translating these basic insights to the design of biological therapies to treat cardiovascular disease and muscle injuries. Ongoing projects include ECM-mediated effects on the endothelial-to-mesenchymal transition, spatially patterned nanofibrillar collagen scaffolds with induced pluripotent stem-cell-derived endothelial cells for the treatment of peripheral arterial disease, scaffold-mediated delivery of therapeutic smooth muscle cells for treatment of abdominal aortic aneurysm, and engineered muscle for the treatment of volumetric muscle loss.

2. What are the latest developments in your research field?
With recent technological advancements, there is a general push towards the use of multi-omics approaches to better understand the pathological progression of cardiovascular diseases, as well as the use of multi-omics to reveal fundamental insights into the effects of experimental therapies. I anticipate that spatial transcriptomics, spatial proteomics, single-cell RNA sequencing, and epigenomics will become widely adopted tools for researchers.

3. Can you briefly share your career development story? For example, what cases have influenced you the most?
My research career began as a high school student, when I had the experience to perform research as a summer intern. This experience motivated me to pursue a graduate degree in research. Along the way, I was fortunate to have been mentored by many influential mentors who took an interest in advancing my career. For this reason, I am grateful and have sought to do the same for my own trainees.

4. Do you have any valuable suggestions you would like to share with young students and early career researchers?
Resilience. Successful researchers do not always have smooth career development. My advice is to not be discouraged by setbacks, but to keep inching forward with resilience.

5. What do you think of the development of Open Access in publishing?
Open Access allows for the widest dissemination of findings to the global community. Overall, I think it is a good idea that moves research advances forward.

We are thankful for Dr. Huang's time and support of Bioengineering.

22 December 2022
Interview with Prof. Dr. Christoph Herwig—Editorial Board Member of Bioengineering

Name: Prof. Dr. Christoph Herwig
Email: [email protected]
Editorial Board Member of Bioengineering
We had the pleasure of speaking with Prof. Dr. Christoph Herwig, Editorial Board Member of Bioengineering (ISSN: 2306-5354), to discuss the recent research trends in the field and his personal career developments. We hope you enjoy the interview.

Prof. Dr. Christoph Herwig, a bioprocess engineer from RWTH Aachen, worked in industry in the design and commissioning of large chemical facilities prior to beginning his interdisciplinary Ph.D. studies at EPFL, Switzerland in bioprocess identification. Subsequently, he positioned himself at the interface between bioprocess development and facility design in the biopharmaceutical industry. Since 2008, he has been a full professor in biochemical engineering at the Vienna University of Technology. His research area of focus includes the development of data science methods for the integrated and efficient bioprocess development of PAT and QbD principles for biopharmaceuticals. In 2013, he founded the company Exputec, which is now part of Körber Pharma, pioneering data science software solutions for the biopharma life cycle.

The following is a short interview with Prof. Dr. Christoph Herwig:

1. What are your research areas?
Methods for efficient and scalable bioprocess development.

2. What are the latest developments in your research field?
Digital twins integrated into real-time solutions for optimized control solutions and continuous biomanufacturing.

3. Can you briefly share your career development story? For example, what cases have influenced you the most?
I have seen the biopharmaceutical industry change during my industrial career. I have also seen many decisions made around empiricism and manufacturing outcomes based on hope rather than on prediction. This is what I wanted to change from the basis: providing robust, transferable and sound scientific methods.

4. Do you have any valuable suggestions you would like to share with young students and early career researchers?
Have affinity for data. Believe that you don’t always need more experiments and data, but take time and use advanced data science methods to turn data into knowledge. Base your decisions on knowledge, and establish knowledge management in your organization.

5. What do you think of the development of open access in publishing?
It is crucial and a basis for the transparent sharing of knowledge between organizations across the world.

We are thankful for Prof. Dr. Herwig's time and support of Bioengineering.

22 December 2022
Interview with Dr. Danièle Noël—Editorial Board Member of Bioengineering

Name: Dr. Danièle Noël
Email: [email protected]
Editorial Board Member of Bioengineering

We had the pleasure of speaking with Dr. Danièle Noël, Editorial Board Member of Bioengineering (ISSN: 2306-5354), to discuss the recent research trends in the field and her personal career development. We hope you enjoy the interview.

Dr. Danièle Noël is currently Research Director at Inserm at the Institute for Regenerative Medicine and Biotherapies (IRMB) in Montpellier. She received her Ph.D. in health biology from Bordeaux University in 1992. She completed a postdoctoral fellowship at the Institute of Molecular Genetics in Montpellier in the field of recombinant retrovirology and gene therapy (1992–1999). She then moved to IRMB to work in cell therapy and became a professor in 2011. She is currently leading the group, “Organoids, Mesenchymal stromal cells and Extracellular vesicles for osteoarticular diseases therapies”, which includes 11 staff members. Her main interests are the biology of mesenchymal stromal cells and their application in the treatment of osteoarticular diseases and systemic sclerosis.

Her main focuses are:

  • The identification of molecular mechanisms regulating the therapeutic effect of mesenchymal stromal cells and the role of extracellular vesicles (EVs);
  • The optimization of cells and EV-based therapeutic approaches for regenerative medicine in rheumatic and autoimmune diseases;
  • The optimization of cartilage tissue engineering approaches and joint organoid generation using a combination of molecular factors, scaffolds and 3D bioprinting.

She has authored more than 180 publications (h-index: 64; citations: 16310) and is currently a partner in three European programs.

The following is a short interview with Dr. Danièle Noël:

1. What are your research areas?
Mesenchymal stromal cells; extracellular vesicles; osteo-articular diseases; and therapies.

2. What are the latest developments in your research field?
Extracellular vesicles from mesenchymal stromal cells for the development of new acellular therapies in various therapeutic applications.

3. Can you briefly share your career development story? For example, what cases have influenced you the most?
I have held an academic position at the French National Institute for Health since 2007, where I integrated a laboratory as a senior researcher and, since 2011, I have become a research director leading a research group of more than 12 people.

4. Do you have any valuable suggestions you would like to share with young students and early career researchers?
Keep motivated to develop your own research projects and lead a research group.

5. What do you think of the development of Open Access in publishing?
I think it is a great opportunity to share your research results to a very large community. I totally agree with Open Access for research.

We are thankful for Dr. Noël's time and support of Bioengineering.

22 December 2022
Interview with Prof. Dr. Reeta Rani Singhania—Editorial Board Member of Bioengineering

Name: Prof. Dr. Reeta Rani Singhania
Email: [email protected]
Editorial Board Member of Bioengineering

We had the pleasure of speaking with Prof. Dr. Reeta Rani Singhania, an Editorial Board Member of Bioengineering (ISSN: 2306-5354), to discuss the recent research trends in the field and her personal career developments. We hope you enjoy the interview.

1. What are your research areas?
My main research expertise is in the areas of microbial and enzyme technology, with the main focus on the development of bioprocesses and bioproducts. I have worked extensively on the production of cellulase and beta-glucosidase for biofuel applications. I have also worked on a major integrated project, with the final aim of producing biohydrogen by utilizing agro-wastes. My current work at NKUST in Kaohsiung, Taiwan, is on the “Bioprocess development for biomass valorization”. In this direction, we have been working on oligosaccharides for prebiotic application and bioethanol production, using locally available abundant biomass. Hydrothermal pretreatment and controlled enzymatic hydrolysis have been explored for this purpose. We have also explored bacterial bioprocesses for nanocellulose production, which has immense applications in various fields and we have explored its potential for heavy metal removal. Overall, in one word, I can summarize my area of research as biorefinery.

2. What are the latest developments in your research field?
Biorefinery is moving quickly, and we have succeeded in developing enzymes for biomass saccharification at high-solid loading with higher efficiencies, which has provided us with several patents and the technology is in the matured stage. Now, I am more focused on understanding biomass deconstruction via hydrothermal pretreatment. Research in this field has resulted in our understanding of how biomass can be deconstructed into each component and the multiple ways of producing cascades of products out of it. Various biomass feedstocks, including lignocellulosic biomass, macroalgae, and microalgae, have been employed to produce various products, including platform chemicals, along with oligosaccharides and bioethanol.

3. Can you briefly share your career development story? For example, what cases have influenced you the most?
I started my career in 2002 as a lecturer at a university (GGV in Bilaspur, India) and shortly switched to research at the CSIR Institute in India, National Institute for Interdisciplinary Science and Technology, Trivandrum, as a project assistant in the group of Professor Ashok Pandey, the leading biotechnologist in India now, where I studied for my doctoral degree with Dr. Rajeev Sukumaran and thereafter, my real research journey started, as I was granted an opportunity to showcase my independent research capabilities at various institutes and in the industry. I moved to France to work at Institute Pascal at Clermont Ferrand and thereafter moved back to India with a prestigious fellowship (“DBT-Energy Bioscience Overseas Fellowship”) to work at the Center for Advanced Bioenergy Research, DBT Center (Indian Oil Corporation Ltd, R & D, Faridabad, India). I think that in the initial stages of my career, I was influenced by biomass conversion using enzymes, which we were producing ourselves in the laboratory. For me, it was amazing to observe how leaves and twigs were converted into ethanol. I realized that in this way, the carbon footprint can be reduced; moreover, lignocellulosic biomass is the most ubiquitous and abundant raw material available that can benefit mankind; hence, technology can be used in the absence or depletion of petro-refinery products. I can see the potential for translational research and laboratory work to be scaled up to an industrial level to see the light of commercialization.

I dedicated my energy to improving my knowledge to a higher standard, so that I could be a well-equipped professional researcher and a teacher.

4. Do you have any valuable suggestions that you would like to share with young students and early career researchers?
I think the best advice I received from my mentors that I can share with young students is to keep learning and to never stop learning because there is always something new to learn to improve your skills and understanding of concepts. There are no alternatives to sincerity and dedication and these are essential in order to succeed in your field. One must also have patience.

5. What do you think of the development of Open Access in publishing?
The concept of Open Access in publishing has opened a new door for students, researchers, and scientists to have easy access to research in their respective areas of interest and expertise to explore innovative ways to understand and perform their research work. I think it is an interesting way to publish research work that is relevant both now and in the future.

We are thankful for Prof. Dr. Singhania's time and support for Bioengineering.

 

22 December 2022
Interview with Dr. Martin Koller—Editorial Board Member of Bioengineering

Name: Dr. Martin Koller
Email: [email protected]
Editorial Board Member of Bioengineering

We had the pleasure of speaking with Dr. Martin Koller, Editorial Board Member of Bioengineering (ISSN: 2306-5354), to discuss the recent research trends in the field and his personal career development. We hope you enjoy the interview.

Dr. Martin Koller was awarded his Ph.D. degree by Graz University of Technology, Austria, for his thesis on polyhydroxyalkanoate (PHA) production from dairy surplus streams. This work was carried out as part of the EU-FP5 financed project, WHEYPOL (“Dairy industry waste as source for sustainable polymeric material production”), and was supervised by Gerhart Braunegg, one of the most eminent PHA pioneers. As a senior researcher, he worked on biomediated PHA production, encompassing the development of continuous and discontinuous fermentation processes and novel downstream processing techniques for sustainable PHA recovery. His research focused on cost-efficient PHA production from surplus materials using bacteria and haloarchaea and, to a minor extent, on the development of PHA for biomedical use.

Moreover, Dr. Martin Koller coordinated the EU-FP7 project ANIMPOL (“Biotechnological conversion of carbon containing wastes for eco-efficient production of high added value products”), which, in close cooperation between academia and industry, investigated the conversion of the animal processing industry´s waste streams toward structurally diversified PHA and follow-up products. In addition to PHA exploration, he was also active in microalgal research and in the biotechnological production of various marketable compounds from renewables using yeasts, chlorophyte, bacteria, archaea, fungi, and lactobacilli.

He currently holds more than 90 Web of Science listed articles in high-ranked scientific journals (h-index 40), has authored more than 20 chapters in scientific books, edited eight scientific books and seven journal Special Issues on PHA, delivered plenty of invited and plenary lectures at scientific conferences, and continues to support the editorial teams of several distinguished journals.

Now, Dr. Martin Koller is active as a research and project manager for the Institute of Chemistry at the University of Graz as a member of the university´s Research Management and Service unit. He is also a lecturer at the FH Joanneum (University of Applied Sciences, Graz) and an external supervisor for PHA-related projects.

The following is a short interview with Dr. Martin Koller:

  1. What are your research areas?
    Microbial biopolyesters.
  1. What are the latest developments in your research field?
    Biopolyester production from ethically clear resources (waste materials); novel fermentation regimes; new, robust production strains (Next Generation Industrial Biotechnology).
  1. Do you have any valuable suggestions you would like to share with young students and early career researchers?
    Stay curious!
  1. What do you think of the development of Open Access in publishing?
    Personally, I am fully committed to Open Access publishing; however, in my opinion, fees are often too high, also for not exceptionally high-ranked journals.

We are thankful for Dr. Martin Koller’s time and his support for Bioengineering.

14 December 2022
"Thanks a Million!" – One Million Articles Published in MDPI Journals

MDPI has just become the first open access (OA) publisher to reach the milestone of one million articles published. That is one million articles freely available to all, to circulate and build upon! We are proud to share this special moment with the global scientific community.

This landmark has been reached thanks to the immeasurable support of more than 600,000 expert reviewers, 66,000 editorial board members and 6700 hard-working colleagues across MDPI’s global offices.

Within more than 25 years of publishing, our journals received 2.1 million manuscripts and generated 4.6 million peer review reports to get to one million papers published.

1 Million Infographic

Reaching the milestone of one million articles published reinforces our mission to remove any existing barriers and to make scientific research accessible to all. Since its inception, MDPI’s goal has been to create reliable processes to make science open. This is a path towards facilitating the dissemination of novel insights in scientific communities.

Regular feedback from authors and reviewers shows that our service is greatly appreciated and needed. At the same time, the feedback helps us identify areas for further improvement.

As it stands, a significant share of published research findings remain closed access. More than half of the content published with the most well-known legacy publishers stays behind a paywall, and that is not including articles published in hybrid OA journals, or made available months or years after publication.

A new policy announced by the US administration in August 2022 requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. While the new policy does not mandate articles be published under an open access license, it is aligned with the open access movement in removing all barriers to research. Similarly, some of the most advanced research institutions in the world intend to have all funded research articles published in open access by 2025.

MDPI is proud to be the leading agent of the transition to open access.

"Thanks a Million" to all the contributors!

9 December 2022
Interview with Prof. Dr. Bin Zheng—Editorial Board Member of Bioengineering

Name: Prof. Dr. Bin Zheng
Email: [email protected]
Role: Editorial Board Member of Bioengineering
We had the pleasure of speaking with Prof. Dr. Bin Zheng, Editorial Board Member of Bioengineering (ISSN: 2306-5354), to discuss the recent research trends in the field and his personal career development.

Prof. Dr. Zheng works as a Professor at the School of Electrical and Computer Engineering, University of Oklahoma, Norman, USA. We hope you enjoy the interview.

  1. What are your research areas?
    Medical imaging informatics, computer-aided diagnosis of medical images, machine learning and artificial intelligence.
  1. What are the latest developments in your research field?
    In the last several years, my medical imaging research laboratory in the School of Electrical and Computer Engineering, the University of Oklahoma, has been working on several research projects that aim to identify new quantitative imaging (QI) markers and develop novel machine learning (ML)-based prediction models. These research efforts include using the QI features computed from: (1) digital mammograms to predict short-term breast cancer risk and classify between malignant and benign lesions; (2) dynamic-contrast-enhanced breast magnetic resonance images (DCE-MRI) to predict the response of breast cancer patients to neoadjuvant chemotherapy; (3) lung computed tomography (CT) images to predict the risk of cancer recurrence in early stage non-small-cell lung cancer patients after surgery; (4) abdominal CT images to predict the 6-month progression-free survival (PFS) of ovarian cancer patients undergoing clinical trials for testing new chemotherapy drugs; (5) abdominal CT images to predict the metastasis status of gastric cancer patients; and (6) brain CT and/or MR images to predict the prognosis of aneurysmal subarachnoid hemorrhage and acute ischemic stroke patients or detect/assess residual brain tumor tissue after surgery. In our studies, we have also applied and tested many new deep-learning-based artificial intelligence (AI) models combined with interactive graphical user interface (GUI) tools to facilitate our research work effort and support physician scientists in conducting translational clinical studies or research projects.
  1. Can you briefly share your career development story? For example, what cases have influenced you the most?
    I was originally educated and trained as an Optical Engineer in my undergraduate and graduate studies to develop and apply optimal or laser-based imaging technology and systems in engineering. After I received my Ph.D. from the Department of Electrical Engineering, University of Delaware, I accepted a postdoc training position in the Medical Imaging Research Division, Department of Radiology, University of Pittsburgh. I worked on a research task that aimed to modify optical imaging components in a new investigative computed radiology (CR) system for breast cancer imaging. After completing this task, the director of Medical Imaging Research Division, Dr. David Gur, introduced and encouraged me to enter a completely new research field of developing computer-aided detection (CAD) schemes of mammograms. I accepted this challenge and started to develop a new CAD scheme based on my master’s thesis work on applying optical theodolites to perform topographic measurement. I published my first CAD research paper entitled “Computerized detection of masses in digitized mammograms using single image segmentation and a multi-layer topographic feature analysis” (Academic Radiology 1995; 2:959–966). Since then, I have been working in the CAD research field for more than 28 years and gradually expanded my CAD research from breast cancer detection to much broader topics and different types of cancer (i.e., breast, lung, ovarian, gastro, leukemia) and strokes, including the prediction of disease risk, the classification of lesion types, and improvement in treatment efficacy. Thus, based on my unique career development experience, I always believe in and promote interdisciplinary research to use and apply complementary knowledge and skills from different fields, which can help generate more novel research ideas and approaches.
  1. Do you have any valuable suggestions you would like to share with young students and early career researchers?
    I am lucky to have had an outstanding mentor, Dr. David Gur, in my early academic career development. Dr. Gur provided me important guidance and great support that encouraged me to try new research ideas, identify research topics with higher translational impact, propose novel study hypotheses, learn lessons from failures, and improve my skills in writing research papers and proposals. Thus, to develop a successful research career, I always provide advice or suggestions to my students that one should have passion and dedication to the research work, keep trying from the failures, and gradually broaden their research vision by absorbing and fusing the knowledge and skills learned from multidisciplinary fields.
  1. What do you think of the development of Open Access in publishing?
    I agree that Open Access publishing provides an excellent platform to effectively promote and exchange new research ideas. It can help disseminate new research methods and results in more broad research communities in multidisciplinary fields.

We are thankful for Dr. Zheng's time and his support for Bioengineering.

8 December 2022
MDPI Sustainability Foundation: New Look and Nominations for the 2023 Sustainability Awards Now Open

We are pleased to announce that the website of the MDPI Sustainability Foundation has been revamped! For the past couple of months, our UX UI team and front-end developers have been working hard to launch the website in time for the opening of the Sustainability Awards nominations.

The website is not the only thing that has had a remodeling. Indeed, the format of the Emerging Sustainability Leader Award (ESLA) has been updated. ESLA is now a competition open to individual researchers or start-ups founded by researchers under the age of 35. Nominee applications will go through 2 rounds of selection until the final 3 are decided. The finalists will then be invited to give pitch presentations during the Award Ceremony to win either first place (10,000 USD) or runner-up (2 x 5000 USD).

The World Sustainability Award, on the other hand, remains the same: a total prize money of 100,000 USD is up for grabs by senior individual researchers or groups of researchers from the international research community.

Nominations for both the World Sustainability Award and the Emerging Sustainability Leader award are now open! Check out our new website for more information on how to nominate.

29 November 2022
Editorial Board Members from Bioengineering Featured among the World’s Top 2% Scientists in 2022

Scientists at Stanford have recently published an update of the list of the top 2% most widely cited scientists—the World’s Top 2% Scientists.

The time node of the statistical data of this list is from 1960 to 2022, and it is divided into two lists: "Lifetime Scientific Influence Ranking" and "2022 Annual Scientific Influence Ranking". The "Lifetime Scientific Influence Ranking" counts the comprehensive influence performance of scientists during their careers, and the "2022 Annual Influence Ranking" focuses on highlighting the academic influence of scientists in the previous year. This ranking, considered the most prestigious worldwide, is based on the bibliometric information contained in the Scopus database and includes more than 200,000 researchers from the more than 10 million scientists considered to be active worldwide, with 22 scientific fields and 176 subfields taken into account.

We are pleased to share that 59 Editorial Board Members from MDPI’s Bioengineering (ISSN: 2306-5354) were featured in the list of the World’s Top 2% Scientists in 2022.

Name

Affiliation

Dr. Anthony Atala

Medical Center Boulevard, USA

Prof. Dr. Abhay Pandit

National University of Ireland, Ireland

Prof. Dr. Ali Zarrabi

Istinye University, Turkey

Prof. Dr. Bin Zheng

University of Oklahoma, USA

Prof. Dr. Jason A. Burdick

University of Pennsylvania, USA

Prof. Dr. Charles Antzelevitch

Thomas Jefferson University, USA

Prof. Dr. Christoph Herwig

Vienna University of Technology, Austria

Prof. Dr. Christoph Wittmann

1. Saarland University, Germany; 2. Technische Universät Braunschweig, Germany; 3. Technische Universät Braunschweig, Germany

Prof. Dr. Chandan K. Sen

Indiana University, USA

Prof. Dr. Qinghua Cui

Peking University, China

Dr. Danièle Noël

University of Montpellier, France

Prof. Dr. Danny Bluestein

Stony Brook University, USA

Prof. Dr. Ziad El Rassi

Oklahoma State University, USA

Prof. Dr. Elazer R. Edelman

Massachusetts Institute of Technology, USA

Prof. Dr. Fengxian Xin

Xi'an Jiaotong University, China

Prof. Dr. Fergal J. O'Brien

Royal College of Surgeons in Ireland (RCSI), Dublin, Ireland

Prof. Dr. Franz Konstantin Fuss

University of Bayreuth, Germany

Prof. Dr. Guy M. Genin

Washington University in St. Louis, USA

Prof. Dr. Giovanni Esposito

University of Napoli "Federico II", Italy

Prof. Dr. George J. Christ

University of Virginia, USA

Prof. Dr. Gary L. Bowlin

The University of Memphis, USA

Prof. Dr. George A. Truskey

Duke University, USA

Prof. Dr. Farshid Guilak

Washington University, USA

Prof. Dr. Anthony Guiseppi-Elie

1. Anderson Universi